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Abstract
Staphylococci are normal colonizers of human and animal skin and mucous 
membranes. However, S. aureus is one of the most pathogenic bacteria isolated from 
humans. S. aureus produces numerous virulence factors that are responsible for the 
pathogenicity of this microorganism. Exposure of bacteria to sub-MICs of antibiotics is 
often encountered clinically, therefore, the effect of sub-MICs on staphylococcal 
virulence has been well studied on planktonic forms. Nevertheless, few studies have 
investigated the alteration of biofilm virulence under sub-MIC conditions.
In this study, after several attempts to support the growth of Staphylococcus 
aureus in chemically defined media containing the basic nutrient requirements, addition 
of seven amino acids improved the growth yield. However, staphylococcal growth in 
biofilm required a complex medium, such as brain heart infusion, which was used in the 
study. The effect of 1/16 MIC of selected antibiotics representing three different groups 
(cefalexin, a cell wall inhibitor; ciprofloxacin, a DNA replication inhibitor and 
roxithromycin, a protein synthesis inhibitor), was investigated on the virulence of S. 
aureus NCTC 11962 biofilms grown in Sorbarod filters. Protease secretion, coagulase 
production, ability to form biofilm and the superantigen (toxic shock syndrome toxin-1 
(TSST-1)) production were evaluated in challenged and control biofilms, eluates and 
supernatants. Moreover, since sub-MICs of antibiotics have the potential to alter vimlence 
and interfere with metabolic processes of the bacteria, the proliferative effect of TSST-1 
was evaluated to determine any modulation in its activity.
SDS-PAGE and 2D-PAGE of biofilm and eluate cells in addition to eluate 
supernatants exhibited remarkable differences in protein profiles among challenged and 
control biofilms. Such protein shifts would imply in part, alterations in biofilm virulence.
Proteases were not detected in the eluates of the treated or control biofilms. 
Coagulase production was reduced in eluates exposed to roxithromycin when compared 
to control, while TSST-1 production was reduced in biofilms exposed to cefalexin and to 
a lesser extent to ciprofloxacin. On the other hand, cefalexin has been shown to induce 
biofilm formation at a wide range of sub-MICs.
TSST-1 was purified from eluate supernatants of treated biofilms and control and 
the proliferative activity of 10-fold serial dilutions of the toxins on mouse splenocytes 
were tested using MTS/PMS assay. No significant difference in activity between the 
treated toxin and the control has been observed. However, the activity of the crude eluate 
supernatants has been found to be more active when compared to equivalent 
concentrations of purified TSST-1, an effect ascribed to the presence of enterotoxin A, 
another superantigen produced by the bacteria. An hypothesis to explain the inhibitory 
effect of cefalexin on TSST-1 production was also discussed.
The results obtained in this thesis, indicate that antibiotics could potentially 
interfere with the virulence of S. aureus biofilms, if concentrations of these agents fall 
below MIC of the infecting strain.
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eluate supernatants (control); lane 5: protein markers from 10 to 
150kDa; lane 6 : TSST-1 standard. Arrows indicate novel protein (N), 
absent protein (A) and strong band at 22kDa. (Protein loading 8pg 
well'1). 109
Figure 4.6: 2D-PAGE analysis of untreated biofilm cells (control).
Protein spots were numbered for identification (Table 4.5). Protein 
loading (30pg).This image was combined from two images for clarity
in presentation. 115
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Figure 4.7: 2D-PAGE analysis of biofilm cells exposed to sub-MIC 
cefalexin. Protein spots were numbered for identification. Missing 
numbers correspond to missing proteins. Newly appearing proteins 
were given alphabetical letters (Table 4.6). Protein loading (30pg).
Figure 4.8: 2D-PAGE analysis of biofilm cells exposed to sub-MIC 
ciprofloxacin. Protein spots were numbered for identification. 
Missing numbers correspond to missing proteins. Newly appearing 
proteins were given alphabetical letters (Table 4.7). Protein loading 
(30pg).
Figure 4.9: 2D-PAGE analysis of biofilm cells exposed to sub-MIC 
roxithromycin. Protein spots are numbered for identification. Missing 
numbers correspond to missing proteins. Newly appearing proteins 
are given alphabetical letters (Table 4.8). Protein loading (30jng). 
This image was combined from two images for clarity in 
presentation.
Figure 4.10: 2D-PAGE analysis of untreated eluate cells (control). 
Protein spots were numbered for identification (Table 4.9). Protein 
loading (30pg).
Figure 4.11: 2D-PAGE analysis of eluate cells exposed to sub-MIC 
cefalexin. Protein spots were numbered for identification. Missing 
numbers correspond to missing proteins. Novel proteins were given 
alphabetical numbers (Table 4.10). Protein loading (30pg).
Figure 4.12: 2D-PAGE analysis of eluate cells exposed to sub-MIC 
ciprofloxacin. Protein spots are numbered for identification. Missing 
numbers correspond to missing proteins. Novel proteins are given 
alphabetical numbers (Table 4.11). Protein loading (30pg).
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Figure 4.13: 2D-PAGE analysis of eluate cells exposed to sub-MIC 
roxithromycin. Protein spots are numbered for identification. Missing 
numbers correspond to missing proteins. Novel proteins are given 
alphabetical numbers (Table 4.12). Protein loading (30pg well'1) ^ 4
Figure 4.14: 2D-PAGE analysis of untreated eluate supernatants 
(control). Protein spots are numbered for identification. Protein 
loading (25jiig). 129
Figure 4.15: 2D-PAGE analysis of eluate supernatants exposed to 
sub-MIC cefalexin. Protein spots are numbered for identification. 
Missing numbers correspond to missing proteins. Newly appearing 
proteins are given alphabetical letters (Table 4.14). Protein loading 
(25pg).
Figure 4.16: 2D-PAGE analysis of eluate supernatants exposed to 
sub-MIC ciprofloxacin. Protein spots are numbered for identification. 
Missing numbers correspond to missing proteins. Newly appearing 
proteins are given alphabetical letters (Table 4.15). Protein loading 
(25pg).
Figure 4.17: 2D-PAGE analysis of eluate supernatants exposed to 
sub-MIC roxithromycin. Protein spots are numbered for 
identification. Missing numbers correspond to missing proteins. 
Newly appearing proteins are given alphabetical letters (Table 4.16). 
Protein loading (25jig).
Figure 5.1: Coagulase titre of eluate supernatants exposed to sub- 
MIC ciprofloxacin (cipro), cefalexin (cefalex), roxithromycin (Rox) 
and control. Error bars represent standard deviation for each 
treatment, where n=4.
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Figure 6.1: 2D-PAGE gels for the mini trial where eluate was diluted 
four times. (A): proteins eluted from Amberlite CG50 after being 
adsorbed on the resin. The arrow shows TSST-1 spot and (B): 
proteins in the solution remaining after batch adsorption where the 
arrow shows that TSST-1 disappeared (adsorbed onto the resin).
Figure 6.2: Ion exchange chromatography on CM-Sepharose CL 6B. 
Fractions (20mL) were collected and absorbance at 280nm was 
measured. Arrows indicate fraction (Fr) number at the apex of the 
peak.
Figure 6.3: SDS-PAGE analysis of the fractions corresponding to the 
eluted peaks from CM-Sepharose CL 6B. Lane 1, SDS-PAGE protein 
marker; lane 2, fraction 181; lane 3, fraction 157; lane 4, fraction 153, 
lane 5: fraction 151, lane 6 : fraction 147, lane 7: fraction 143, lane 8 : 
fraction 72, lane 9: TSST-1 standard. Volume applied: maximum 
well capacity (23jiL).
Figure 6.4: Gel filtration chromatography on Sephacryl S 200HR 
(Sigma), (5mL) fractions were collected and absorbance at 280nm 
was measured. Arrows indicate fraction (Fr) number.
Figure 6.5: SDS-PAGE analysis of fractions eluted from gel 
filtration column (Sephacryl S200 HR). Lane 1: TSST-1 standard 
(sigma), lane 2: SDS-PAGE marker, lane 3: fraction 37, lane 4: 
fraction 65, lane 5: fraction 67, lane 6 : fraction 71, lane 7: fraction 73, 
lane 8: fraction 76, lane 9: fraction 86. Volume applied: the 
maximum well capacity (23pl well"1).
Figure 6.6: Proliferative effect of the mitogen PHA-P on mouse 
splenocyte. MTS/PMS assay was performed and optical density (OD 
at 450nm) was plotted against different concentrations of PHA-P. 
Error bars indicate ± standard deviations from the mean (n=3).
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Figure 6.7: Proliferative effect of purified TSST-1 from biofilm 
eluates of control, cefalexin (cefa) and ciprofloxacin (cipro) on mouse 
splenocyte. Optical density (OD) at 450nm was measured and OD of 
negative control was subtracted. OD of the samples was calculated as 
percentage from OD of PHA-P. Error bars indicate ± standard 
deviations from the mean (n=3).
Figure 6.8: Proliferative effect of eluate supernatants exposed to 
cefalexin (Cefalex), ciprofloxacin (Ciproflox) and roxithromycin 
(Roxith) on mouse splenocytes. The activity was calculated as a 
percentage from PHA-P activity, assuming the activity of PHA-P to 
be 100%. Error bars indicate ± standard deviations from the mean 
(n=3).
Figure 7.1: Synthesis and secretion of TSST-1 and the postulated 
inhibitory effect of cefalexin. When the nascent protein (TSST-1 
precursor) is produced, it is accompanied by chaperones in the 
cytoplasm to the translocation machinery present on the cytoplasmic 
membrane. During or after translocation, signal peptidase (SPase) 
acts at the cleavage point of the precursor (ala-ser, amino-acids 40 & 
41) thus, cleaving the signal peptide. The TSST-1, is now present in 
the periplasmic space in an unfolded state. Immediately the folding 
catalyst acts on the toxin and the mature toxin is released outside the 
cell since it has no retention signal (Sibbald et al., 2006). It is 
postulated that cefalexin, at 1/16 MIC, binds to the active site of the 
signal peptidase as it is an analogue of the ala-ser residue in much the 
same way it is also an analogue of the ala-ala residue of 
peptidoglycans. Thus, inhibiting the activity of signal peptidase. 
Therefore, the process of releasing the toxin is inhibited.
Figure 7.2: Similarity in structures between alanine-serine residue 
(A), that is the cleavage point in TSST-1 precursor (amino-acids 40 
and 41) and alanine-alanine (B). The arrow indicates the cleavage 
point between the alanine (left) and the serine residue (right). 
Structurally, serine is an alanine with a hydroxyl (OH) group (circled) 
replacing one of the Hydrogen (H) atoms of the methyl (-CH3) 
moiety. Key for the colours: yellow: Hydrogen, green: Nitrogen, 
black: Carbon, red: Oxygen. Single lines represent single bonds 
between atoms and double lines represent double bonds.
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(PBPs) which catalyze transpeptidation, caboxypeptidation and other reactions (Kozarich 
and Strominger, 1978). Four PBPs have been identified in S. aureus. Selective 
inactivation of each Penicillin Binding Protein will result in different effects on bacterial 
cells. For example, spheroplast formation or change in the bacterial shape (elongation, 
filamentation or the formation of spheroid cells) (Petri, 2001). In addition, it is postulated 
that there is a balance system between cell wall synthesis mediated by PBPs and wall 
hydrolysis, which is essential for cell wall growth. By binding to PBPs, p-lactams disrupt 
this balance causing cell autolysis (Petri, 2001). Cell autolysis may occur due to 13- 
lactams triggering the action of cell wall autolytic enzymes (Blumberg and Strominger, 
1974; Spratt, 1983).
Staphylococci confer resistance to P-lactam antibiotics by producing p-lactamase 
that hydrolyses the p-lactam ring, rendering the antibiotic inactive. The gene for p- 
lactamase is located on a transposable element on a large plasmid. The synthesis of this 
enzyme is upregulated when the bacteria are exposed to P-lactam antibiotics (Lowy,
2003). On the other hand, S. aureus strains, which are resistant to methicillin (a 
semisynthetic penicillin-related antibiotic, which is resistant to P-lactamase), were found 
to increase the production of P-lactamase or to reduce the affinity of P-lactam 
compound’s binding to Penicillin Binding Protein (PBP) present in the cell wall. The 
reduced affinity could be a result of modifying the native PBP and or producing PBP 2a, 
which is encoded by chromosomal gene (Utsui and Yokota, 1985; Murakami et al., 1987; 
Chambers, 1997). PBP 2a has 100 to 1000 times less affinity to P-lactams than normal 
PBPs (Chambers, 2006).
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Figure 1.3: Cross linking of peptidoglycan and the action of cephalosporins. 
Transpeptidase enzyme acts on the terminal D-ala-D-alanine residue of one strand 
of the glycan (A). It cleaves terminal D-alanine and binds to remaining D-alanine 
residue forming reactive acyl enzyme intermediate (C). The enzyme intermediate 
transfers the terminal D-alanine residue to the terminal glycine residue of 
pentaglycine bridge (B) which originates from other glycan strand. A new peptide 
bond is formed (D) and the enzyme is released. Thus, the two adjacent strands are 
now cross linked via the pentaglycine bridge. If cephalosporin (p-lactam) drug is 
present, transpeptidase recognizes the drug as its substrate and a covalent bond 
forms resulting in inactive cephalosporin-enzyme complex. This will block 
transpeptidation reaction (adapted from Blumberg and Strominger, 1974).
1.2.2 Ciprofloxacin
Ciprofloxacin (Figure 1.2B) is a synthetic antibiotic belonging to the 
fluoroquinolone family. It is bactericidal and has broad spectrum activity against a wide 
range of microoganisms. Some reports have shown that the activity of ciprofloxacin is 
enhanced when used with other antimicrobials, such as aminoglycosides against S. aureus 
and Pseudomonas spp and cefotaxime or clindamycin against anaerobic bacteria. 
Ciprofloxacin can be administered orally, parenterally and topically (Sweetman, 2007).
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Fluoroquinolones act by inhibiting bacterial DNA replication. To do this, they 
have two targets; DNA gyrase (which changes DNA supercoiling during replication) and 
topoisomerase IV (which decatenates or separates interlocked DNA strands to allow 
segregation of daughter chromosomes into daughter cells) (Drlica and Zhao, 1997). 
Fluoroquinolones form complexes with these enzymes on DNA (Figure 1.4), which block 
DNA replication (Hooper, 2002). In Gram-positive bacteria, resistance develops to these 
antibiotics via spontaneous chromosomal alterations. These mutations lead to changes in 
amino-acids in certain regions of the enzymes’ subunits known as Quinolone-resistance- 
determining-region (QRDR), which will reduce the affinity of the enzyme to the drug 
(Hooper, 2002; Lowy, 2003). Since fluoroquinolones act on the two enzymes, single 
mutations on either one of them could result in reduced susceptibility to the drug, but not 
complete resistance. Nevertheless, fully resistant isolates of S. aureus are common where 
more than one mutation in each enzyme was found. In fact, single changes in Par C (a 
type of topoisomerase IV subunit) were found to be sufficient to produce resistance to 
Ciprofloxacin (Hooper, 2002). Another mechanism of resistance in S. aureus is by 
increasing the expression of multidrug resistance (MDR) pumps called NorA. These 
pumps reduce the concentration of antibiotics inside the cell (Piddock, 1999; Hooper, 
2002; Lowy, 2003).
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Figure 1.4: schematic diagram showing complex formation between fluoroquinolone 
antibiotics (Q) and topoisomerase IV and DNA gyrase. These complexes block the 
progression of the multicomponent DNA replication complex. GyrA and GyrB are 
subunits of DNA gyrase enzyme. ParC and ParE are subunits of topoisomerase IV 
enzyme. DnaB, primase, PriA and polymerase are components of the DNA 
replication complex (Hooper, 2002).
1.2.3 Roxithromycin
Roxithromycin (Figure 1.2C) is a semi-synthetic macrolide, structurally related to 
erythromycin. Unlike erythromycin, roxithromycin is acid stable, has fewer side effects 
and a wider spectrum of activity than erythromycin. It is active against Gram-positive and 
Gram-negative cocci, Gram-positive bacilli and some Gram-negative bacilli. Since it 
penetrates and accumulates within cells, it is active against intracellular pathogens like 
Legionella, Chlam ydia and M ycobacterium  spp (Bryskier, 1998; Sweetman, 2007). In 
addition, based on a suggested link between atherosclerosis and C hlam ydia pneum oniae  
infection, roxithromycin and other macrolides are being investigated in the prevention of
atherosclerotic cardiovascular diseases (Wiesli et al., 2002; Grayston, 2003; Berman et
al, 2005). Roxithromycin is given orally in a dose of 150mg twice daily or 300mg once 
daily, which makes it more convenient to patients (Sweetman, 2007).
Macrolides act by inhibiting protein synthesis in bacteria. The exact mode of 
action of macrolides depends on the chemical structure of each compound, as the size of 
the molecule and the orientation of its chemical groups on the target binding sites 
determine its action (Gaynor and Mankin, 2005). So far three mechanisms of inhibiting 
protein synthesis have been identified for roxithromycin; (i) inhibition of the progression 
of long peptide chain synthesis by blocking the nascent polypeptide exit tunnel, a process 
that may cause (ii) stimulation of early peptidyl tRNA dissociation from the ribosome 
which results in incomplete peptide formation, (iii) prevention of 50S subunit formation 
or assembly in growing bacteria (Menninger and Otto, 1982; Champney and Burdine, 
1996; Schlunzen et a l, 2001; Gaynor and Mankin, 2005).
Resistance to macrolides emerged in many countries shortly after their 
introduction to clinical use. In general, three mechanisms by which bacteria resist 
macrolides were described: the first mechanism is by modification of the target site. This 
modification could be a result of mutations in some of the ribosomal proteins. This 
mutation will result in the formation of a wider tunnel, through which the growing protein 
can pass through without being affected by the hindrance caused by the macrolides. The 
most predominant mechanism of target site modification is by dimethylation of single 
nucleotide in the 23S rRNA portion of the 50S subunit, by methyl transferase enzymes. 
This will result in reduced affinity of the site to macrolides and other antibiotics which 
are lincosamides and streptogramins type B. This pattern of resistance is known as MLSb 
(macrolides-lincosamide-streptogramin B) resistance (Leclercq and Courvalin, 1991; 
Schmitz et al., 2000; Gaynor and Mankin, 2005). The second mechanism has been 
described in some strains of staphylococci by which the bacteria produce esterase
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enzymes, which hydrolyse macrolides rendering them inactive (Wondrack et a l., 1996).
The third mechanism is by excreting the drug outside the cells via efflux pumps (Ross et 
al., 1990).
1.3 S ta p h y lo co ccu s  a u reu s  virulence factors
The diversity of diseases caused by staphylococci is believed to be a consequence 
of virulence factors expressed by these microorganisms. Staphylococcus spp are known to 
express numerous virulence factors. These factors are either cell associated factors, such 
as capsular polysaccharide, bacterial components involved in biofilm formation and cell 
proteins used to adhere to host tissue, or secreted factors like proteins, enzymes and 
toxins (Figure 1.5). Some of the virulence factors expressed by staphylococci and a 
summary of their effects are shown in Table 1.1. Toxic shock syndrome toxin-1 and 
biofilm formation will be described in more detail.
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Figure 1.5: Staphylococcus aureus structure. Panel A shows cell associated proteins 
and secreted proteins; the synthesis of many proteins is dependent on the growth 
phase. Panels B and C show cross section of cell envelope (Lowy, 1998).
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Chapter 1
Introduction
1.1 Staphylococcal infections and significance
Staphylococci are considered one of the most virulent human pathogens. In spite 
of the fact that they are common colonizers of human skin and mucous membranes, they 
are responsible for a wide spectrum of infections targeting a broad range of organs and 
tissues. Staphylococci can cause many forms of infections such as skin and soft tissue 
infections (including cellulitis, impetigo, furunculosis, scalded skin syndrome and soft 
tissue abscesses), deep-seated infections (endocarditis and osteomyelitis) and surgical site 
infections like wound infections and endophthalmitis (John, 2004; Casey et al., 2007).
Staphylococcus aureus is a common cause of bacteraemia. Reports of S. aureus 
bacteraemia across England and Wales more than doubled from around 5000 in 1991 to 
more than 11,000 in 2000 (Figure 1.1) according to Communicable Disease Surveillance 
Centre (Anon, 2000). By releasing enterotoxins into food, S. aureus causes food 
poisoning (enterocolitis). In fact many outbreaks of food-bome illness are reported 
worldwide in which Staphylococcus spp were a common cause (John, 2004). Some 
strains also release superantigens, which interact with the immune system causing the 
serious systemic disease, Toxic Shock Syndrome.
Staphylococci are a major cause of nosocomial infections. S. aureus was the 
primary cause of nosocomial pneumonia and surgical site infections and the second 
leading cause of nosocomial blood stream infections (after coagulase negative 
staphylococci) in USA between 1990 and 1996 according to the National Nosocomial 
Surveillance System (Anon, 1996).
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Figure 1.1: Staphylococcus aureus bacteraemia reports in England and Wales 
between 1991 and 2000 (Anon, 2000).
Clinically, it is well recognized that the most feared complication of implanted 
prosthetic devices is microbial infection; where S. aureus and S. epidermidis have a 
significant share (Bayston, 2000; Vuong and Otto, 2002). The problem with these 
infections is that most of them are incurable due to the formation of biofilms of bacteria, 
which are highly resistant to antimicrobials and their ultimate solution is surgical 
replacement of the infected device. The outcome of such operations is often catastrophic 
in terms of distress, trauma, possible disability of the patients and huge expenditure of 
national resources.
The importance of staphylococci has increased dramatically in the last two 
decades due to the increase in resistance to antimicrobials. In order to overcome penicillin 
resistant S. aureus, methicillin was developed. Unfortunately, strains resistant to 
methicillin emerged in hospitals shortly after its introduction. Later multi-resistant strains 
of methicillin-resistant Staphylococcus aureus (MRSA) prevailed, not only as 
nosocomial, but also as community acquired infections (Casey et al., 2007).
Vancomycin was considered the drug of choice for MRSA infections, but 
increasing reports across the world of the occurrence of isolates with reduced 
susceptibility to vancomycin (vancomycin intermediate-resistant Staphylococcus aureus
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(VISA)) (Hiramatsu, 1997) and later vancomycin resistant S. aureus (VRSA) (Siever, et 
al., 2002) have alarmed the medical community and prompted the generation of new 
guidelines for prevention and control of staphylococcal infections in the health care 
system. Such resistance predicts a gloomy chemotherapeutic era in which efficient 
antibiotics against this organism may no longer be possible (Lowy, 2003; Casey et ah, 
2007).
1.2 S ta p h y lo co ccu s  a u reu s resistance to antimicrobials
Mechanisms of microbial resistance towards antibiotics can be categorised into 
three general groups; (i) direct inactivation of the drug, (ii) changing the organism’s 
susceptibility to the antibiotic (for example by altering the target site) and (iii) reduction 
of the active molecule’s concentration that reaches the target, either by preventing drug 
access into the target or by pumping the drug out of the organism (efflux pumps) 
(Piddock, 1999; Hogan and Kolter, 2002). In fact staphylococci employ all three 
mechanisms to resist antimicrobials.
In the following sections, the mechanism of action of selected antibiotics and 
staphylococcal resistance to these antibiotics is discussed in more details. The selected 
drugs were used in this project and chosen as representatives of different groups of 
antibiotics that have different modes of action within the bacterial cell.
1.2.1 Cefalexin
Cefalexin (Figure 1.2A) belongs to cephalosporin antibiotics, which are part of the 
p-lactam family. It is a first generation cephalosporin, administered orally and some of its 
derivatives administered parenterally. Cefalexin is active against Gram-positive cocci,
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including penicillinase and non-penicillinase producing staphylococci and has moderate 
activity against Gram-negative bacilli (Sweetman, 2007).
Figure 1.2: Chemical structure of (A) Cefalexin, (B) Ciprofloxacin and (C) 
Roxithromycin (adapted from Sweetman, 2007).
Cefalexin, and (3-lactams in general, are bactericidal antibiotics that act through 
inhibition of cell wall synthesis in actively growing bacteria. These compounds are 
structurally similar to the terminal D-alanyl-D-alanine residue of the glycan strand of 
peptidoglycan and therefore, they are recognised as substrates by the enzymes responsible 
for transpeptidation and cross linking of peptidoglycan. Subsequently, a covalent bond is 
formed between the drug and the enzymes rendering the enzymes inactive (Figure 1.3). 
These enzymes belong to a group of enzymes called the Penicillin Binding Proteins
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diminished production of biofilm associated protein (Bap), fibronectin binding protein 
and polysaccharide intercellular adhesin. These compounds are required in the first and 
second stage of biofilm formation and their reduction or loss would reduce biofilm 
formation dramatically (Beenken, et al., 2003; Trotonda et al., 2005).
1.5.3 Sigma factor B (a®)
Under normal conditions g b  factor is bound to anti-GB factor preventing it from 
acting on RNA-polymerase enzyme. Upon stress conditions, such as extreme pH, 
osmolarity and temperature, g b  is released and acts on more than 23 promoters. In a 
study, g b  was found to down regulate the production of eleven exoproteins, among them 
enterotoxin B, a- and p-haemolysin and serine proteases (Ziebandt et al., 2001), beside 
its role to repress agr system by inducing the synthesis of agr repressor molecule 
(Bischoff et al., 2001).
The g b  role in biofilm formation is not essential although it is important. Valle et
n
al., (2003) have shown that complete deletion of G in a S. aureus clinical isolate did not 
affect polysaccharide intercellular adhesin (PIA) production or biofilm formation, while 
sarA deletion resulted in complete loss of ability to form biofilm. Interestingly, sarA-oB 
double mutation resulted in increased PIA production. One of the explanations suggested 
was the presence of a repressor to PIA synthesis that SarA inhibits its transcription while 
g b  activates it. Recent study demonstrated that g b  affects biofilm formation through 
enhancing phenotypic switch of S. aureus to biofilm positive phenotype (Valle et al., 
2007).
29
1.6 Hypothesis
The pathogenicity of S. aureus is due to its production of large number of 
virulence factors whether secreted or cell bound. Furthermore, the ability of bacteria to 
form biofilm is one of its virulence mechanisms. Virulence factors are regulated by 
quorum sensing systems, which mediate the environmental conditions (nutrients, pH, 
oxygen, presence of antibiotics) and the growth phase of the microorganism.
Numerous antimicrobial agents are used to treat bacterial infections. Drug doses 
are prescribed to achieve serum concentrations above the minimum inhibitory 
concentration (MIC) of the particular organism assuming that, achieving such 
concentration would be clinically effective. However, the exposure of bacteria to sub- 
inhibitory concentrations of antibiotics under clinical conditions is highly probable. For 
example, drug-drug interaction, drug-food interaction or certain clinical or health 
conditions of the patient, could result in decreased bioavailability of certain antibiotics 
into the systemic circulation and therefore, sub-therapeutic levels of the drug will be 
obtained (Deppermann and Lode, 1993; Cohn et al., 1995; Komori et al., 2007). On the 
other hand, establishing a certain drug concentration in semm does not necessarily 
guarantee achieving this concentration in tissues or site of infection (Ugurbas et al., 
2007), thus, bacteria invading tissues will be exposed to lower levels of antibiotics (Keren 
et a l, 1991). Moreover, systemic absorption of antibiotics applied topically will result in 
sub-therapeutic levels of these antibiotics (Thiboutot et al., 2007) to possibly present 
asymptomatic infections or chronic bacteria colonizers in other parts of the body. 
Therefore, the effect of subinhibitory concentrations of antibiotics on microorganisms has 
developed much interest and research (Dunne, 1990; Rupp and Hamer, 1998; Rachid et 
al., 2000; Winder, 2000; Winder et al., 2000; Abdel Malek, 2002; Abdel Malek et al., 
2002; Al-Hmoud, 2002; Bernardo et al., 2004; Masadeh, 2005; Koszczol et al., 2006).
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The main hypothesis forwarded in this thesis is that: exposing S. aureus to sub- 
MICs of antibiotics may have differing effects on its virulence expression. Additionally, 
antibiotic type, concentration and strain of bacteria are among the factors that will 
determine the net effect on the expression of certain virulence factor (Dickgiesser 
andWallach, 1987; Gemmell and Ford, 2002; Edwards-Jones and Foster, 2002; Stevens 
et al., 2007).
1.6.1 Aims of the study
It is the aim of this study to investigate the difference in expression of some 
virulence factors (coagulase, protease and Toxic shock syndrome Toxin-1 (TSST-1)) 
from S. aureus biofilms, when exposed to sub-MIC of three selected antibiotics 
(Cefalexin, Ciprofloxacin and Roxithromycin) and to investigate the ability of this 
pathogen to form biofilm when challenged with subinhibitory concentrations of these 
drugs. In addition, one of these virulence factors, TSST-1, will be isolated and its 
biological activity assessed based on the assumption that exposing biofilm cells to sub- 
MIC may have an impact at the transcription or translation level of this toxin resulting in 
a protein with altered activity.
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625nm. The absorbance should be between 0.08 to 0.10 otherwise it should be adjusted 
by dilution. The suspension was distributed into screw capped tubes in 6mL aliquots and 
stored in a darkened cupboard at room temperature. Before use, the standards were 
vortexed vigorously to produce homogenous suspension (NCCLS, 2000).
2.8 Protein quantitation
In this project, two methods for protein quantitation were used: Bicinchoninic acid 
Assay (BCA) and modified Coomassie (Bradford) protein assay. BCA was used for 
quantitation of proteins at concentrations from 50  to 1000|LLg mL'1. Bradford microplate 
assay was used to quantitate proteins in the range of 1 to 25pg mL'1.
2.8.1 Bicinchoninic acid Assay (BCA) for protein quantitation
Bicinchoninic acid, sodium salt, is a stable, water-soluble compound that reacts 
with cuprous ions (Cu+1) in alkaline media forming an intense purple complex. The 
concept of this assay relies on the reduction of cupric ions into cuprous ions by proteins. 
Two molecules of bicinchoninic acid then chelate cuprous ions forming intense purple 
complex that absorbs light at 562nm. The colour produced from this reaction is stable and 
is proportionally related to the increase of protein concentration over a broad range of 
concentrations. This method has good tolerance toward commonly encountered 
interferences like non ionic detergents and simple buffer salts. In addition, it has high 
sensitivity and low protein-to-protein variation (Smith et al., 1985).
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2.8.1.1 Preparation ofBCA reagent
BCA reagent was prepared by mixing ready made Bicinchoninic acid solution 
(Sigma) with Copper II sulphate solution (Sigma) in 100:2 ratio immediately before use 
to produce a bright apple green coloured solution.
2.8.1.2 Preparation o f standard calibration curve
A  stock of bovine serum albumin (BSA) of lmg mL' 1 was prepared in distilled 
water. Aliquots were diluted in distilled water to obtain a concentration range of (0.05 to 
lmg mL'1). Aliquots (50pL) of each concentration were transferred to Eppendorf tubes, 
lmL of BCA reagent was added, vortexed and incubated at 37°C for 30min. The 
absorbance was measured at 562nm using BCA reagent as a blank. The calibration curve 
was produced by plotting the absorbance of each sample against the corresponding 
protein concentration (Figure 2.4).
Figure 2.4: Standard calibration curve for bicinchoninic acid assay. Absorbance of 
standards at 562nm versus bovine serum albumin concentration (BSA). Each point 
represents average absorbance values. Error bars represent ± standard deviation 
(n=3).
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2.8.1.3 Analysis of samples
Aliquots (50pL) of samples were mixed with lmL BCA reagent and incubated at 
37°C for 30min. Their absorbencies were measured at 562nm using appropriate blanks 
and protein concentration was estimated from the calibration curve. Suitable blanks were 
prepared for each measurement, in which the blank solution contained all the components 
of sample solutions except the proteins.
2.8.2 C oom assie  (B ra d fo rd )  p ro te in  a ssay
Coomassie (Bradford) protein assay relies on the interaction of Coomassie 
brilliant blue G 250 dye with proteins (Bradford, 1976). Under acidic conditions, the dye 
is doubly protonated and in its most stable form. Acidic conditions turns the dye to brown 
colour with absorption maximum at 465nm. When it binds to proteins, an immediate shift 
in absorption maximum occurs from 465nm to 595nm accompanied by colour change to 
blue. The increase in absorbance at 595nm due to reaction with protein is monitored. At 
increasing protein concentrations, the colour response is non-linear, which necessitates 
the use of standard calibration curve with each set of samples. This assay is rapid, 
reproducible with low interferences from cations and carbohydrates. Some interference 
may occur with alkaline buffers or detergents but can be compensated by the use of 
suitable controls (Bradford, 1976).
2.8.2.1 Sample analysis using Coomassie protein assay kit (Pierce, USA)
The instructions provided by (Pierce, USA) for determining protein concentration 
using microplate protocol were followed. Bovine serum albumin standard solution 
2000pg mL'1 (Pierce, USA) was diluted in the same buffer as the sample to produce final 
BSA concentration range 2.5 to 25pg mL'1. Aliquots (150pL) of each standard and
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sample were added to 96 well-flat bottom microtiter plate in triplicates. Coomassie 
reagent solution (Pierce, USA) was mixed and equilibrated to room temperature. 
Immediately before use, Coomassie reagent solution was mixed gently and aliquots 
(150jiL) were added to each well. A blank was prepared in triplicate by mixing 150pL 
reagent with 150pL buffer. The plate was shaken for 30seconds at medium speed and was 
incubated for 10 minutes at room temperature. The absorbance was measured at 595nm 
using ELISA reader (Rosys Anthos ht m, Anthos Labtecc Instruments, Salzburg, 
Austria). A calibration curve was plotted between the absorbance at 595nm against BSA 
concentration (Figure 2.5).
F ig u re  2.5: S ta n d a rd  c a lib ra tio n  c u rv e  fo r  m ic ro p la te  B ra d fo rd  p ro te in  assay . 
A b so rb an c e  (A bs) a t  595nm  a g a in s t bov ine  se ru m  a lb u m in  (B SA ) c o n c e n tra tio n . 
E a c h  p o in t re p re se n ts  av erag e  a b so rb a n c e  values a f te r  s u b tra c t in g  b la n k  v a lu e . 
E r r o r  b a rs  re p re se n t ± s ta n d a rd  d ev ia tio n  (n=3).
2.8.3 P re p a ra tio n  o f cell pe lle ts f ro m  b io film s a n d  e lu a te s  a n d  p re p a r a t io n  o f  cell 
f ree  e lu a te  (e luate  s u p e rn a ta n ts )  f ro m  b io film s exposed  to  s u b -M IC  o f  a n tib io tic s .
Biofilms of S. aureus NCTC 11962 were established on Sorbarod filters as was 
described earlier in this Chapter. Sorbarods were conditioned with 5mL normal saline 
before inoculation. Subsequently, the filters were inoculated with (3mL) of mid
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exponential phase S. aureus suspension grown in brain heart infusion. The filters were 
incubated at 37°C. Sorbarods were perfused with BHI medium containing 1/16 MIC of 
one of the antibiotics (cefalexin, ciprofloxacin, roxithromycin) at a flow rate of 0.4mL 
min'1 maintained by peristaltic pump. The amount of antibiotic required to prepare 1/16 
MIC of each antibiotic, was taken from sterile stock solutions of antibiotics and was 
added to already sterilized and cooled BHI medium. After achieving the steady state after 
48hrs, the filters were removed, sacrificed (adherent cells were removed) and 
resuspended in normal saline. Biofilm cells and eluate cells were pelleted by 
centrifugation using refrigerated centrifuge (Jouan CR312, Jouan Ltd, Ilkeston, UK) at 
3500 rpm, 4°C, for 60 minutes. The supernatant of eluate cells was decanted and placed 
in centrifuge tubes for subsequent analysis. Pellets of biofilm and eluate cells were 
washed with distilled water three times (Berber et al., 2003). If cell pellets were not used 
immediately they were stored at -20°C for further analysis.
2.8.4 E x tra c tio n  o f  in tra c e l lu la r  p ro te in s  fro m  S. aureus
In order to extract intracellular proteins, the cells have to be lysed. Several 
procedures can be used to lyse cells such as physical, mechanical or chemical methods. In 
this study, mechanical dismption of cells by homogenization was used. In order to avoid 
excessive homogenization, the optimum time to produce lysis to cells was determined. 
1.5mL of washed cell pellets were suspended in 3mL of normal saline (in subsequent 
work -  see 4.3.3 and 4.4.1.1, protease inhibitors were included in the homogenisation 
buffer). The suspension was distributed in small equal aliquots into conical centrifuge 
tubes. The cell suspension of the first tube was homogenized by hand held homogenizer 
(Ultra Turrax T8, S8N-5G, IKA Labotechnic, Staufer, Germany) for 1 minute on ice. The 
homogenizer was set at an arbitrary speed of 3, which was evaluated and used throughout
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Chapter 2
General experimental methods
2.1 Introduction
The purpose of this chapter is to provide details of experimental techniques and 
reagents (composition and preparation) that are associated with testing protocols and 
analyses that are undertaken in subsequent chapters. In addition, identification and 
maintenance of cultures are described.
2.2 Reagents and media
A m e rsh am  B iosciences, U p p sa la , S w eden  ( p a r t  o f  G E  H e a lth  c a re )
Dithiothreitol (DTT); Dry strip cover fluid; Urea.
F lu k a  (a S ig m a-A ld rich  b ra n d )
2-mercaptoethanol, Na-Tosyl-L-lysine chloromethyl ketone hydrochloride (TLCK), 
N,N,N',N',Tetramethyl ethylenediamine (TEMED), Crystal violet; Polyethylene glycol 
(PEG 20000), Sodium dihydrogen phosphate monohydrate.
O xoid  L T D , H a m p sh ire , E n g la n d
Brain Heart Infusion (Code: CM0225); Brain Heart Infusion agar (Code: CM0375); 
Mannitol salt agar (Code: CM0085); agar bacteriological (agar No. 1, Code: LP0011); 
Tryptone Soya agar (Code: CM0131).
R iedel D e H aen  (a S ig m a-A ld rich  b ra n d )
Congo red; Sodium chloride; Sodium phosphate dibasic heptahydrate; Trichloroacetic 
acid.
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S ig m a-A ld rich  C o m p an y  L td , D o rse t, E n g la n d
Amberlite weakly acidic cation exchanger, hydrogen form CG50; Ammonium persulfate; 
Azocasein; Bicinchoninic acid solution; Bromophenol blue sodium salt for 
electrophoresis; Copper II sulfate solution; Glycine for electrophoresis; Lectin from 
Phaseolus vulgaris (red kidney bean) phytohemagglutinin PHA-P, contains buffer salts 
and NaCl; Marker for 2D electrophoresis; Proteinase K (>30 units/mg protein); Rabbit 
plasma citrated; Sodium carbonate anhydrous; Sodium lauryl sulfate; Sodium thiosulfate 
pentahydrate; Toxic Shock Syndrome Toxin 1 from Staphylococcus aureus; Trypan blue 
solution 0.4% prepared in 0.81% NaCl and 0.06% potassium phosphate dibasic.
T h e  a n tib io tic s  u sed  in  th e  s tu d y
Cefalexin from Orchid Chemicals and Pharmaceuticals Ltd., India; ciprofloxacin HC1 
from Dr Reddy's Laboratories Ltd, India and roxithromycin from Alembic Ltd, India.
2.3 Maintenance of bacterial cultures
Staphylococcus aureus ATCC 6538, ATCC 27659, NCTC 11962 and 
Staphylococcus epidennidis ATCC 12228 were used in this project. The original cultures 
of these bacteria came from either American Type Culture Collection (ATCC) or The 
National Collection of Type Cultures (NCTC) (London, UK). Bacterial strains were 
chosen to have different characteristics from each others. While S. aureus ATCC 6538 
strain is recommended for quality control purposes and for testing antimicrobial agents 
and disinfectants, ATCC 27659 is penicillinase positive strain and NCTC 11962 is Toxic 
Shock Syndrome Toxin 1 and enterotoxin A producing strain. S. epidennidis ATCC 
12228 is recommended for antibiotic assays and quality control purposes. Cultures of 
these bacteria were maintained in tryptone soya agar (Oxoid) slopes in quadruplicate. One 
slope was used for inoculation for experimental purposes, the second was kept as a back
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up slope in case of contamination. The third slope was used for further subculturing to 
renew the slopes and the forth was kept as a stock. The slopes were stored in a darkened 
cupboard at room temperature. They were replaced at monthly intervals. Each time 
culture identification and characterisation was performed.
2.4 Preparation and Sterilization of media
Several media were used in this project:
2.4.1 B ra in  h e a r t  in fu s io n  a g a r  (B H A ) (O xoid , C ode: C M 0375) a n d  T ry p to n e  so y a  
a g a r  (TSA ) (O xoid , C ode: C M 0131).
These media were prepared according to manufacturer’s instructions. They were 
sterilized by autoclaving at 121°C, 15psi for 15 minutes. When the media cooled down to 
about 50°C, they were poured in Petri dishes (9cm, Plastiques Gosselin, France) under 
laminar flow.
2.4.2 B ra in  H e a r t  in fu s io n  (B H I) (O xo id , C ode: C M 0375)
A highly nutritious media. It was prepared according to manufacturer’s 
instructions and sterilized by autoclaving at 121°C, 15psi for 15 minutes.
2.4.3 M an n ito l s a lt a g a r  (O xoid , C ode: C M 0085)
A high salt content medium (7.5% salt) that selects for staphylococci since most 
other bacteria are inhibited by the high salt content. The medium was prepared according 
to manufacturer’s instructions and sterilized by autoclaving at 121°C, 15psi for 15 
minutes.
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2.4.4 C hem ica lly  d e fin ed  m e d iu m  (C D M )
CDM was prepared according to Dinning (1995). This medium is composed of 
four solutions (A, B, C and D); each one was sterilized individually and then mixed 
aseptically in a 1000:5:15:10 ratio respectively. Solution A was prepared by dissolving 
K2HP04 (2.56g), KH2PO4 (2.08g) and NH4C1 (l.OOg) in 900mL distilled water. The pH 
was adjusted to 6.8 with either 1M HC1 or 1M NaOH and the volume made up to 1L with 
distilled water. The solution was sterilized by autoclaving at 121°C, 15psi for 15 minutes. 
Solution B was prepared by adding ferric ammonium citrate (l.Og) and anhydrous 
calcium chloride (O.lg) to distilled water to make lOOmL. The solution was sterilized by 
filtration (0.2pm pore size, sterile mixed cellulose ester filter, Advantec MFS, USA) by 
the aid of vacuum. Solution C was prepared by dissolving glycerol (46.45g) in 400mL 
water, pH adjusted to 6.0 if necessary, and then volume made up to 500mL by distilled 
water. It was sterilized by autoclaving at 121°C, 15psi for 15minutes. Finally, solution D 
was prepared by dissolving MgS04 .7H20  in 1L distilled water and then sterilized by 
autoclaving at 121°C, 15psi for 15 minutes.
2.5 Identification of bacteria
The following tests were performed to confirm the identity of S. aureus and S. 
epidennidis cultures obtained from ATCC and NCTC.
2.5.1 C a ta la se  te s t
Catalase enzyme breaks down hydrogen peroxide (H2O2) into water and oxygen. 
It is produced by most cytochrome-containing aerobic and facultative bacteria except 
Streptococcus spp and Micrococcus spp. When catalase producing bacteria are exposed to 
hydrogen peroxide solution vigorous bubbling occurs (MacFaddin, 2000). In this test, one 
drop of freshly prepared hydrogen peroxide solution 6% (v/v) was placed on a glass slide.
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A loopful of colonies grown on tryprone soya agar was transferred to a cover slip, which 
was placed over the drop of hydrogen peroxide. Vigorous bubbling indicates catalase 
positive bacteria (Anon, 2006).
2.5.2 Growth on selective medium-Mannitol salt agar
This medium contains mannitol and a pH indicator phenol red. Pathogenic 
staphylococci, like S. aureus, ferment mannitol producing acidic by-products, which turn 
the colour of the phenol red indicator yellow. Thus, coagulase positive staphylococci 
produce colonies with bright yellow zones, while coagulase negative staphylococci are 
surrounded by a red or purple zone (Figure 2.1).
Figure 2.1: Mannitol salt agar medium. Staphylococcus aureus colonies grow 
surrounded by bright yellow zones (left of the plate), while Staphylococcus 
epidermidis colonies grow surrounded by red zones (right of the plate).
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2.5.3 S ta p h y la se  te s t k i t  (O xoid , C ode: D R 0595)
Staphylococci are divided into two groups by their ability to clot plasma, to 
coagulase-positive and coagulase-negative staphylococci. In human isolates, a coagulase 
positive result is almost exclusive to S. aureus (Mack et al., 2006).
The Staphylase test is specific for S. aureus by detecting the presence of clumping 
factor on the cell surface. In this test, the presence of clumping factor is detected through 
clumping of fibrinogen-sensitised sheep red blood cells (Cremer and Gruneberg, 1988).
The test was performed according to manufacturer's instructions. Two bacterial 
smears were placed separately on a reaction card provided with the kit. Each smear was 
performed by transferring one to three colonies grown on tryptone soya agar plate. One 
drop of the test reagent containing rabbit fibrinogen-sensitised sheep red blood cells was 
added to the first smear and mixed with loop. One drop of the control reagent containing 
unsensitised sheep red blood cells was added to the second smear and mixed as negative 
control. S. aureus gives a positive result where clumping of the test suspension occurs 
during mixing. No clumping should occur with the negative control suspension. S. 
epidermidis gives a negative result with test suspensions.
2.5.4 T es tin g  th e  a b ility  o f s taphy lococc i to  p ro d u c e  p o ly sa c c h a r id e  in te rc e l lu la r  
a d h e s in  (PIA )
Three different formulations of Congo red agar have been described. These differ 
in the amount of carbohydrate supplement, agar and Congo red (Deighton et al., 2001). In 
this study, Congo red agar was prepared according to Freeman et al., (1989), by 
aseptically mixing 90mL of sterile liquid agar medium at 55°C, composed of (3.7g brain 
heart infusion broth, 5g sucrose and lg agar bacteriological (agar No.l) in distilled water; 
sterilized by autoclaving) with lOmL sterile solution of Congo red (0.08% w/v; sterilized
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by autoclaving). Congo red agar medium was poured in plates and left to solidify. A 
loopfull of bacterial culture was transferred from BHI agar slants and streaked on Congo 
red agar plate. The plates were incubated at 37°C over night. In this medium, PIA 
producers appear as black colonies with a dry crystalline consistency (Figure 2.2). PIA 
non producers remained pink.
Figure 2.2: Growth of S. aureus NCTC 11962 on Congo red agar plates. 
Polysaccharide intercellular adhesin producing strains appear as black colonies with 
a dry crystalline consistency.
2.6 Sorbarod Model as an in  v itro  model for growth of microbial 
biofilms
The Sorbarod model was developed by Hodgson et al., (1995) for growth control 
of bacterial biofilms (Figure 2.3). The Sorbarod filter consists of a cylindrical paper 
sleeve, encasing a compacted concertina of cellulose fibres. A single Sorbarod filter 
(20mm x 10mm) was inserted into one end of 10cm polyvinyl chloride (PVC) tubing and
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to the other end a 3mL disposable syringe was inserted. The plunger of the syringe was 
removed leaving the rubber seal within the syringe lumen. A disposable needle was 
inserted in the centre of the rubber seal. The whole assembly was sterilized by 
autoclaving. The medium was delivered by peristaltic pump (Gilson miniplus 3, France) 
to the assembly through sterile silicone tubings connected to the needle. The Sorbarod 
assembly was placed in an incubator at 37°C.
10  mm
F ig u re  2.3: D ia g ra m  o f th e  S o rb a ro d  a ssem b ly  show ing  th e  tu b in g s  d e liv e rin g  th e  
m e d iu m  (A ); (B): th e  ru b b e r  p lu n g e r  sea l in to  w h ich  th e  need le  (D) is in s e r te d ;  (C ) 
3m L  s te rile  d isp o sab le  sy ringe ; (E ): 10cm  P V C  a tta c h e d  to  th e  sy rin g e  f ro m  o n e  e n d  
a n d  th e  o th e r  en d  a tta c h e d  to  S o rb a ro d  p lu g  (F ), (H odgson  et ah, 1995).
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Before pumping the media, Sorbarod filter was wetted with 5mL normal saline 
and then 3mL of mid exponential phase bacteria was added drop wise on to the top of the 
Sorbarod. Since the major portion of the inoculum attaches within 5 minutes (Deighton et 
al., 2001) the flow was started 5 min after inoculation at a flow rate of 0.4mL min'1. The 
effluent from Sorbarod (the eluate) was collected in sterile receivers.
2.6.1 S acrifice  o f  S o rb a ro d  b io film
After reaching the steady state, Sorbarod filters were removed from their PVC 
housing using sterile forceps. The paper sleeve surrounding the fibres was cut open with 
sterile scissors and the filter was placed into a sterile plastic disposable tube. The 
Sorbarod was then stored at -20°C for future use or was disintegrated for further analysis. 
In order to release biofilm cells, 9mL normal saline (0.9%w/v) was added to each 
Sorbarod filter and the filter was disintegrated by vortexing for 2 minutes. A tight fitting 
plunger was used to compress the diffusing fibres to the bottom of the tube, thus allowing 
the suspension of cells and matrix to be decanted. The Sorbarod was washed twice more. 
The decanted suspensions were collected in a sterile test tube. The cells were pelleted by 
centrifugation at 3500 rpm for 60 minutes (Jouan CR312, Jouan Ltd, Ilkeston, UK).
2.7 Turbidity standard for inoculum preparation
In order to standardize inoculum concentration or density, a barium sulfate 
turbidity standard was prepared equivalent to 0.5 McFarland. Bacterial suspensions 
adjusted to this standard would contain approximately 2xl08 CFU mL' 1 for most species 
(NCCLS, 2000). The standard was prepared by slowly adding 0.5mL of BaCL (1.175% 
w/v BaCL H20) to 99.5mL of H2SO4 (1% v/v) with constant stirring. An aliqout of the 
suspension was placed in a quartz cuvette and measured spectrophotometrically at
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T a b le  1.1: Som e o f th e  v iru len ce  fa c to rs  (a r ra n g e d  a lp h a b e tic a lly )  e x p re sse d  b y  
S taphy lococci a n d  a  su m m a ry  o f th e ir  effects.
V iru len ce
fa c to r
D escrip tio n  a n d  A ctio n R efe ren c e
Broad
specificity
adhesin
These proteins bind to wide range of host proteins. 
The first described was Major histocompatibility 
complex type II analogue protein (Map), which binds 
to fibronectin, fibrinogen, vitronectin, bone 
sialoprotein and osteopontin. It has significant role in 
chronic staphylococcal infections and has inhibitory 
effect on T cells of the immune system. Others like 
extracellular adherence protein (Eap), which 
facilitates bacterial aggregation on eukaryotic cell 
substrates.
Lee et al., 
2002; Hussain 
et al., 2002.
Capsular
polysaccharide
The majority of clinical isolates produce capsules of 
serotype 5 or 8, which are repeating trisaccharide 
units. The capsule protects the bacterium from 
phagocytosis by impeding its interaction with 
leukocyte and plays an important role in inducing 
abscess formation.
Fournier et 
al., 1984; 
Moreau et al., 
1990;
Karakawa et 
al., 1988; 
Thakker et al., 
1998;
Tzianabos et 
al., 2001.
Coagulase
An extracellular protein secreted by some species 
including S. aureus. It binds to prothrombin and 
activates fibrinolytic activity. Its role as virulence 
factor was shown in some staphylococcal infection 
models while excluded in others.
Moreillon et 
al., 1995; 
Sawai et al., 
1997.
Collagen
binding
proteins
These proteins mediate adherence of the bacteria to 
collagen and cartilage. They are regarded as 
important vimlence factors in septic arthritis, 
endocarditis and contact lens-associated ulcerative 
keratitis.
Patti et al., 
1994; Hienz, 
et al., 1996; 
Rhem et al., 
2000).
Exfoliative
toxins
A group of toxins that are involved in scalded skin 
syndrome disease. They have enzymatic activity 
capable of degenerating desmosomes required for 
cell-cell adhesion and causing intraepidermal skin 
peeling.
Amagai et al., 
2000.
Fibrinogen 
binding 
proteins (FbPs)
A group of proteins bound to the cell wall. They bind 
to fibrinogen specifically. These include clumping 
factor A (ClfA) and B (ClfB), which promote 
bacterial attachment to blood clots. ClfA plays 
significant role in inducing endocarditis in rat model. 
FbPs bind to platelets and inhibit their aggregation 
thus delaying wound healing.
Boden and 
Flock, 1989; 
Moreillon et 
al., 1995; 
Shannon et 
al., 2005.
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Table 1.1 continued
Fibronectin
binding
adhesins
Two related fibronectin binding proteins are 
expressed by most S. aureus strains. They mediate 
bacterial attachment to plasma clots and fibronectin 
which is a component of epithelial and endothelial 
surfaces. This attachment is considered a bridge 
required for tissue invasion. Also these proteins were 
shown to activate platelets, resulting in aggregation 
and thrombus formation, a step that is important for 
infective endocarditis.
Fowler et al., 
2000;
Fitzgerald et 
al., 2006.
Membrane 
active toxins
These compounds act on the host cells’ membranes 
causing lysis or cytoxic effect. They include a-toxin 
(hemolysin), (3-toxin, 8-toxin, leukocidin, Panton- 
Valentine leucocidin (PVL) and y-toxin. 
a-toxin: produced by most S. aureus strains, it has 
haemolytic, cytotoxic (erythrocytes, mononuclear 
cells, epithelial and endothelial cells), dermonecrotic 
and neurotoxic effect. Some animals have high 
affinity binding sites on their erythrocytic membrane 
to the toxin, like rabbits, which make them 1000 
times more susceptible to hemolysis than other 
animals with lower sensitivity like humans, a-toxin 
also induces release of proinfiammtory cytokines and 
procoagulatory compounds. Strains expressing a- 
toxin were found to be more virulent than a-toxin 
mutants.
(3-toxin is a sphingomyelinase enzyme. Mostly 
expressed by staphylococci isolated from animals 
with mastitis. Its activity as haemolytic agent differs 
according to the animal species. It has leukotoxic 
effect.
8-toxin: it has a broad range of cytolytic activity with 
some surface activity properties. Rabbit erythrocytes 
are most sensitive to it while humans' cells are 1000 
times less sensitive.
PVL has leukotoxic effect and lytic effect on 
neutrophils and macrophages, which is species 
dependent.
y-toxin a haemolytic toxin with low leukotoxic 
activity, almost produced by all strains of S. aureus.
Bhakdi and 
Tranum- 
Jensen, 1991; 
Dinges et al., 
2000.
Plasmin
sensitive
surface
proteins
Expressed in some strains of S. aureus. It promotes 
cell binding to cellular lipids and glycolipids and 
promote bacterial cell-cell interactions.
Huesca et al., 
2002.
Polysaccharide
intercellular
adhesins
A linear polysaccharide. Considered the primary 
constituent of the exopolymeric matrix of 
Staphylococcus biofilm. It mediates biofilm 
formation and accumulation.
Cramton et 
al., 1999; 
Mack et al., 
2004.
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Table 1.1 continued
Proteases
The major groups of these extracellular proteins are 
cysteine protease, metallo-protease and serine 
proteases. Produced by most strains. They contribute 
to bacterial invasion and spread through inactivating 
certain proteins in the immune system and structural 
proteins of the host. They also act on the proteins 
secreted by the pathogen itself like fibrinogen 
binding protein, and protein A, a role necessary to 
change bacterial status from adhesive to invasive.
Potempa et 
al., 1988; 
Rapala-Kozik 
et al, 1999; 
Shaw et al., 
2004.
Protein A
Cell wall anchored surface protein produced by most 
S. aureus isolates. Its role in virulence is 
controversial and depends on animal model used for 
the study. It binds to IgG molecules in the wrong way 
through Fc region, which principally will interfere 
with opsonization and phagocytosis. It binds to many 
mammalian proteins and to the Fab region of human 
immunoglobulin, which makes it a potential B cell 
superantigen. It also binds to von Willbrand factor (a 
glycoprotein produced in endothelium which 
mediates platelets aggregation to damaged 
endoepithelia) thus suggesting its role in 
endovascular infection.
Mascellino et 
al., 1989; 
Jendeberg et 
al.y 1996; 
Hartleib et al., 
2000.
Staphylococcal
pyrogenic
toxin
superantigens
(PTSAgs)
Group of toxins that share similar biological 
characteristic. They include Staphylococcus 
enterotoxin (SE) A to Q excluding F and toxic shock 
syndrome toxin 1 (TSST-1). They induce 
pyrogenicity (fever), T-cell proliferation 
(superantigenicity), induction of cytokines and 
enhance lethality to endotoxins. SEs are responsible 
for food poisoning (gastroenteritis), they are potent 
emetics, heat stable and resist degradation in 
gastrointestinal tract while TSST-1 can pass mucous 
membranes.
Bohach et al, 
1990); Dinges 
et al., 2000; 
Lee and 
Bohach, 2004.
Staphylokinase
An exoprotein enzyme. It activates plasminogen and 
causes thrombolysis and fibrinolysis, which help the 
bacteria in invasion and spread in the host tissues. 
Staphylokinase was found to induce secretion of a- 
Defensins peptides from neutrophils, interact with 
them and abolish their bactericidal activity.
Jin et al., 
2004; Braff et 
al, 2007.
1.3.1 T oxic  S hock  S y n d ro m e  T ox in  1 (T SST -1)
1.3.1.1 The disease
Toxic shock syndrome (TSS) as a disease, was first described in 1978 in children 
as a systemic illness caused most probably by secreted toxins of S. aureus, since the
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bacteria were isolated from localised tissues, but not from the blood (Todd et al., 1978). 
This disease is caused by pyrogenic toxins released from some strains of S. aureus or 
streptococci (Bohach et al., 1990). TSST-1 was the first toxin identified from this disease 
(Bergdoll et al., 1981). In fact, not every strain producing the toxin would necessarily 
cause this disease. Several surveillance studies have isolated TSST-1 producing 
staphylococci from healthy carriers or asymptomatic persons and the nares were the most 
common site for this microorganism (Daghistani et al., 2000; Warner and Onderdonk, 
2004; Fueyo et al., 2005). The Centres for Disease Control and Prevention in USA define 
toxic shock syndrome by five clinical criteria: fever, hypotension, rash, desquamation 
(unless the patient dies before desquamation) and abnormalities in three or more organ 
system (Hajjeh et al., 1999).
In 1979 to 1980 toxic shock syndrome emerged as national health threat in USA, 
in women in the reproductive age group, with a high morbidity and mortality rate. Most 
of the cases occurred in menstruating women, and were linked to the use of high 
absorbency tampons (Shands et al., 1980). The incidence of the disease in other countries, 
like Britain and Switzerland, was much lower than the States. This was attributed to the 
type of tampons used in these countries (De Saxe et al., 1982; Vischer et al., 1985). The 
link of the disease to menstruating women and tampon usage initiated a wide range of 
actions in order to increase the awareness of women and to change tampon usage and 
production. These actions led to dramatic decrease in TSS cases in the following years 
(Hajjeh et al., 1999).
In general, Staphylococcal Toxic Shock Syndrome is categorized into two major 
types; menstrual and non-menstmal (Shands et al., 1980; Reingold et al., 1982). TSST-1 
is responsible for almost 100% of menstrual TSS cases and only 50% of non-menstrual 
cases, of which the other 50% is caused mostly by staphylococcal enterotoxin B or C.
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These non-menstrual cases may occur in any age group regardless of the patient gender 
(Schlievert, 2005).
A surveillance study between 1979 and 1996 in the United States found that 
during that period TSS menstrual cases were reduced significantly, while the proportion 
of non-menstrual cases (due to surgical wound infection in both genders, nonsurgical 
cutaneous lesions in children and the use of barrier contraceptives in women) has 
increased (Hajjeh et a l , 1999). Recent reports show a four fold increase in TSS in the 
Minneapolis-St. Paul (Twin Cities) metropolitan area between years 2000 and 2003 
(Schlievert et al., 2004). This increase was attributed partly to a strain of methicillin 
resistant S. aureus, termed USA 1100, which was able to produce ten to hundred times 
more TSST-1 in vitro than methicillin sensitive staphylococci (Schlievert, 2005).
1.3.1.2 TSST-1 as superantigen
TSST-1 belongs to staphylococcal pyrogenic toxin superantigens (PTSAgs). 
Being a superantigen, it exhibits highly potent non-specific lymphocyte stimulatory 
properties, causing 500 to 3000 times more stimulation to T-cells than in normal antigenic 
recognition reaction, which will lead to a severe immunological response (Dinges et a l, 
2000; Schlievert, 2005). Normally, conventional antigen is degraded by antigen 
presenting cells (APCs) and presented by major histocompatibility complex class II 
molecules (MHC II), which are expressed on the surface of APCs to T-lymphocyte 
through a groove formed by a  and p chains of T-cell receptor (TcR) (Figure 1.6). While 
superantigens are not degraded by APC, they bind intact to MHC molecules outside the 
conventional binding site and the complex formed by superantigen-MHC-APC, 
recognizes only the VP element of T cell receptor (Figure 1.6). Thus, any T-cell with 
appropriate Vp element will be stimulated. As a result of this stimulation T-cells and
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APCs will release enormous amounts of cytokines (interleukins, lymphokines and tumour 
necrosis factor). This reaction goes beyond the control of the regulatory system of the 
host leading to systemic shock and death (Dinges et al., 2000; Lee and Bohach, 2004).
Superantigens have been shown to enhance the activity of endotoxins, which 
could be responsible for their lethal effect. This effect is believed to be a result of 
inhibiting reticuloendothelial system (liver) clearance of circulating endotoxins, which in 
turn will induce release of lethal amounts of monokines, mainly tumor necrosis factor-a 
(Schlievert, 1982; Fujiwaka et a l , 1986). TSST-1 also causes hypotension and shock, 
which could be attributed to its interaction with endothelial cells (Dinges et al., 2000). In 
a study, TSST-1 was shown to have a cytotoxic effect on porcine aortic endothelial cells 
at high concentration, while at lower concentrations it caused leakage of albumin from 
these cells (Lee et al., 1991).
Figure 1.6: Stimulation of T cell by a conventional antigen (Ag) or by a 
superantigenic toxin (SAg). TcR: T cell receptor; APC: antigen-presenting cell; 
MHC II: major histocompatibility class II complex molecule (Muller-Allouf et al., 
2001).
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1.3.1.3 TSST-1 structure and activity
Toxic shock syndrome toxin 1 is encoded by tst on the staphylococcal 
chromosome in a mobile genetic element called a pathogenicity island (Lindsay et al.,
1998). The gene is translated into a 234 amino acid precursor protein (Figure 1.7) with a 
molecular weight of 26.3kDa and isoelectric point of 8.8 (Blomster-Hautamaa et al., 
1986; http://www.expasv.org). This precursor has an N-terminal signal peptide composed 
of 40 aminoacids that is required in order to transfer the newly synthesized protein from 
the ribosome to the translocation machinery in the cytoplasmic membrane. Before 
secretion, the signal protein is cleaved from the Alanine/Serine point (aminoacids 40/41) 
to give the mature protein (Blomster-Hautamaa, et al., 1986; Dinges, et al., 2000; 
Sibbald, et a l , 2006). The mature toxin is a single polypeptide chain composed of 194 
amino acids (Figure 1.7) with molecular weight of 22 kDa and isoelectric point of 7.2 
(Blomster-Hautamaa et al., 1986). Structurally, TSST-1 is composed of two adjacent 
domains (Figure 1.8). Domain A contains long central a-helix and a short N-terminal 
helix. The central helix is surrounded by five strand P-sheets. Domain B is composed of a 
barrel motif made from five p-strands (Prasad et al., 1993). Studies on TSST-1 crystal 
forms revealed the presence of a zinc ion between two symmetrrical molecules. Zinc was 
found to potentiate mitogenic activity at micromolar concentrations, but is not essential 
for activity (Prasad et al., 1997). Studies on TSST-1 mutants revealed that major 
histocompatibility complex II (MHC II) contact residues are localized within the 
p-barrel, whereas superantigenic activity is localized to the central a-helix. In fact, the 
superantigenic activity of TSST-1 and the binding properties to MHC have been shown to 
be separable (Wahlsten and Ramakrishnan., 1998).
Single or double aminoacid mutations in the p-barrel abolished the ability of 
TSST-1 to bind to MHC n, while mutations to the a-helix resulted in significant
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reduction in superantigenic activity and lethality (i.e. inducing lethal toxic shock 
syndrome). On the other hand, some mutations in the a-helix resulted in more 
superantigenic toxin, but with lower lethality effect, suggesting that lethality is not 
necessarily connected to T-cell proliferation and can be related to cytokine release, direct 
interaction with endothelial cells or endotoxin enhancement. However, the antigenicity of 
TSST-1, which is measured by reactivity of the toxin to its specific antibody in some 
TSST-1 mutants, was not affected (Blanco et al., 1990; Murray et al., 1996).
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
1 Met Asn Ly s L y s Leu Leu Met Asn Phe Phe l i e Val S e r Pro Leu 15
16 Leu Leu A la Thr Thr A la Thr Asp Phe Thr Pro Val Pro Leu S e r 30
31 S e r Asn Gin l i e l i e Ly s Thr A la L y s A la S e r T h r Asn Asp Asn 45
46 l i e Lys Asp Leu Leu Asp T rp T y r S e r S e r G ly S e r Asp T h r Phe 60
61 T h r Asn S e r G lu V a l Leu Asp Asn S e r Leu G ly S e r M et A rg l i e 75
76 Lys Asn T h r Asp G ly S er l i e S e r Leu l i e l i e Phe Pro S e r P ro 90
91 T y r T y r S e r Pro A la Phe T h r Lys G ly G lu Lys V a l Asp Leu Asn 105
106 T h r Lys A rg T h r Lys Lys S e r G in H is T h r S e r G lu G ly T h r T y r 120
121 l i e H is Phe G in l i e S er G ly V a l T h r Asn T h r G lu Lys Leu P ro 135
13 6 T h r Pro l i e G lu Leu Pro Leu Lys V a l Lys V a l H is G ly Lys Asp 150
151 S e r Pro Leu Lys T y r G ly Pro Lys Phe Asp Lys Lys G in Leu A la 165
166 l i e S e r T h r Leu Asp Phe G lu l i e A rg H is G in Leu T h r G in l i e 180
181 H is G ly Leu T y r A rg S er S e r Asp Lys T h r G ly G ly T y r T rp Lys 195
196 l i e T h r M et Asn Asp G ly S e r T h r T y r G in S e r Asp Leu S e r Lys 210
211 Lys Phe G lu T y r Asn T h r G lu Lys P ro Pro l i e Asn l i e Asp G lu 225
226 l i e Lys T h r l i e G lu A la G lu l i e Asn
F ig u re  1.7: A m ino  ac id  sequence  o f  T S S T -1  p re c u rs o r  sh o w in g  th e  s ig n a l p e p tid e  
(am ino  ac id  1-40) a n d  th e  m a tu re  T S S T -1  seq u en ce  (am in o  a c id  41-234). 
(h ttp  ://w w w .expasv .o rg /cg i-b in /sp ro t-ft-de ta ils .p l?P 06886@  C H A IN  @ 41 @234). 
(A ccessed on  2/09/2007).
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Central a-helix
Barrel motif
Domain A Domain B
Figure 1.8: Ribbon Diagram of TSST-1 showing the N and C terminus of the 
protein. The central a-helix and the p-barrel motifs are indicated by arrows 
(adapted from Dinges et al., 2000).
1.4 Biofilm formation
The ability of bacteria to form biofilms is considered one of the most important 
virulence effects of concern in the medical community, as these structures are highly 
resistant to antimicrobials and to the host defences. Biofilms can form on inert surfaces 
like catheters, prosthetic devices and contact lenses, on dead tissues like bone sequestra or 
even on living tissues (Costerton et al., 1999).
Staphylococci have been shown to represent a large proportion of isolates from 
infected prosthetic devices. Most of the prosthetic device infections occur at the time of 
surgical placement of the device. Since staphylococci colonize nasal passages and the 
skin, they can gain access via medical staff or the patient to the device (Kluytmans et al.,
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1997; Bayston, 2000). In recent surveys, biofilms of staphylococci were found to be the 
main causative reason of endocarditis according to survey carried out in 25 European 
countries (Tomos et al., 2005). These biofilms were also found to be involved in other 
diseases like otitis media, bacterial prostatitis and cystic fibrosis (Donlan and Costerton, 
2002).
Staphylococcus spp biofilm formation passes through three major phases (Higashi 
and Sullam, 2006). The initial phase is the adherence of the organism to a surface, where 
forces like hydrophobic, ionic and van der Waals interactions mediate cell adherence to 
inert surfaces. On the other hand, interaction with biotic surfaces or with tissues occurs 
through specific molecular adhesins. In the case of staphylococci these adhesins could be 
fibronectin binding protein, fibrinogen binding protein, protein A or clumping factors. A 
surface protein called biofilm associated protein (Bap) was found to play a role in biofilm 
formation by affecting the first stage and to some extent the second stage. This protein 
promotes non-specific interaction through enhancing surface hydrophobicity of bacteria. 
The ability of bap mutants to attach to polystyrene was significantly reduced and they 
were not able to form biofilm (Cucarella et al., 2001). Other physicochemical factors such 
as oxygen tension, pH, hydrodynamic flow and nutrient conditions also affect this phase. 
The second phase involves cell division and the formation of an exopolysaccharide matrix 
that aggregates the cells into multilayers. In this phase, S. aureus and S. epidennidis 
produce exopolysaccharide matrix to facilitate cellular aggregation. Several studies have 
shown that this material is composed of polysaccharide intercellular adhesin (PIA, also 
known as slime or polymeric N-acetyl glucosamine) (Joyce et al., 2003; Mack et al., 
2004; Higashi and Sullam, 2006). PIA expression was found to be induced by anaerobic 
conditions and such conditions may be encountered clinically in some diseases like 
airway plugs of patients with cystic fibrosis (Cramton et al., 2001).
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In S. aureus, a-toxin has been shown to be an essential compound for cell-to-cell 
interaction, but not for attachment to surfaces. This cellular interaction is required for 
multilayer formation in the second phase of biofilm formation (Caiazza and O'Toole, 
2003). Bap protein in this stage has conflicting roles as its presence in certain infection 
models was necessary for biofilm formation (Cucarella et al., 2004), while in others, its 
absence has no effect (Cucarella et al., 2001). However, there is evidence that Bap has a 
biofilm potentiating relationship with PIA (Higashi and Sullam, 2006) or even a 
compensatory role if PIA is deficient (Cucarella et al., 2004). However, in vitro studies 
have shown that bap mutants have weak intercellular interactions (Cucarella et al., 2001). 
The final phase is the spatial arrangement of encased bacteria into a complex three 
dimensional structure containing channels through which nutrients and waste products 
circulate (Dunne, 2002; Higashi and Sullam, 2006). This phase is regulated and 
controlled by quorum sensing systems (Davies et al., 1998; Maddula et al., 2006).
The use of antibiotics to treat such infections has proved to be ineffective in most 
of the cases. Antibiotics may reverse the symptoms caused by planktonic cells released 
from the biofilm, but fail to eradicate the biofilm, especially if the infection is due to S. 
aureus or Candida (Darouiche, 2004). For this reason, biofilm infections of prosthetic 
devices cause recurring symptoms with antibiotic therapy and the ultimate solution is the 
surgical removal of the device (Table 1.2) (Costerton et al., 1999).
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Table 1.2: Clinical and economical consequences of biofilm infections of 
implanted devices in the United States (adapted from Darouiche, 2004).
Implants Projected Average Estimated
Inserted Infections Rate of Average
Implant in the of Infection Cost of CombinedU.S. Implants Medical and
Annually Annually Surgical
No. No. % Treatment (U.S. $)
Cardiovascular: 
Mechanical heart valve 85000 3400 4 50000
Vascular graft 450000 16000 4 40000
Pacemaker- 300000 12000 4 35000
defibrillator 
Ventricular assist 
device
700 280 40 50000
Orthopaedic: 
Joint prosthesis 600000 12000 2 30000
F ractur e-fixation 
device
2000000 100000 5 15000
Neurosurgical — 
ventricular shunt 40000 2400 6 50000
Plastic — mammary 
implant (pair) 130000 2600 2 20000
Urologic — inflatable 
penile implant 15000 450 3 35000
There are many possible mechanisms that account for biofilm resistance to 
antimicrobials, which vary with the microorganism forming the biofilm, the drug applied 
and the environment. No one mechanism can explain the increased resistance to 
antimicrobials. Some of the characterized mechanisms include:
1. Restricted penetration of antibiotics into biofilm.
It has been shown that biofilms retard the diffusion of some antimicrobials 
and large molecules of the host defence system. This retarded diffusion will 
decrease the concentration of antimicrobial entering the biofilm, allowing 
enzymes like p-lactamase to inactivate the incoming antibiotic (Lewis, 2001).
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Souli and Giamarellou (1998) showed that the diffusion of one of the quinolones, 
pefloxacin, and some glycopeptides (vancomycin, teicoplanin, but not 
daptomycin) was retarded by staphylococcal slime. In another experiment, 
tobramycin penetration through Pseudomonas aeruginosa biofilms was retarded 
for 12 hours (Walters et al., 2003).
2. Decreased growth rate.
Slow growth of the bacteria is observed in mature biofilms. Since some 
antibiotics act on growing cells, this could explain the resistance of some 
microbial biofilms to certain antibiotics. For example, penicillin and ampicillin do 
not kill non-growing cells, and it was found that their activity is proportional to 
growth rate (Lewis, 2001). Duguid et al., (1992) proved that susceptibility of S. 
epidermidis biofilms towards tobramycin increased significantly with increasing 
growth rate. Eng et al (1991), by controlling growth rate of bacteria through 
nutrient limitation, were able to demonstrate that stationary phase Gram-negative 
organisms were resistant to a wide range of antibiotics, where only 
fluoroquinolone antibiotics produced bactericidal effects. Furthermore, no class of 
antimicrobial agent in that study was bactericidal in the range of 3 orders of 
magnitude killing versus growth limited S. aureus (Eng et al., 1991).
3. Expression of specific genes that contribute to biofilm cell resistance:
Genetic studies revealed that generally more genes were expressed in 
biofilms than in batch culture of planktonic cells (Jiang and Pace, 2006). Several 
studies indicated that high cell density induces stress response in the bacteria with 
the resulting expression of stress response factors that protect the organism from
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heat/cold shock, pH variation and chemical agents (Brooun et a l, 2000; Mah and 
O’Toole, 2001). Studies in Escherichia coli suggested that growth within biofilm 
initiates stress response with production of trehalose (an osmo-protectant) and 
catalase (Liu et al, 2000).
4. High rate of gene transfer.
Due to the close contact of bacteria and their spatial stability in biofilms 
structure, genes transfer by conjugation was found to be much higher than 
between planktonic cells suspensions and this is believed to increase the spread of 
antibiotic resistance genes (Jiang and Pace, 2006).
5. Biofilm microenvironment.
The microenvironment might have a role in tolerance of biofilms to 
antibiotics. It has been suggested that oxygen limitation in a 48 hours old P. 
aeruginosa biofilm, explains 70% of the protection afforded to biofilm cells 
against tobramycin, ciprofloxacin, carbencillin, ceftazidime and chloramphenicol 
(Borriello et al, 2004; Walters et al., 2003).
6. Heterogeneity within a biofilm.
Any given cell within the biofilm will experience a different 
microenvironment compared with other cells in the biofilm in terms of gradients 
of nutrients, waste products and signaling factors. This heterogeneity will result in 
the establishment of gradients in response to antimicrobials depending on the 
location of the cell. Fleroxacin caused extreme elongation to Pseudomonas
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biofilm cells located close to the exposed side of the biofilm compared to other 
cells (Mah and O’Toole, 2001).
7. Persister cells.
It has been observed that when exposing Pseudomonas spp biofilm cells to 
antibiotics, most of the cells were killed at concentrations of antibiotics not much 
higher than those of planktonic cells, except a very small fraction of cells which 
tolerated high concentrations of drugs. These cells are known as persister cells 
(Brooun et al., 2000). Persister cells are not mutants; rather, they are variants that 
are susceptible to growth inhibition as other biofilm cells, but are resistant to 
killing. Persister variants are believed to be responsible for the high resistance of 
biofilms and to play a role in recurrence of biofilm infection when the treatment is 
stopped (Lewis, 2001; Jiang and Pace, 2006).
1.5 Gene regulation of virulence factors
The ability of staphylococci to produce a wide variety of virulence factors, which 
are expressed during different stages of cell cycle or infection, assumes that the 
expression of virulence genes is regulated and coordinated in response to environmental 
signals. For instance, the initial stages of colonization require the bacteria to produce cell- 
surface molecules to aid the pathogen in adhesion to surfaces, while at a later stage, the 
bacteria release toxins and enzymes to enhance their spread and invasion. The way the 
bacteria control these numerous processes suggests the existence of global regulators 
(Higashi and Sullam, 2006).
S. aureus generally has three types of global regulators: the first one is the two 
component signal transduction systems (TCSs), which is typically composed of
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membrane-associated proteins that extend through cytoplasmic membrane. These proteins 
bind to factors from the environment and initiates intracellular responses resulting in 
changes in gene expressions. The agr (accessory gene regulator) locus is the most studied 
TCS global regulator. The second global regulator is a group of transcription factors that 
mediate gene expression by binding to promoter regions of other transcription factor 
genes. SarA was the first one identified in this group. The third type is sigma factor B 
(oB), which is a transcription factor that induces transcription of genes needed to respond 
to stress conditions (Arvidson, 2004). However, some of the virulence factors themselves 
could have regulatory effects. TSST-1 and enterotoxin B were shown to act as global 
repressors to exotoxin synthesis, an effect which was attributed to the precursor of these 
toxins rather than the mature protein (Vojtov et al., 2002). In addition, proteases were 
found to cause down regulation to cell-associated proteins like protein A and fibronectin 
binding protein (Karlsson et al, 2001). Interestingly, some of the N-acyl homoserine 
lactones, the quorum sensing mediators of many Gram-negative bacteria, have been 
shown to inhibit S. aureus growth in a concentration-dependent-manner, while at 
subgrowth-inhibitory concentration they down regulate exotoxin production and sarA and 
agr expression, which are the quorum sensing system of S. aureus (Qazi et al., 2006).
1.5.1 The accessory gene regulator (agr)
The agr locus is the major quorum sensing system of staphylococci. It is 
responsible for coordinating the switch of protein expression in vitro in S. aureus from 
surface proteins to exoproteins in post exponential phase (Arvidson, 2004). It has been 
shown to up regulate more than 100 genes and down regulate 34. About 80% of these 
genes were related to cellular processes and 20% responsible for encoding virulence 
factors (Dunman et al., 2001). The effect of agr system on biofilm formation seems not to
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be significant, as mutations of the agr system do not affect S. aureus biofilm formation 
(Beenken et al., 2003). However, other studies found that disruption of the agr system 
could either enhance, inhibit, or even have no effect on biofilm formation. These effects 
depend on the environment and experimental conditions (Yarwood et al., 2004).
The agr locus consists of two divergent transcriptional units, RNAII and RNAIII 
which are transcribed from promoters P2 and P3 respectively (Arvidson, 2004). RNAII 
codes for four polypeptides AgrB, AgrD, AgrC and Agr A, which activate transcription 
from the agr promoters, while RNAIH is the actual effector of virulence gene regulation 
(Higashi and Sullam, 2006). AgrD is the peptide precursor of autoinducing peptide (AIP), 
which is processed by AgrB (a membrane protease) to a mature form (Figure 1.9). AIP 
binds to AgrC (the agr system receptor) and causes its activation. The activated AgrC in 
turn activates AgrA (the response regulator), which stimulates the transcription of P3, 
resulting in encoding regulatory RNA molecule (RNAIII) that acts as primary effector of
S. aureus quorum sensing. In addition, AgrA induces expression of Agr proteins through 
RNAII transcription by stimulating the transcription of P2 (Figure 1.9) (Arvidson, 2004; 
Horswill et a l, 2007). The transcription of RNAEH occurs in mid to late exponential 
phase resulting in the stimulation of expression of extracellular proteins, toxins and 
enzymes, but repressing surface protein genes (Novick et a l, 1993). It has been shown 
that each AIP activates only the agr system of strains of its own group and may act as 
inhibitor between different strains (Lyon et a l, 2002).
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Figure 1.9: Schematic diagram of agr systems of S. aureus. The gene locus for agr 
consists of two divergent transcripts, RNAII and RNAIII, driven by the P2 and P3 
promoters, respectively. RNAII transcript encodes the agrBDCA operon, which 
encodes, processes and activates autoinducing peptide (AIP), resulting in RNAIII 
and RNAII induction (adapted from Horswill et al., 2007).
1.5.2 SarA (,Staphylococcus accessory regulator)
This is a member of inter-regulatory network of transcription factors family 
(including SarR, SarT, SarS) and considered the major regulatory protein (Higashi and 
Sullam, 2006). It is encoded by the sarA  locus. Studies on sarA  have shown that it acts 
independently from agr  and also it acts by activating the transcription of RNAII and 
RNAIII of agr system (Chien and Cheung, 1998). SarA up-regulates the production of a -  
and p-haemolysin, TSST-1, coagulase and enterotoxin B and down-regulates protein A 
production, proteases and lipase (Lee and Bohach, 2004).
SarA has a significant effect on biofilm formation. Several studies proved that 
mutations in sarA  would result in loss of biofilm forming ability of S. aureus in vitro  and 
in vivo (Beenken et al., 2003; Beenken et al., 2004). Mutagenesis of sarA  resulted in
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the study. In order to remove cell debris from the solution (cytosol), the homogenized 
suspension was centrifuged at 13000 rpm (Genfuge 24D, Progen, Mexborough, UK) for 5 
minutes. The absorbance of the supernatant was measured at 260nm using 
spectrophotometer (Genesys 10UV, Thermo Spectronic, New York, USA). Normal 
saline was used as a blank. The second tube of cell suspension was homogenized for two 
minutes and the absorbance of the supernatant at 260nm was recorded. The same 
procedure of homogenization and subsequent measuring of absorbance was continued for 
the other tubes of cell suspensions, where each tube was homogenized for an extra one 
minute more than the previous one, until no increase in absorbance values was noticeable. 
By plotting the absorbance at 260nm against homogenization time, the minimum time 
required for homogenization can be determined. Figure 2.6 shows that the optimal 
homogenization time is 5 minutes at the set speed (speed 3).
Figure 2.6: Determination of optimal homogenization time of S. aureus using hand 
held homogenizer at speed 3. Absorbance at 260nm vs homogenization time.
2.8.5 Extraction of exoproteins from eluate supernatant
A portion of the eluate supernatant (45mL) was placed in a centrifuge tube and 
placed on ice. Trichloroacetic acid (TCA) (5g) was dissolved in the eluate supernatant to 
give a final concentration of 10% w/v. The solution was left on ice for 30 min to allow for 
protein precipitation. In order to isolate the precipitated proteins, the tube was centrifuged
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at 4°C (Jouan CR312, Jouan Ltd, Ilkeston, UK) at 3500 rpm, for 1 hr. the supernatant was 
decanted and discarded. The precipitated proteins were washed five times by ice-cold 
ethanol (99%) to remove the residual TCA. The washed proteins were dried by nitrogen 
gas to prevent oxidation. At this point the proteins are ready to be immediately 
reconstituted with suitable solvent for further analysis.
2.8.6 Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE)
The following solutions were required for preparing separating gel mixture and 
stacking gel mixture:
Protogel Ultrapure (National diagnostics, Hessle Hull, England): 30% w/v acrylamide, 
0.8% bisacrylamide stock solution (37.5:1).
Separating gel buffer: lg, SDS and 45g, Tris buffer (2-amino-2-(hydroxymethyl)- 
propane-l,3-diol) dissolved in 200mL distilled water, pH was adjusted to 8.8 with HC1 
and volume made up to 250mL with distilled water.
Stacking gel buffer: lg, SDS and 15.lg, Tris buffer dissolved in 200mL distilled water, 
pH was adjusted to pH 6.8 with HC1 and volume was made up to 250mL with distilled 
water.
Ammonium persulfate solution: lg, ammonium persulfate dissolved in lOmL distilled 
water.
2.8.6.1 Preparation o f 10% separating gel mixture
lOmL of Protogel, 12mL of distilled water and 7.5mL of separating gel buffer 
were mixed together and degassed using vacuum. 45pL of ammonium persulfate was 
added to the mixture, mixed gently and followed by 15 pL of TEMED (N,N,N',Nr, 
tetramethylethylene diamine) to start polymerisation. The mixture was mixed gently and
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immediately poured into a previously prepared 0.75mm gel cast (Mini PROTEAN 3 
system, Bio-Rad, Hercules, CA, USA). Distilled water was overlaid on the top of the gel 
to produce a flat top of the gel and to remove air bubbles. The gel was left to set at room 
temperature.
2.8.6.2 Preparation o f stacking gel mixture
750jliL of Protogel, 3mL of distilled water and 1.25mL of stacking gel buffer were 
mixed and degassed using vacuum. Then, 15jaL of ammonium persulfate was added 
mixed gently and followed by 5pL TEMED. The mixture was mixed gently. After 
leaving the separating gel for at least one hour to polymerise, the overlaying water layer 
was decanted and the surface of the gel was rinsed with distilled water. Stacking gel 
mixture was poured over the separating gel and a well-forming comb (0.75mm, 10 wells, 
Bio-Rad) was inserted. The gel was left to set at room temperature for at least one hour.
Once the stacking gel had polymerised, the comb was removed and the wells were 
rinsed with distilled water. The gel was transferred to mini PROTEAN 3 system (Bio- 
Rad, Hercules,CA, USA) and the tank was filled with tank buffer (glycine (14.4g), Tris 
buffer (3.0g) and SDS (l.Og), distilled water added to 1L, pH about 8.3 without 
adjustment) so that the buffer covers the wells.
The samples and marker were loaded into the wells using special tips (Gel saver II Tips, 
Fisherbrand) and the tank was connected to electrophoresis power supply (Power 300, 
Fisher Scientific Labosi, France) to provide constant current (30mA). Once the 
bromophenol blue in the sample buffer/sample mixture migrated to reach 3 to 5mm from 
the bottom of the gel, the power was switched off. The gel was removed and immersed in 
fixing solution to be silver stained.
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2.8.6.3 Preparation of sample buffer (double strength) (Smithy 1984; Boyer, 2000)
Sample buffer is used to denature protein sample and make it suitable for use with 
SDS-PAGE. It is used by mixing the sample with sample buffer in 1:1 ratio. Sample 
buffer is composed of reducing agent (p-mercaptoethanol), which breaks up disulfide 
bonds in the protein. SDS, anionic detergent that disrupts the secondary, tertiary, and 
quaternary structure of the protein to produce linear polypeptide chains. These chains are 
coated with negative charged SDS molecules. Bromophenol blue a dye that helps in 
tracking the migration of the sample during electrophoresis. Glycerol, since it has higher 
density than water, it makes the sample settles down the well during sample application 
rather than being mixed with tank buffer. Sample buffer was prepared according to 
Laemmli's method (1970) as follows:
Bromophenol blue (2mg), p-mercaptoethanol (2mL), glycerol (4.0g), SDS (0.92g), trizma 
base (4.0g), water added up to lOmL. pH adjusted to 6.8 by 5M HC1 then volume 
completed to 20mL by water.
2.8.7 Protocol for preparing and running Two-dimensional polyacrylamide gel 
electrophoresis (2D-PAGE).
2.8.7.1 Preparation of lysis / rehydration buffer (Anon, 2004)
The solution in which the sample will be dissolved before isoelectric focusing 
(IEF), should ensure complete solubilization and disaggregation of the proteins. 
Therefore, the solution should contain certain components in order to achieve well 
focused IEF seperation. Sample solutions such as Lysis buffer and rehydration buffer 
usually contain urea and detergents. Urea is used as denaturant. It solubilizes and unfolds 
protein to expose it to the solution. A non-ionic detergent (such as 3-[(3- 
cholamidopropyl)-dimethyl-ammonio]-l-propane sulfonate (CHAPS)) is also used to
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ensure complete sample solubilization and to prevent hydrophobic interactions leading to 
aggregation. In order to reduce disulfide bonds and maintain the proteins in their reduced 
state, a reducing agent (dithiothreitol) is added. IPG buffer (GE health care, Sweden) can 
be added to improve protein solubility by decreasing charge-charge interactions and to 
ensure even charge distribution all through the pH gradient during first dimension 
analysis.
Since the composition of rehydration buffer is very similar to lysis buffer, one 
buffer was prepared, distributed in small Eppendorf tubes and stored at -20°C, until 
needed. Before use, the buffer was molten by leaving it at room temperature or by 
holding the tube by hand (because at temperatures above 37°C, the risk of protein 
carbamylation due to urea decomposition increases). After melting the buffer, some 
additives were added according to the buffer specific use (lysis or rehydration) as 
described below. The buffer was prepared by dissolving urea (19.2g) in distilled water up 
to 35mL, then CHAPS (1.6g) and 800jiL IPG buffer (GE Healthcare, Sweden) were 
added and dissolved. The volume was completed to 40mL by distilled water.
Before using this buffer as lysis buffer, protease inhibitors (PMSF and TLCK) 
were added to achieve a final concentration of ImM and 0.5mM respectively. Before 
using the buffer as rehydration buffer, bromophenol blue 1% w/v solution was added 
(20]iL per lmL lysis buffer) and dithiothreitol (DTT) was added to give a final 
concentration of 0.28% w/v.
2.8.7.2 Preparation of agarose sealing solution
In a 250mL Erlenmeyer flask, agarose (0.5g ) and 200pL of bromophenol blue 
(0.002% w/v) were added to lOOmL of tank buffer. The flask was placed on heating 
stirrer and the contents were heated until agarose was completely dissolved. The solution
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was not allowed to boil. The contents were distributed in 2mL aliquots into screw cap 
tubes and stored at room temperature until needed (Anon, 2004).
Before use, the agarose tube was heated to melt the gel, then it was cooled to 
about 50°C before application on IPG strip on the top of the polyacrylamide gel.
2.8.7.3 Rehydrating the Immobiline pH gradient (IPG) strip (Anon, 2004)
Aliquot (125pL) of sample solution in rehydration buffer were pipetted into the 
slot of IPG re-swelling tray. The backing of IPG strip (Immobiline dry strip pH 3-10NL, 
7cm, GE Healthcare) was peeled off and the strip was placed over the solution, with the 
gel side facing the solution, carefully so as not to trap air bubbles. The strip was overlaid 
with mineral oil (DryStrip Cover fluid, Amersham Biosciences) to minimise evaporation 
and urea crystallization. The tray was covered and the IPG strip was left to rehydrate at 
room temperature for 12 to 20 hours.
2.8.7.4 Running the first dimension (isoelectric focusing)
The rehydrated IPG strip was washed briefly with water and laid in a groove of 
the Immobiline DryStrip tray with the gel layer upward and the positive side toward the 
anode of the tank. The tray was previously prepared according to manufacturer’s 
instructions and positioned on the Immobiline DryStrip Tank (Multiphor n, Amersham 
Biosciences). The tank was connected to thermostatic circulator (LKB Bromma, model 
2219 Multitemp II, Sweden) to maintain the temperature at 20°C since heat will be 
generated from high voltage. Two damped isoelectric focusing electrode strips (IEF 
electrode strips, GE Healthcare) were placed just contacting each end of the IPG strip. 
Then, the suitable electrodes (anode and cathode) were positioned over the IEF strips. 
DryStrip Cover fluid (Amersham Biosciences) was poured in the tray to cover the strip.
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The tank was connected to electrophoresis power supply (Model EPS-3501XL, 
Amersham Biosciences) to provide gradient voltage program at 1mA current divided into 
three phases. Phase one for lmin, voltage from zero to 200 volt, phase two for 90min, 
voltage from 200 to 3500 volt and the third phase for 55min at 3500 volt.
2.8.7.5 Preparation and running the second dimension
Protogel lOmL (30% w/v acrylamide, 0.8% bisacrylamide stock solution 
(37.5:1)), separating gel buffer 7.5mL (lg, SDS and 45g, Tris buffer (2-amino-2- 
(hydroxymethyl)-propane-l,3-diol) dissolved in 200mL distilled water, pH was adjusted 
to 8.8 with HC1 and volume made up to 250mL with distilled water), and 12mL distilled 
water were mixed together and degassed using vacuum. Ammonium persulfate solution 
45|xL (lg, ammonium persulfate dissolved in lOmL distilled water) was added, mixed 
gently and followed by TEMED (N,N,N',N', tetramethylethylene diamine), 15pL to 
initiate polymerisation. The mixture was mixed gently and immediately poured into a 
previously prepared 1.0mm gel cast (Mini PROTEAN 3 system, Bio-Rad). Distilled 
water was overlaid on the top of the gel to produce a flat top of the gel and to remove air 
bubbles. The gel was left to set at room temperature for at least one hour. The water on 
the surface of the gel was decanted and the top of gel rinsed with water. The rehydrated 
IPG strip was inserted between the glass plates to rest on the top of the gel, after it had 
been washed with tank buffer (glycine (14.4g), Tris buffer (3.0g) and SDS (l.Og), 
distilled water added to 1L, pH about 8.3 without adjustment) for 15min with shaking. 
Warm liquid agarose sealing solution was pipetted over the IPG strip to form a sealing 
layer. The gel was transferred to mini PROTEAN 3 system (Bio-Rad) and the tank was 
filled with tank buffer so that the buffer covers the agarose layer. The tank was connected 
to an electrophoresis power supply (Power 300, Fisher Scientific Labosi, France) to
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provide constant current (30 mA). Once the bromophenol blue front migrated to reach 3 
to 5mm from the bottom of the gel, the power was switched off. The gel was removed 
and immersed in fixing solution to be silver stained.
2.8.7.6 Preparing and running 2D-PAGE markers
Markers for two dimensional electrophoresis (Sigma) (isoelectric point range (pi) 
7.6-3.8; molecular weight range (Mr) 17000 to 89000 Da) (Table 2.1) were analysed by 
2D-PAGE. According to supplier instructions, the marker was diluted 1/10 using 
rehydration buffer. IOjllL  of the diluted marker were mixed with 115pL of rehydration 
buffer. The mixture (125pL) was used to rehydrate Immobiline dry strip for 20hrs. IPG 
strips used covered the range of pH values from 3.5 to 10 (nonlinear range). After running 
the first dimension, the strip was washed with tank buffer and laid on top of 1mm 
previously prepared gel, sealed by agarose sealing solution and the second dimension was 
run. The gel was silver stained.
T ab le  2.1: com position  o f tw o  d im en s io n a l e le c tro p h o res is  m a rk e rs  
(S igm a).
P ro te in A p p ro x im a te
p i
A p p ro x im a te  M r 
(D a)
Amyloglucosidase from (Aspergillus 
niger) 3.8 89000; 70000
Ovalbumin 5.1 45000
Carbonic anhydrase from human 
erythrocytes 7.0 29000
Myoglobin from horse heart 7.6 17000
After staining the gels, retardation factor Rf was calculated for each protein spot 
in both dimensions (Table 2.2) according to the equation
R f = D istan ce  tra v e lle d  b y  th e  p ro te in  /  D is tance  tra v e lle d  b y  th e  d y e  f r o n t
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Then, two graphs were plotted. For the first dimension (pi dimension), Rf versus pi was 
plotted (Figure 2.7). For the second dimension (Mr dimension), Rf was plotted versus 
molecular weight (Figure 2.8). These calibration plots were used to estimate (pi) and (Mr) 
of all proteins analysed by 2D-PAGE through this study.
T a b le  2.2: M e a su re m e n t d a ta  o f  tw o  d im en sio n a l e le c ro p h o re s is  p ro te in  
m a rk e rs , in d ic a tin g  ca lc u la te d  re ta rd a t io n  fa c to r  (R f) o f  iso e lec tric  p o in t  (p i)  
d im en sio n  a n d  c a lcu la ted  R f  o f m o le c u la r  w eig h t (M r) d im en sio n .
p i R f  o f  1st d im en sio n M r (kD a) R f  o f  2 nd d im e n s io n
3.8 0.87 89,000; 70,000 0.18; 0.30
5.1 0.73 45,000 0.52
7.0 0.4 29,000 0.69
7.6 0.32 17,000 1
F ig u re  2.7: 2D -PA G E  m a rk e rs  (S igm a). R f  v e rsu s  iso e lec tric  p o in t (p i) . D a ta  p o in ts  
e x tra p o la te d  w ere  connec ted  w ith  d isco n tin u o u s  line. D a ta  o b ta in e d  f ro m  ta b le  2 .2 .
5 4
1.2
10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90
Mr (kDa)
F ig u re  2.8: 2D -P A G E  m a rk e rs  (S igm a). R f  v e rsu s  m o le c u la r  w e ig h t (M r). D a ta  
o b ta in e d  fro m  ta b le  2.2.
2.8.8 P re p a ra t io n  o f  so lu tions  a n d  p ro c e d u re  fo r  s ilv e r s ta in in g
The following solutions were prepared for silver staining and were used according 
to the sequence below (Walker, 1984):
Fixing solution: (methanol, lOOmL; glacial acetic acid, 24mL; 37% formaldehyde, 
lOOpL; the volume was completed to 200mL with distilled water).
Wash A: 50% v/v ethanol.
Pre-treatment solution: (0.04g sodium thiosulfate pentahydrate in 200mL distilled water). 
Impregnate solution: (0.4g silver nitrate (anhydrous), 37% formaldehyde, 150pL and 
distilled water up to 200mL).
Developing solution: (12g of sodium carbonate (anhydrous); 37% formaldehyde, 100jiL, 
4mL of pre-treatment solution and the volume was made up to 200mL with distilled 
water).
Stop solution: (100mL methanol, 24mL glacial acetic acid and distilled water up to 
200mL). After immersing the gel in fixing solution for 1 to 16 hours, the solution was
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decanted and wash A was added to the gel for 20min with shaking. This step was 
repeated another two times. Wash A was replaced by pre-treatment solution for one 
minute with shaking, then the solution was decanted and the gel was washed with 
distilled water three times each time for 20 seconds with shaking. Water was decanted 
and impregnate solution was added to the gel for 20 min and then washed twice with 
distilled water each time for 20 seconds. Then the gel was transferred to developing 
solution until the bands or spots were clearly visible. Immediately the gel was washed 
with distilled water for 20 seconds and was transferred to stop solution for ten minutes to 
stop staining reaction. The gel can be stored in distilled water at 4°C.
2.8.9 C heck ing  th e  p o ssib ility  o f  in te rfe re n c e  fro m  b r a in  h e a r t  in fu s io n  in  SD S- 
P A G E .
Since BHI is a complex medium that has high concentration of proteins, the 
possibility of having interference with SDS-PAGE analysis was checked. BHI medium 
was prepared as described previously from two different bottles. An aliquot (IOOjiL) of 
the prepared medium was mixed with equal volume of sample buffer and heated for 5 
minutes at 90°C. Samples (25pL aliquots) were applied on previously prepared gels. 
After running the gels under constant current (30 mA), they were silver stained. Figure
2.9 shows SDS-PAGE analysis of BHI. No protein bands appeared in the region of 10 to 
150kDa.
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Figure 2.9: SDS-PAGE analysis of two BHI media. Lanes (1) and (2), BHI media 
from two different bottles; lane (3), SDS-PAGE marker and lane (4), TSST-1 
standard (Sigma).
2.9 Virulence factors of S. a u reu s  11962
2.9.1 Determining coagulase titre
Rabbit plasma (lyophilised and citrated) (Sigma) was reconstituted in sterile 
distilled water according to manufacturer instructions and a solution of 20% v/v was 
prepared.
BHI (80pL) was added to each well of 96-well round bottom microtiter plates, leaving the 
first row of wells empty. Eluate supernatants (80pL) were placed in triplicate in the first 
row and the second row of 96-well round bottom microtiter plates and the contents were 
mixed. Double serial dilutions of eluate supernatants were done in BHI in the range of 2 
to 1.3xl05 starting from the second row to the next row by transferring 80pL and mixing. 
Equal volumes of rabbit plasma were added and mixed with eluate supernatants in the 
wells. Negative control was prepared by mixing brain heart infusion medium with the
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plasma. The plates were covered and incubated at 37°C. After 4 hours, the plates were 
inspected visually against a black background for coagulation.
2.9.2 B iofilm  assay  in  m ic ro tite r  p la te
2.9.2.1 Preparation of Gram stain Hucker’s modification
Crystal violet (2g) was dissolved in 96% ethanol to make 20.0mL. The solution was 
added to 80.0mL of ammonium oxalate solution (1% w/v).
2.9.2.2 Biofilm assay
The method used by Stepanovic et al., (2000) was applied. Stock solutions of 
antibiotics were prepared in BHI. The concentration of these stocks were adjusted so that 
when 90 pL aliquots were mixed with 20 pL bacterial suspension the final concentration 
of antibiotics would be equivalent to 90% of MIC.
Aliqouts (90pL) of antibiotics solutions in BHI were placed in triplicate in sterile 
96-well round bottom microtiter plates. Double serial dilutions were performed to cover 
the range from 90% MIC to 0.35% MIC of the final concentration. Aliquots (90pL) of 
BHI were placed in other wells as controls. Aliquots (20pL) of bacterial culture in mid 
exponential phase (adjusted to 0.5 McFarland absorbance) were added to all the wells 
including the control wells. The plates were covered and incubated for 24hr at 37°C. The 
contents of the wells were aspirated and the wells were washed with 150pL sterile normal 
saline (0.9% w/v) with vigorous shaking. The contents were aspirated and each well was 
washed three times more with 150pL sterile normal saline. In order to fix the remaining 
attached bacteria, 90pL of methanol (99%) was added to the wells and left for 15 
minutes, then removed by decanting. After the wells dried, Hucker’s crystal violet 
(71 pL) was added to each well and left for 5 minutes then discarded. Excess stain was
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rinsed off by washing the plate with plenty of running water until water is colourless and 
then the plate was left to air dry. In order to solubilize the dye bound to biofilms, 160 jiL 
of glacial acetic acid 33% v/v was added to the wells and the plate was placed in ELISA 
reader (Rosys anthos ht IH, Anthos Labtec Instruments, Salzburg, Austria) to measure the 
absorbance at 562nm after shaking the plate at medium speed for 30 seconds.
2.9.3 P ro tea se  te s t
2.9.3.1 Zymography
Zymography is an electrophoretic technique to detect for proteolytic activity in 
polyacrylamide gels. Sample buffer (5x strength) consisting of 0.4M Tris base, SDS (5% 
w/v), glycerol (20% w/w) and bromophenol blue (0.03% w/v), final pH 6.8 adjusted by 
5M HC1, was prepared to dilute the samples (Kleiner and Stetler-Stevenson, 1994). 
Separating gel containing 0.5mg mL'1 casein was prepared by dissolving 14.8mg casein 
in 12mL of distilled water and 7.5mL of separating gel buffer. Protogel (lOmL) was 
added and the solution was mixed together and degassed using vacuum. Ammonium 
persulfate (45pL) was added to the mixture, mixed gently and followed by 15 pL of 
TEMED (N,N,N',N'» tetramethylethylene diamine) to start polymerisation. The mixture 
was mixed gently and immediately poured into a previously prepared 0.75mm gel cast 
(Mini PROTEAN 3 system, Bio-Rad, Hercules, CA, USA). Distilled water was overlaid 
on the top of the gel to produce a flat top of the gel and to remove air bubbles. The gel 
was left to set at room temperature. Stacking gel was prepared as described in Section
2.8.6.2 and poured on top of the separating gel. Tank buffer was prepared as described in 
Section 2.8.6.2. When stacking gel has polymerised, samples were applied to the gel and 
constant current (35 mA) applied. Once the dye front migrated to the bottom of the gel, 
the gel was removed and incubated for 1 hour at room temperature with shaking in
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detergent solution (composed of 2.5% v/v Triton X-100; Kleiner and Stetler-Stevenson, 
1994; Leber and Balkwill, 1997). The Triton X-100 solution was decanted and the gel 
was washed twice in enzyme buffer (50mM Tris, pH7.6, 200mM NaCl, 5mM CaC12, 
0.25% v/v Triton X-100; King et al., 1996), then incubated in the same buffer for 18hr at 
37°C. After brief rinsing in distilled water, the gel was stained in Coomassie briliant blue 
R-250 stain (0.2g coomassie briliant blue, 125mL methanol, 25mL glacial acetic acid and 
lOOmL distilled water) for 4 hours at room temperature with gentle shaking. Destaining 
was performed by several changes of destain solution (450mL methanol, lOOmL glacial 
acrtic acid and 450mL distilled water) on the gel until colourless areas of substrate 
degradation appeared.
2.9.3.2 Azocasein assay
The method used by Miedzobrodzki et al., (2002) was used with slight 
modification. An aliquot (50pL) of the sample was added to 750pL incubation mixture 
(0.1M tris-HCl buffer, pH 7.8, 450pl and 300pL of 1.5% w/v azocasein in water) in an 
Eppendorf tube. The contents were vortexed and incubated for three hours at 37°C. The 
enzymatic reaction was stopped by adding 800pL of 6% w/v trichloroacetic acid and 
mixing. The precipitated unreacted protein was removed by centrifugation for 20 minutes 
at 13000 rpm (Genfuge 24D, Progen, Mexborough, UK). The absorbance of the released 
acid-soluble azo-peptide was measured at 365nm in quartz cuvette.
2.9.4 A ssay ing  T S ST -1  in  e lu a te  s u p e rn a ta n t
2.9.4.1 Determining the titre of TSST-1 in eluate supernatant
This test was performed using Toxin detection kit (TST-RPLA Staphylococcal 
Toxic Shock Toxin, Oxoid, UK) according to manufacturer's instructions. RPLA diluent
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(25|TL aliquots) were added into the wells of 96-well V-shaped bottom microtiter plate 
leaving the first row wells empty. Eluate supernatants of each treatment were added in 
25jxL aliquots, in triplicate, into the first and second row and mixed. Double dilution was 
performed by transferring 25pL from the second row wells to the next one with mixing. 
This was repeated until serial dilutions in the range (5x1 O'1 to 1.5x1 O'5) were achieved. 
To these wells, 25 jiL of latex suspension sensitised with specific rabbit IgG antibody 
against staphylococcal TSST-1 was added. Two negative controls were prepared; the first 
one by mixing equal volumes (25jiL) of latex suspension sensitised by non-immune 
rabbit serum with all samples' dilutions, and the second one by mixing equal volumes 
(25 JiL) of latex suspension sensitised with specific rabbit IgG antibody against 
staphylococcal TSST-1 with RPLA diluent. On the other hand, purified TSST-1 provided 
by the kit served as positive control.
The plates were mixed, covered with lids and incubated for 24hr at room 
temperature on a vibration free surface. After incubation, the plates were visualised 
against black background for agglutination and results were interpreted according to 
manufacturer’s criteria. The highest dilution of supernatant showing agglutination was 
considered the titre.
2.10 Protocols for toxin purification.
In this project, Toxic Shock Syndrome Toxin 1 (TSST-1) purification from eluate 
supernatant was done using column chromatography techniques; ion exchange and gel 
chromatography in addition to other steps for desalting and concentrating the protein. The 
following buffer solutions were required for purification steps and prepared in ultra pure 
water (18 Q cm'1).
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5m M  so d iu m  p h o sp h a te  b u ffe r  p H  5.6: 0.6545g NafbPC^.^O, 0.069g Na2HP0 4 .7H20  
and water added up to 1L.
0 .5M  so d iu m  p h o sp h a te  b u ffe r  w ith  0 .5M  N aC l p H  6.2 : 38.99g Na^PCU- H2O; 
58.28g Na2HP04.7H20; 29.22 g NaCl; water added to less than 1L, pH adjusted with 1M 
NaOH (if necessary) and volume completed to 1L with water.
5 m M  so d iu m  p h o sp h a te  b u ffe r  p H  6.0: 0.605g NaH2P04.H20; 0.165 g
Na2HP04.7H20 and water added up to 1L.
0.03M  so d iu m  p h o sp h a te  b u ffe r  p H  6.0: 3.63g NaH2P04.H20; 0.988g Na2HP04.7H20; 
water added to less than 1L, pH adjusted with 1M NaOH (if necessary) and volume 
completed to 1L with water.
0.045M  so d iu m  p h o s p h a te  b u ffe r  p H  6.4: 4.564 g NaH2P04.H20; 3.20g 
Na2HP04.7H20 and water added to less than 1L, pH adjusted with 1M NaOH (if 
necessary) and volume completed to 1L with water.
0.05M  so d iu m  p h o sp h a te  b u ffe r  p H  6.8 c o n ta in in g  1M  N aC l: 3.52g NaH2P04.H20; 
6.566g Na2HP04.7H20; 58.44g NaCl; 900mL water added, pH adjusted to 6.8 by 5M 
NaOH and volume completed to 1L with water.
5m M  so d iu m  p h o sp h a te  b u ffe r  p H  6.8: 0.37lg NaH2P04.H20; 0.62g Na2HP04.7H20 
and water added up to 1L.
2.10.1 P re p a ra tio n  o f  A m b e rlite  C G -50  ion  ex ch a n g e r
Amberlite CG50 (Sigma) is a weakly acidic cationic exchanger. Its matrix is 
composed of 4% cross linked methacrylate with carboxylic acid functional group. A 
quantity equal to 210mL wet resin was washed with 0.01M NaOH followed by washing 
with 0.01M HC1. The resin was then washed several times and equilibrated with 5mM 
sodium phosphate buffer pH 5.6.
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2.10.2 P re p a ra tio n  o f  ion  exchange  co lu m n  C M -S ep h aro se  C L  6B
CM-Sepharose CL 6B (Sigma) is a cationic exchanger. It is composed of carboxy 
methyl functional groups attached to cross linked agarose gel Sepharose CL-6B. CM- 
Sepharose CL 6B is supplied pre-swollen in 20% ethanol. A sufficient quantity was 
poured in a beaker and equilibrated to room temperature. The solvent was decanted and 
replaced with 5mM sodium phosphate buffer pH 5.6 (previously filtered through 0.45pm 
membrane filter) to form 75% settled medium to 25% buffer. The slurry was degassed 
under vacuum. The ion exchanger mixture was mixed by swirling the beaker and poured 
slowly in XK column 26/40 (GE Healthcare) already mounted vertically and contained 
few millilitres of the buffer. The ion exchanger was left to settle down, excess buffer was 
removed by aspiration and additional ion exchanger-buffer mixture was poured slowly. 
The process was repeated until a column bed height of 38 to 40cm settled ion exchanger 
is reached. Then, the 5mM sodium phosphate buffer pH 5.6 was pumped at a flow rate of 
120mL hr'1 from a reservoir to the top of the column using a pump (Pharmacia, model P- 
500, Sweden). The column was allowed to condition with buffer until the conductivity 
and pH of the buffer from the column outlet equals that of the fresh buffer (after 
approximately two days).
2.10.3 P re p a ra tio n  o f G el f i l tra tio n  co lu m n  S e p h a c ry l S200 H R
Sephacryl S200 HR (Sigma) is a hydrophilic matrix composed of cross linked 
allyl dextran with N,N'-methylene bisacrylamide. It is supplied pre-swollen in 20% 
ethanol. A sufficient quantity equivalent to 115% of the required bed volume was poured 
in a beaker and equilibrated to room temperature. The solvent was decanted and the gel 
was washed twice with degassed and filtered (0.45pm) water. Then the gel was 
suspended in water to form 75% settled medium to 25% water. The slurry was degassed
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under vacuum. A packing reservoir was attached to a column XK 26/100 (GE Healthcare) 
and mounted vertically. The whole amount of gel mixture was mixed by swirling the 
beaker and poured slowly in the column, which already contained few millilitres of water. 
Water was pumped from solvent reservoir to the top of the packing reservoir at flow rate 
180mL hr'1 for two hours, and then the flow rate was increased to 320mL hr'1 for one 
hour. Excess water was removed from the top of the gel bed and the column adapter was 
connected. The column was then washed by delivering ten column volumes of 0.05M 
sodium phosphate buffer pH 6.8 containing 1M NaCl at FR 60mL hr'1.
2.11 Statistical analysis
All tests were performed in triplicate and the average result was recorded. 
Standard deviation of the data points from the mean was calculated.
Where stated, one way analysis of variance (ANOVA) was performed for multiple 
comparisons followed by Tukey multiple intergroup comparison. P values <0.05 were 
considered significant. Normality of results was tested using Anderson-Darling test (p 
>0.05). Equal variance was tested using Bartlett's test (p >0.05). All calculations were 
carried out using Minitab 15 software.
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Chapter 3
Development of suitable biofilm growth regimes and initial 
antibiotic sensitivity testing for S taphylococcu s a u reu s  and 
S taphylococcu s ep iderm idis
3.1 Introduction
Staphylococci are natural colonizers in animals and humans. The number of 
infections caused by them is minor when compared to their widespread nature. S. aureus 
preferentially colonizes the anterior nares and is also isolated from healthy skin and throat 
(Kluytmans et al., 1997; Casey et al., 2007). S. epidermidis mainly colonizes the skin and 
is considered one of the predominant human skin flora (Casey et al, 2007). Staphylococci 
are chemoheterotrophs that require organic carbon as their source of energy. Nutritional 
requirements of staphylococci are generally complex and depend on the strain (Keller et 
al, 1978; Onoue and Mori, 1997). Several investigators had shown that the components 
and their concentrations in a culture medium have great impact on the growth and 
virulence of Staphylococcus aureus (enterotoxin and capsule polysaccharide production) 
(Bhaduri, 1983; Stringfellow et al., 1991; Onoue and Mori, 1997).
In general, synthetic chemically defined media are preferred to complex media 
because chemically defined media guarantee reproducibility in composition, support 
growth at suitable rates and avoid unnecessary excess nutrients, which in turn reduces or 
avoids unwanted interactions that may occur with other materials added (Foucaud et al., 
1997).
The objective of this section is to find a suitable medium that supports the growth 
of S. aureus and S. epidermidis in planktonic and biofilm mode, for use in subsequent 
experiments. Initially, the suitability of a chemically defined medium CDM (Dinning,
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1995; Al-Hmoud, 2002; Masadeh, 2005; described in Chapter 2) to support the growth of 
S. aureus ATCC 6538 and S. epidermidis ATCC 12228 was investigated. This medium 
includes an organic source of carbon (glycerol) and a source of nitrogen (ammonium 
chloride and ferric ammonium citrate). It also has chloride, calcium, potassium, 
magnesium and iron sources.
3.2 Assessing Bacterial growth
Several methods have been used to measure bacterial growth (Fuchs and Kroger,
1999) . The most widely used ones are the viable count and turbidimetric methods. Viable 
count is used to estimate the viable population in a bacterial culture. In this method, a 
bacterial suspension is serially diluted and plated onto solid medium in order to determine 
the number of colonies after each incubation period. Each colony is assumed to arise from 
individual bacterial cell. Therefore, by counting the number of colonies and knowing the 
dilution factor, colony forming units (CFU) can be determined (Salvesen and Vadstein,
2000) .
Bacterial cell size lies within the order of wavelength of visible light. Therefore, it 
has been shown that measuring the amount of visible light scattered or absorbed by 
bacterial cells can be used to estimate bacterial concentration (Fuchs and Kroger, 1999). 
At low cell densities, the optical density (absorbency) is proportional to bacterial 
concentration. Since secondary light scattering increases as particles concentration 
increases, it is necessary to dilute bacterial suspensions with optical densities above 0.5 
(Lawrence and Maier, 1977).
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3.3 Experimental approach
3.3.1 Preparation of inoculum culture
A sterile lOOmL Erlenmeyer flask containing 25mL of sterile medium was 
inoculated with pure culture of the bacteria to be studied. The flask was incubated in a 
shaking incubator at 150 osc min'1 (Infors Ecotron AG CH-4103, Belgium) at 37°C 
overnight.
3.3.2 The test culture
Sterile lOOmL Erlenmeyer flasks containing 25mL of fresh medium were 
inoculated with 250pL of inoculum culture. The flasks were incubated in shaking 
incubator 150 osc min'1 at 37°C. Two test cultures were prepared; one for viable count 
test the other for turbidimetric assay.
3.3.3 Viable count
At hourly intervals, an aliquot (lOOpL) of test culture was removed and serially 
diluted in normal saline (0.9% w/v) in the range of 10'2 to 10'8. Aliquots (O.lmL) of the 
dilutions were spread plated onto tryptone soya agar plates (pre-dried at 60°C for 
5minutes). The plates were prepared in triplicate for each dilution. After 48hr incubation 
at 37°C, colonies were counted in each plate and viable count was calculated by the 
following equation:
CFU mL'1 = N(1/DF) equation 3.1
Where N is the average number of colonies on the three plates (it should be between 30- 
300 to be statistically valid) and DF is the dilution factor (taking into account the 
dilutions and the volume used on the spread plate).
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3.3.4 Turbidimetric growth assay
An aliquot (lmL) of test culture was removed aseptically at hourly intervals. The 
optical density (OD) was measured at 470nm using spectrophotometer (Genesys 10UV 
Thermo Spectronic, USA). Fresh medium was used as a blank. After measurement, the 
sample was aseptically returned to the culture flask so as not to alter the culture volume 
significantly. If OD values were above 0.5, a minimal volume (O.lmL) of culture was 
removed and diluted in fresh medium to bring OD below 0.5 (Lawrence and Maier, 
1977). The diluted cultures were discarded after measuring their OD. The optical density 
of the diluted samples was calculated by multiplying OD by the reciprocal of the dilution 
factor.
3.3.5 Modification of chemically modified medium (CDM)
CDM was prepared and sterilized as mentioned in Chapter 2. Several 
modifications were performed on this medium. Whenever glucose was added, it was 
sterilized separately by autoclaving at 121°C, 15psi for 15 minutes. All amino acids used 
were of HC1 salt except Glycine. Stock solutions of aminoacids were prepared by 
dissolving specific amount in lOmL water (Table 3.1) and then sterilized by autoclaving. 
For media preparation, 0.5mL of amino acid stock solution was aseptically added to 
24.5mL of sterile CDM.
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Table 3.1 : Weight of amino acids dissolved 
in lOmL water to prepare different 
formulations of CDM media.
Amino acids Weight (mg)
L-Valine (Val) 40
L-Arginine (Arg) 250
L-Cystine (Cys) 15
L-Aspartic acid (Asp) 45
Glycine (Gly) 25
L-Leucine (Leu) 45
L-Proline (pro) 40
L-Glutamic acid (Glu) 50
L-Tryptophan (Try) 15
L-Methionine (Met) 15
L-Isoleucine (lie) 15
L-Histidine (His) 15
3.3.6 Results and discussion
Chemically defined medium (CDM) (Chapter 2) was used as a starting medium 
to study the growth of S. aureus ATCC 6538 and S. epidennidis ATCC 12228. Figures
3.1 (A) and (B), present growth curves of S. aureus and S. epidermidis in CDM assayed 
by viable count and turbidimetric methods, respectively. In this medium, the lag phase of 
both bacterial cultures (Figure 3.1C) was around two hours. The exponential phase of S. 
aureus, which lasted for 3.5 hours, was much shorter than that of S. epidermidis which 
lasted for 15 hours. As a result of the shorter exponential phase, S. aureus entered the 
stationary phase much earlier than S. epidermidis (5hrs and 17hrs after inoculation, 
respectively). Bacterial growth yield, which reflects dry cell mass per unit volume, is 
defined as the final optical density (OD) minus the initial OD measured immediately after 
inoculation (Stringfellow et al., 1991). Bacterial growth yield of S. epidermidis (OD47onm
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1.6) was much higher than that of S. aureus (OD47onm 0.4). The generation time or 
doubling time for S. epidermidis (200 minutes) was about 20% greater than that of S. 
aureus (165 minutes). The same growth pattern of S. aureus ATCC 6538 was noticed in 
other strains of bacteria; S. aureus ATCC 27659 and NCTC 11962.
In order to improve the growth of S. aureus, many modifications to the CDM were 
investigated and for each modification, growth yield and / or growth curve was 
constructed and compared with the original one. Only one modification was done at a 
time maintaining the other parameters constant.
The initial steps performed were to change the composition of the medium. 
Doubling or tripling nitrogen content by increasing the amount of ammonium chloride in 
the medium did not improve growth yield. The same was noticed with magnesium and 
with carbon source (glycerol). Replacing the glycerol with glucose had no noticeable 
effect on the growth. Increasing the content of iron or changing its source by replacing 
ferric ammonium citrate with ferric chloride had no effect. Even when all sources of 
carbon, nitrogen, magnesium and iron were doubled or tripled growth yield remained the 
same. These results indicate that the components of this medium cannot support the 
growth of S. aureus and other nutritional sources should be tested.
Specific amino acids were shown to enhance the growth of S. aureus in different 
chemically defined media depending on the strain and media composition (Mah et al., 
1967; Keller et al., 1978; Bhaduri, 1983). L-valine, L-arginine and L-cystine were found 
to be necessary for the growth of several S. aureus strains (Onoue and Mori, 1997). In 
order to determine aminoacid requirements, a series of CDM starting with these three 
aminoacids were prepared (Table 3.2). Each medium differed from the previous by 
addition of new aminoacid. Aminoacids investigated in this study were selected from 
previously published work (Mah et al., 1967; Keller et al., 1978; Bhaduri, 1983;
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Stringfellow et cil., 1991) and the concentrations prepared were the same concentrations 
used by Onoue and Mori (1997), except that aminoacid concentrations were adjusted so 
that no final concentration was below 30pg mL'1 (Keller et ah, 1978; Bhaduri, 1983) 
(Table 3.1). For reasons of simplicity, bacterial growth yield at OD 470nm was used to 
compare the results of different media formulations (Table 3.2).
In order to simplify the formulation of the medium, the CDM with lowest number 
of components giving highest OD was chosen for further work. Thus, the CDM with 7 
aminoacid added (formula 5) was selected (referred to as CDM-7 throughout). Figure 3.2 
shows comparison between growth curves of S. aureus ATCC 6538 in CDM and in 
CDM-7. Addition of amino acids increased the duration of exponential phase from 3.5 
hours to 5 hours and the generation time was reduced from 165 minutes to 63 minutes. 
This was reflected in bacterial growth yield, which was improved from less than OD 0.5 
to about OD 2.0. Other strains of S. aureus (ATCC 27659 and NCTC 11962) were tested 
using this medium and gave similar results.
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Figure 3.1: S. a u r e u s  ATCC 6538 and S. epidermidis  ATCC 12228 growth curves in 
CDM. (A) mean viable count vs time. Non-logarithmic Y-axis gives non-linear 
details at values below 1.00E+08. (B) OD at 470nm vs time and (C) OD at 470nm vs 
time in log scale. Error bars indicate ± standard deviation of individual points, 
where n=3.
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Table 3.2: Different formulations of aminoacids were prepared; each one differs 
from the previous by addition of one new aminoacid to the basic CDM. Growth 
yield at 470nm was measured and used to compare between the formulations. 
(For concentrations and abbreviation of aminoacids see table 3.1).
Formula
number Medium
Growth
yield
OD 470nm
1 Val, Arg, Cys 0.601
2 Val, Arg, Cys, Asp 0.613
3 Val, Arg, Cys, Asp, Gly 0.615
4 Val, Arg, Cys, Asp, Gly, Leu 0.588
5 Val, Arg, Cys, Asp, Gly, Leu, Pro 1.965
6 Val, Arg, Cys, Asp, Gly, Leu, Pro, Glu 1.896
7 Val, Arg, Cys, Asp, Gly, Leu, Pro, Glu, Try 1.914
8 Val, Arg, Cys, Asp, Gly, Leu, Pro, Glu, Try, Met 1.968
9 Val, Arg, Cys, Asp, Gly, Leu, Pro, Glu, Try, Met, lie 1.888
10 Val, Arg, Cys, Asp, Gly, Leu, Pro, Glu, Try, Met, He, Hist 1.921
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Figure 3.2: Staphylococcus a u r e u s  ATCC 6538 growth curve in CDM and CDM-7 
medium. Optical density at 470nm vs time. (A) linear scale, (B) log scale. Error bars 
indicate mean ± standard deviation of individual data points, n=3.
This work and the work of others (Mah et al, 1967; Keller et ah, 1978; Bhaduri, 
1983; Onoue and Mori, 1997) indicates that in order to support the growth of S. aureus in 
chemically defined medium, other sources of nutrients are required in addition to the 
compound sources of carbon, nitrogen, iron, magnesium and other ion sources normally 
supplied. It has been found that addition of seven aminoacids (L-valine, L- argenine,
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L-cystine, L-aspartic acid, glycine, L-leucine, L-proline) to the normal CDM formula was 
necessary to support the growth of S. aureus ATCC 6538, ATCC 27659 and NCTC 
11962. On the other hand, CDM alone has been found to be sufficient to support S. 
epidennidis growth. Addition of the seven aminoacids has no effect on growth dynamics 
of S. epidennidis (data not shown). After formulating suitable medium for each 
bacterium, these media will be used to grow the bacteria in biofilm systems to be 
subjected to subsequent studies.
3.4 Molecular basis of biofilm development
Biofilm formation involves transformation of free flowing planktonic cells into a 
sessile population attached to a surface. This surface (substratum) is normally coated with 
a conditioning film resulting from the interaction of a surface with the medium (Dunne, 
2002). Conditioning films are organic in nature and form within minutes after exposure to 
an overlying solution containing biological and biochemical components (Donlan, 2002). 
Their composition is variable depending on the surrounding environment. Biofilm 
formation passes through several stages that involve physico-chemical and biological 
interactions. These stages are discussed in the following sections. 1
1) Primary adhesion
The initial step in biofilm formation is the adherence of microbial cells to a 
surface. Microorganisms freely flowing in the bulk fluid could be brought into close 
proximity to a body or surface either randomly (for example by Brownian motion, 
convection by a stream or turbulence of fluid flowing over surface), or in a directed 
fashion by the chemotactic ability of the microorganisms and subsequent mobility 
(Donlan, 2002). When a microorganism reaches a distance of about 50nm from a
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surface, electromagnetic forces initiate adhesion via long and short range forces 
(Gorman and Jones, 2006). Microorganisms can be regarded as living colloidal 
particles, hence, Derjaguin-Landau-Verwey-Overbeek (DLVO) hypothesis, which 
describes electromagnetic forces that attract and repulse colloidal particles, may be 
applied to them (Gorman and Jones, 2006).
According to this hypothesis, the net interaction, Vr, between a cell and a surface 
is a balance between attractive forces, Va (Figure 3.3), resulting from London-type 
van der Waals attractions and repulsive interaction, V r (Figure 3.3), resulting from 
the electrostatic interaction between charged bacterial cells and the surface 
(substratum). In general, bacterial cells and substratum are negatively charged at 
physiological pH (Hermansson, 1999). According to DLVO theory, the composite 
potential energy or the net interaction, VT, of these forces will have a potential 
attraction near the origin, called the primary minimum (point of irreversible 
adhesion), and high potential barrier or repulsion (the positive maximum) at a 
moderate distance (Figure 3.3). In some cases, a shallow secondary attraction or 
minimum (reversible adhesion) is observed at longer distances of separation (Martin 
and Bustamante, 1993). Thus, when a negatively charged bacterium approaches a 
negatively charged surface, the composite potential energy is a function of separation 
and the ionic strength of the medium (Dickinson and Bisno, 1989).
For a microorganism to adhere to a surface, it has to move from a situation where 
the cell is reversibly attached in a secondary minimum, to reach the primary minimum 
(point of irreversible adhesion) and subsequently contact the substratum. This step 
requires that repulsive forces (positive maximum) should be overcome (Hermansson, 
1999). The interfacial free energy of adhesion, ionic strength of the medium and 
presence of specific bacterial mechanisms for attachment are the key players in order
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for adherence to occur (Dickinson and Bisno, 1989; Gorman and Jones, 2006). For 
adhesion between particles and surfaces to occur, the interfacial free energy of 
adhesion should be thermodynamically favourable (Strevett and Chen, 2003). In other 
words, (bacterium-surface) interaction should be thermodynamically more favourable 
than (bacterium-water) and (surface-water) interactions. Hydrophobic groups on the 
bacterial cell surface limit bacterium-water interactions thus, favouring bacterium- 
surface interactions. This effect may help explain the role of cell surface 
hydrophobicity in bacterial adhesion (Dickinson and Bisno, 1989). However, bacterial 
cell hydrophilicity or hydrophobicity depends largely on bacterial growth stage and 
the growth medium which may influence the process of attachment (Grasso et a l, 
1996; Chen and Strevett, 2002). For example, the hydrophilicity and hydrophobicity 
of Escherichia coli has been shown to be altered depending on carbon and nitrogen 
source and on the abundance of these elements (Chen and Strevett, 2002). In 
stationary phase, Pseudomonas aeruginosa was found to have more hydrophobic 
surfaces and to significantly partition more to dolomite surfaces than in the 
exponential or decay phase (Grasso et al., 1996).
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Figure 3.3: DLVO theory as applied to the adherence of microorganism to a 
substratum. Vr repulsive forces, Va attractive forces and Vj net interaction 
(adapted from Martin and Bustamante, 1993).
On the other hand, the substratum hydrophobicity reduces surface-water 
interactions, thus, favouring bacterium-surface interactions. In a study, P. aeruginosa 
and S. epidermidis adhered more to hydrophobic type contact lenses than to 
hydrophilic types (Henriques et al., 2005). The same observation was reported by 
Santos et al. (2007) where hydrophobic lenses were the highest in microbial 
colonization compared to other hydrophilic types.
Increasing ionic strength of the medium will reduce the positive maximum, 
allowing a greater proportion of microorganisms to reach primary minimum and 
adhere to the surface (Gorman and Jones, 2006). Adhesion of several strains of P. 
aeruginosa, Burkholderia cepacia, E. coli and Bacillus subtilis to inorganic surfaces 
was significantly increased when the ionic strength of the medium was increased from
78
ImM to lOOmM (Li and Logan, 2004). Adherence of many strains of S. epidermidis 
to plastic has been shown to be enhanced by the presence of calcium and magnesium 
ions (Dunne and Burd, 1992). However, addition of ethylenediaminetetraacetic acid 
(EDTA) results in a dramatic decrease in their adherence (Dunne and Burd, 1992).
The other tactic used by microorganisms to overcome the potential barrier 
(positive maximum) is not accounted for by DLVO theory. For this step, 
microorganisms use their cell surface structures or molecules to bridge the gap 
between secondary minimum (distance range 20-100nm) and primary minimum 
(lnm) by attaching to specific substratum structures (Costerton et ah, 1999; 
Hermansson, 1999; Donlan, 2002). S. aureus may use its adhesin-like compounds 
(fibronectin binding protein, clumping factor, polysaccharide intercellular adhesin, 
etc.; Dickinson and Bisno, 1989; Que et al., 2001) to attach to surfaces. Other bacteria 
use their fimbriae, pili or flagella for this purpose (O'Toole and Kolter, 1998a; 
Watnick and Kolter, 2000). P. aeruginosa mutants defective in flagellar-mediated 
motility, were found to exhibit a poor ability to attach to PVC surface when compared 
with the wild type. The wild type was able to form microcolonies that dispersed on 
the surface forming a monolayer (O'Toole and Kolter, 1998a). On the other hand, 
fimbriae have been found to increase cell surface hydrophobicity and therefore, to 
enhance bacterial adhesion to abiotic surfaces (Zita and Hermansson, 1997; 
Hermansson, 1999).
2) Microbial attachment to the surface and microcolony formation
The forces involved in the initial adhesion are reversible ones, and so far the 
microorganism is loosely bound to the surface (Costerton et al., 1999). Subsequently, 
cells may become firmly attached to the surface through the action of surface 
structures. This irreversible attachment of the microorganism to the surface is
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mediated by the adhesins of the microorganism and complementary receptors on the 
biomaterial surface (Gorman and Jones, 2006). After attaching to the surface, 
microorganisms start to multiply, adhere to each other and form microcolonies. 
Microcolonies are relatively small groups of bacteria and are considered the basic unit 
of biofilm growth (Costerton et al, 1995; Costerton et al, 1999; Watnick and Kolter, 
2000).
3) Biofilm maturation
In this stage, the complexity, heterogeneity and density of biofilms increase. 
Microorganisms bound to the surface replicate and more extracellular components are 
generated by the bacteria. In this stage, bacterial cells are encased by a polymeric 
matrix and separated from other colonies by water channels (Costerton et al, 1995). 
Exopolymeric substances interact with inorganic and organic molecules in the 
environment, such as host-derived proteins (eg: fibrinogen, fibronectin and 
complement system), which increases the heterogeneity of the biofilm (Dunne, 2002). 
The growth of any bacterial biofilm is controlled via a quorum sensing system 
(Maddula et al, 2006), which is affected by the availability of nutrients, optimum 
hydrodynamic flow, oxygen perfusion, pH, carbon source and osmolarity (O'Toole 
and Kolter, 1998b). A double mutant strain of P. aeruginosa, which could not make 
quorum sensing signals, was able to adhere and proliferate on a glass surface. When 
its biofilm was compared to the wild type biofilm, the biofilm of the mutant bacteria 
was thin and the cells packed densely with no water channels separating them. This 
indicates that quorum sensing is involved in biofilm differentiation and maturation 
rather than early attachment (Davies et al, 1998). Several strains of E. coli produced 
tall mushroom like biofilm structures with pores and channels under aerobic
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conditions, while the biofilms produced under anaerobic conditions were thinner and 
less heterogeneous (Bjergbaek et al, 2007).
4) Detachment of planktonic cells from biofilms
It is known that at a certain point, dispersal of bacterial cells from biofilms occurs 
where the released planktonic cells are free to colonize other surfaces (Costerton et 
al, 1999). This dynamic process of biofilm dispersal explains the high rate of 
metastatic infections caused by S. aureus (Fatkenheuer et al., 2002). The detached 
biomass ranges from single cells to 500pm aggregates (Stoodley et al, 2001). Two 
mechanisms are proposed for the escape of cells from biofilm (Figure 3.4). The first 
mechanism postulates a physical detachment pathway. When biofilm reaches critical 
mass, the turbulence and bulk fluid flow takes away fragments of microcolony or 
planktonic cells that are generated by the outermost layer of the biofilm (Dunne, 
2002). In addition, it has been reported that increases in turbulence in the medium 
surrounding mature biofilm beyond that present during biofilm formation, would 
result in sloughing of biofilm masses (Simoes et al, 2007). The other mechanism 
suggests the presence of programmed events leading to local breakdown of the 
biofilm and conversion of a subpopulation of sessile cells into motile ones. This 
breakdown is believed to be cell density dependent and regulated by cell-cell 
signalling (Costerton et al, 1999, Dunne, 2002). A study on Pseudomonas 
fluorescens has shown the involvement of enzymes in the detachment of cells from 
biofilm exopolymers. The same effect has been noticed after addition of quorum 
sensing molecules (Allison et al, 1998). Some researchers believe that sloughing of 
biofilm could be a result of starvation. The response of bacteria to starvation is by 
degrading exopolysaccharide for consumption and to free cells to seek a better
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environment (Watnick and Kolter, 2000). A computer model agreed with
experimental model in predicting bacterial sloughing from P. aeruginosa  in which
starvation was the triggering factor (Hunt et al., 2004).
Program of mobilization to planktonic cells
Physicaldetachment,shearforces
-♦
Figure 3.4: Biofilm detachment could be physical one due to shear forces or 
programmed through quorum sensing (adapted from Costerton et ah, 1999).
3.5 S. a u reu s  and S. ep id e rm id is  biofilm cultures in CDM-7 and CDM 
media, respectively
Many in vitro laboratory scale models have been developed to study different 
aspects of bacterial biofilms. One model, is the small scale perfused biofilm fermenter 
based on syringe membrane filters (Swinnex, Millipore, UK) (Gander and Gilbert, 1997). 
In this system cells are attached to one side of the filter and the medium is perfused from 
the other side (Figure 3.5A). Another method to study biofilms is a microtiter plate-based 
model. Bacterial suspension is inoculated into the wells of the plate and biofilms form on 
the surface of the wells (Stepanovic et al., 2000). Modified Robbins device (Tyler 
instruments, Canada) (Figure 3.5B) is based on a flow cell that has 24 detachable coupons 
on which bacteria adhere and grow into biofilms (Lewis, 2001). Another model which 
combines shearing force and microtiter plate is the Calgary Biofilm Device (Ceri et al., 
1999). In this device (Figure 3.5C), the lid has 96 pegs that sit in grooved tray.
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Figure 3.5: Schematic diagrams of different models to study biofilms. Panel (A): 
small scale perfused film fermenter, cells are loaded on 0.22 pm pore size filter 
membrane (b) through port (d), membrane is supported by sintered surface (c). The 
unit is inverted and media introduced through port (e). (a) air vent, (modified from 
Gander and Gilbert, 1997). Panel (B): Modified Robbins device showing media inlet, 
outlet and the detachable coupons on which biofilms form, (Manz et al., 1993). Panel 
(C): Calgary biofilm device showing the lid containing 96 pegs resting on grooved 
tray containing media. The whole system sits on tilting device to create shear force 
(Ceri et al., 1999).
The tray is filled with medium inoculated with cells and placed on a tilting device. The 
movement will cause the medium to flow creating shear force on the pegs and the formed 
biofilm. The Sorbarod model (described in Chapter 2) is a continuous flow system based
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on a filter plug contained in a tube (Hodgson et al., 1995). The filter is inoculated with 
bacteria and perfused with medium from one side and the cells shed from the other side. 
The Sorbarod model was used during this study. It has the advantage over some other 
biofilm models in that relatively high cell numbers can be recovered from it, which 
facilitates biochemical studies of biofilm populations and cells released from the biofilm 
(Hodgson et a/., 1995).
3.5.1 Experimental approach
3.5.1.1 Testing the ability o f staphylococci to produce polysaccharide intercellular 
adhesin (PIA)
As was mentioned in Chapter 1, PIA or polymeric N-acetyl glucosamine (PNAG) 
or slime is the exopolysaccharide matrix produced by S. aureus and S. epidermidis 
(Cramton et al., 2001; Mack et al., 2004; Higashi and Sullam, 2006). PIA has been found 
to play an important role in biofilm formation. It is synthesized by intercellular adhesin 
(icaADBC)-encoded proteins (Cramton et al., 1999). PIA mediates bacterial accumulation 
into multilayer in the second stage of biofilm formation (Higashi and Sullam, 2006) and 
is implicated in bacterial colonization (Baselga et al., 1993). PIA vaccine protected mice 
from kidney infection and death from S. aureus strains that produced little PIA 
(MeKenney et al., 1999). One of the techniques that has been used to detect the ability of 
staphylococci to produce biofilm is to test for the production of PIA. Congo red agar 
method was used widely for this purpose (Baselga et al., 1993; Arciola et al., 2001; Al- 
Laham et al., 2007; Valle et al., 2007). In this method slime positive strains appear as 
black colonies with dry crystalline appearance while slime negative strains appear as pink 
colonies and some times with central dark specks (Chapter 2, Section 2.5.4).
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In this project, before growing the bacteria in biofilm systems, they were tested 
for their ability to produce PIA. S. aureus ATCC 6538, 27659 and NCTC 11962 and S. 
epidermidis ATCC 12228 were cultured on Congo red agar (procedure details described 
in Chapter 2), and all of these strains were found to be PIA positive.
3.5.1.2 Growth o f biofilm on Sorbarod
A mid exponential phase culture (3mL inoculum) of S. aureus ATCC 6538 grown 
in CDM-7 medium was used to inoculate a sterile Sorbarod filter (pre-wetted with 5mL 
normal saline) contained in 10cm PVC tube (Figure 2.3, Chapter 2 ). The Sorbarod was 
perfused with sterile CDM-7 medium delivered through peristaltic pump at a constant 
flow rate of 0.4mL min'1. Sorbarod assembly was incubated at 37°C. Since the number of 
cells eluting from the biofilm indicates the number of cells dividing within the biofilm 
(Gander et al., 2005), biofilm growth was monitored by collecting the perfusate at regular 
intervals. The perfusate (eluate) was collected in sterile receivers and number of cells 
eluting was estimated by performing viable count after subjecting them to serial dilutions. 
The same experiment was repeated for S. epidermidis ATCC 12228, but replacing CDM- 
7 with CDM alone.
3.5.2 Results and discussion
Figures (3.6A and 3.6B) present biofilm eluate count of S. aureus and S. 
epidermidis, respectively. After inoculating the Sorbarod, there was an initial sharp fall in 
the count of cells due to the shedding of loosely attached cells into the eluted medium. 
This behaviour was noticed in all trials using this model (Al-Hmoud, 2002; Masadeh, 
2005; Gander et al, 2005). The striking behaviour in these two experiments was that as 
time passed, count loss was continuous indicating that the rate of bacterial detachment
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from the filter was faster than bacterial attachment. In addition, the dynamics of these 
models were not reproducible, as replicate experiments resulted in different rates for cells 
detachment.
Figure 3.6: Eluate cells count in Sorbarod perfusate with time. (A) S. aureus ATCC 
6538 in CDM-7 medium. (B) S. epidermidis ATCC 12228 in CDM. After the initial 
sharp loss of loose cells, bacterial loss remained higher than adherent cells and 
steady state was not achievable. Error bars indicate mean ± standard deviation of 
individual data points, n=3.
Several attempts were made to change the dynamics of these systems in order to 
reach steady state, in which bacterial loss and adherent biomass become equal and 
constant. It is known that during the early stages of biofilm formation on abiotic surfaces, 
a conditioning film is formed on the surface. The interaction of the surface with its
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surrounding environment will result in coating the surface by polymers from the medium 
(Donlan, 2002). For example, if a foreign material is placed in blood stream, 
proteinaceous materials, lipids, albumin, inorganic salts and fibronectin will be adsorbed 
on the surface forming this film (Dunne, 2002). This change in the surface properties of 
the abiotic surface will increase the affinity and rate of bacteria attaching to it (Donlan, 
2002). Moreover, Cabellos-Avelar et al. (2006) reported that the use of spent medium 
from cultures of a strain of E. coli promoted the formation of biofilm in another strain, 
which was unable to form biofilm under anaerobic conditions.
Based on conditioning film concept, two trials were performed in order to 
improve cell adherence to the Sorbarod. In one trial, an aliquot (5mL) of sterile spent 
medium was used to pre-wet Sorbarod filter before inoculating it with bacterial culture. 
Spent medium was prepared by inoculating 25mL of the medium with 250pL of 
overnight culture of the bacteria. The medium was sterilized by filtration (0.2pm 
membrane filter). In another trial, the Sorbarod was wetted with 50% human plasma 
(diluted in sterile normal saline) before inoculation. In both trials, Sorbarods were 
perfused with medium for 48hrs and growth was assayed by viable count. In these trials 
steady state was not achievable and cell detachment was higher than the rate of cells 
adhering to the Sorbarod. Finally, replacing bacterial strain from S. aureus ATCC 6538 
with strain ATCC 27659 did not change the dynamics of this system. Since these changes 
had no positive impact on these biofilm systems in terms of achieving steady state, it was 
decided to change the medium to a complex medium, eg: brain heart infusion. This 
medium has been used in many studies to support the growth of staphylococci (Rosten et 
al., 1987; Sacilik et al., 2001; Miedzobrodzki et al., 2002; Berber et al., 2003).
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3.6 Growth curve of S ta p h y lo co ccu s  a u re u s in Brain Heart Infusion 
(BHI)
3.6.1 Preparation of inoculum culture
A sterile Erlenmeyer flask (lOOmL) containing 25mL of sterile BHI was 
inoculated with pure culture of Staphylococcus aureus NCTC 11962. The flask was 
incubated in shaking incubator 150 osc min'1 at 37°C overnight.
3.6.2 The test culture
A sterile Erlenmeyer flask (lOOmL) containing 25mL of fresh BHI medium was 
inoculated with 250pL of inoculum culture. The flask was incubated in shaking incubator 
150 osc min'1 at 37°C. Two test cultures were prepared; one for viable count test, the 
other for turbidimetric assay, which were performed as previously described (section3. 3, 
Chapter 3).
3.6.3 Results and discussion
Figure (3.7A) shows the growth curve of S. aureus NCTC 11962 in brain heart 
infusion medium. This medium is a nutrient rich one and has considerably higher 
amounts of nutrients when compared to CDM or even CDM-7. The lag phase of S. aureus 
in BHI medium lasted for just two hours before the onset of exponential phase. The cells 
remained in exponential phase for about five hours after which they entered the stationary 
phase. Mid exponential phase was achieved after 5 hours from inoculation time and the 
generation time was 31 minutes.
The lag phase of S. epidermidis ATCC 12228 was five hours (Figure 3.7 B), after 
which the bacteria entered in the exponential phase which lasted for seven hours. The 
generation time (66 minutes) is almost double that of S. aureus. Also the stationary phase
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was delayed where S. epidermidis entered this phase 13 hours after inoculation compared 
to S. aureus (7 hours after inoculation).
Figure 3.7: S. aureus NCTC 11962 growth curve in Brain Heart Infusion medium. 
(A) mean viable count (log scale) vs time and OD 470nm (log scale) vs time. (B) S. 
aureus growth curve compared to S. epidermidis ATCC 12228 growth curve in brain 
heart infusion medium. Error bars indicate mean ± standard deviation of individual 
data points, n=3.
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3.7 Biofilm cultures of S ta p h y lo co ccu s  a u re u s  NCTC 11962 in Brain 
Heart infusion
An aliquot (3mL) of a mid exponential phase culture of S. aureus NCTC 11962 
grown in BHI medium was used to inoculate (drop wise) a sterile Sorbarod filter (pre­
wetted with 5mL normal saline) contained in 10cm PVC tube. The Sorbarod was perfused 
with sterile BHI medium delivered through peristaltic pump at a constant flow rate of 
0.4mL min'1. The Sorbarod assembly was incubated at 37°C. Three Sorbarod units were 
established and placed in the incubator. To monitor the growth of the biofilm, the 
perfusate was collected periodically in sterile receivers and assayed for growth by viable 
count. After 48 hours and after reaching steady state, the Sorbarod filters were removed 
and either stored at -20°C until required or sacrificed for further studies.
3.7.1 Assay of growth
Aliquots (IOOjiL) of the eluates were serially diluted in normal saline in the range 
10'2 to 10'8. Aliquots of the dilutions (IOOjliL) were spread plated onto brain heart infusion 
agar plates (pre-dried at 60°C for 5minutes). The plates were prepared in triplicate for 
each dilution. After 48hr incubation at 37°C, colonies were counted in each plate and 
viable count was calculated.
3.7.2 Results and discussion
Shortly after inoculation (Figure 3.8) the loosely attached cells were washed out 
by the flowing medium and the count was reduced by about three log values. Then the 
loss of cells declined until steady state was achieved where the numbers of detached cells 
equalled those adhering to the Sorbarod. In this system, steady state was achieved after
9 0
11 hours for S. epidennidis (Figure 3.8A) and 7 hours for S. aureus (Figure 3.8B) from 
inoculation time.
Figure 3.8: Mean biofilm eluate count of (A) S. epidermidis ATCC 12228 and (B) S. 
aureus NCTC 11962 in brain heart infusion medium. Each point represents average 
viable count, n=3 replicates. Error bars represent ± standard deviation of individual 
point.
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3.8 In  v itro  evaluation of antibiotic activity against biofilm and eluate 
cultures of S. a u reu s 11962
Standardized methodologies and interpretation that provide reproducible and 
quantitative results are essential in evaluating antimicrobial agents against bacteria. A 
generally accepted in vitro susceptibility testing is the measurement of minimum 
inhibitory concentration (MIC; Bloomfield, 1991). By definition MIC is the lowest 
concentration of antimicrobial agent required to inhibit visible growth of microorganism 
under certain conditions (Bloomfield, 1991; Andrews, 2001; Curtin and Cormican, 2003). 
The general principle of MIC determination is to expose a bacterial population 
(inoculum) to varying concentrations of antimicrobial agent under question, in conditions 
that are suitable for growth (Curtin and Cormican, 2003). Following an incubation period, 
the culture medium is inspected for growth. The lowest concentration of antibiotic where 
no visible growth can be seen in the culture medium is considered to be the MIC 
(Bloomfield, 1991).
MIC is not a biological constant. Therefore, MIC values are influenced by many 
factors; the size of inoculum (Svensson et ah, 1997), the nature of culture media and 
incubation period affect MIC values (Bloomfield, 1991; Curtin and Cormican, 2003). The 
use of higher inoculum density or using enriched media or incubating the culture for 
longer periods will result in higher MIC values (Bloomfield, 1991; Curtin and Cormican, 
2003; Svensson et al, 1997). Thus, MIC values should be compared only if these 
conditions were standardized. Even with a standardized methodology, a variation within 
the range of ±1 log2 is considered acceptable for a particular strain (Curtin and Cormican, 
2003).
Minimum inhibitory concentration may be determined by several methods. 
However, two methods are most widely used. These are, (a) the broth dilution method in
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which liquid medium is used or (b) the agar dilution method in which solid medium is 
used. A universally accepted range of antibiotic concentrations to be used for determining 
MIC is doubling dilution steps up or down from lOOOpg mL'1 as required (Andrews, 
2001).
In this study, broth dilution (macrodilution method) has been used. In this method, 
screening to MIC is done by performing two-fold serial dilutions of antibiotic under 
question in a wide concentration range. The tubes containing the antibiotics are 
inoculated with a standardized inoculum. After incubation period, MIC is determined. 
However, it must be remembered that the actual MIC lies between the lowest antibiotic 
concentration showing no visible growth and the next highest concentration. Once this 
approximate MIC value is determined, an arithmetic series of dilutions is performed to 
determine the actual MIC (Bloomfield, 1991).
The aim of this section is to determine minimum inhibitory concentrations (MIC) 
of selected antibiotics, cefalexin, ciprofloxacin and roxithromycin against biofilm cells 
and eluate cells of S. aureus NCTC 11962. MIC determination will allow selection of 
suitable sub-MIC of antibiotics to be used to challenge S. aureus biofilms. As mentioned 
earlier in this thesis, the antibiotics were selected from different classes of antibiotics, 
each one representing a different mechanism of action. The antibiotics used were, (a) 
Cefalexin ((3-lactam; cell wall synthesis inhibitor), (b) ciprofloxacin (fluoroquinolone; 
interferes with bacterial DNA synthesis) and (c) roxithromycin (macrolide; protein 
synthesis inhibitor).
3.8.1 Preparation of inoculum
The method described elsewhere was applied after slight modification (Al- 
Hmoud, 2002; Masadeh, 2005). Three biofilms of S. aureus were established on
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Sorbarods. They were perfused by brain heart infusion medium (BHI) and incubated at 
37°C. After reaching steady state after 48hr, eluate cells were collected into a sterile 
receiver vessel. The density of bacterial suspension was adjusted to 0.5 McFarland before 
inoculation.
Sorbarods were sacrificed and disintegrated as described in Chapter 2. The 
resulting suspension of cells and matrix was decanted into sterile tubes. In order to 
standardize inoculum size, the density of the suspension was corrected to 0.5 McFarland 
standard (described in Chapter 2).
3.8.2 Preparation of antibiotic solutions
Cefalexin (potency 93.9%) from Orchid Chemicals and Pharmaceuticals Ltd., 
India; ciprofloxacin HC1 (potency 93.1%) from Dr Reddy's Laboratories Ltd, India and 
roxithromycin (potency 96.4%) from Alembic Ltd, India, were tested and found to 
comply with the current European Pharmacopeia .
Stock solutions of antibiotics were prepared in sterile BHI medium to have a final 
concentration of lOOOpg mL"1. The weights of the antibiotics needed to prepare the stock 
solutions were calculated based on the percentage potency of each antibiotic. Suitable 
amounts of cefalexin and ciprofloxacin were dissolved separately in BHI medium to 
prepare lOOmL volumes. Due to solubility factors, the required weight of roxithromycin 
was dissolved first in small volume of sterile dimethylsulfoxide then the volume made up 
to lOOmL with BHI medium. Aliquots (lOmL) of the antibiotic stock solutions were 
distributed in sterile test tubes in triplicate. Double serial dilutions were performed to the 
amount of stock solutions remaining by adding equal volumes of fresh medium, mixing 
and distributing lOmL aliquots in other tubes to obtain 500 jig mL'1, 250 jig mL'1 and so 
on. Dilutions were prepared to cover the range of 1000 to 0.25 jig mL'1.
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3.8.3 MIC determination (broth Macrodilution method)
Aliquots (IOOjiL) of biofilm and eluate inocula were added separately to the tubes 
containing antibiotics. The tubes were mixed by vortexing and incubated at 37°C for 
24hrs. After incubation, the tubes were observed for growth and the initial screening MIC 
value was recorded. The test was repeated where linear dilutions were performed between 
the concentrations in which growth was seen and absent.
3.8.4 Results and discussion
Table 3.3 shows the results of MIC for cefalexin, ciprofloxacin and roxithromycin 
against biofilm cells and eluate cells of S. aureus NCTC 11962. MIC results of eluate 
cells when challenged with the antibiotics were the same as those of biofilm cells. Similar 
results were obtained by Al-Hmoud (2002) when P. aeruginosa biofilm cells and eluate 
cells were tested against benzisothiazolone and zinc pyrithione biocides and the MICs of 
biofilm cells and eluate cells were found to be equal. Also when the MICs of Ps. 
aeruginosa biofilm cells and eluate cells were determined for cetrimide or sodium 
pyrithione, MICs of biofilm cells were slightly higher than those of eluate cells (28% and 
20% more, respectively). In another study (Masadeh, 2005), the MICs of Ps. aeruginosa 
biofilm cells were two times higher than those of eluate cells when tested against 
ampicillin, nalidixic acid and streptomycin antibiotics. The same was found when E. coli 
biofilm cells and eluate cells were tested against nalidixic acid and ampicillin. However, 
the MIC was the same when E. coli biofilm cells and eluate cells were challenged with 
streptomycin (Masadeh, 2005).
MIC results obtained in this study have been used to prepare subinhibitory 
concentrations of antibiotics in order to investigate their effects on virulence of S. aureus 
biofilms.
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Table 3.3: MIC values for biofilm cells and eluate cells of S. aureus 
NCTC 11962 exposed to antibiotics.
Antibiotic MIC (ng m L 1)
Biofilm cells Eluate cells
Cefalexin 8 8
Ciprofloxacin 0.8 0.8
Roxithromycin 1 1
3.9 Conclusion
The aim of this chapter was to find a suitable chemically defined medium (CDM) 
that supports the growth of staphylococci as planktonic and as biofilm structures. A CDM 
containing the basic nutrients (compound sources of carbon, nitrogen, iron and other ionic 
sources) was suitable for the growth of S. epidermidis, but it was found to give a low S. 
aureus growth yield. Several modifications of the normal CDM formula were studied by 
step-wise addition of aminoacids until a medium containing seven amino acids (L-valine, 
L-arginine, L-cystine, L-aspartic acid, glycine, L-leucine and L-proline; named CDM-7), 
produced the highest growth yield with longer exponential phase and shorter generation 
time than other media tested. This was tested on three different strains of S. aureus and 
produced similar results. Interestingly, the additional aminoacids gave no effect on 
growth dynamics of S. epidermidis. However, CDM-7 and CDM were not able to support 
the growth of S. aureus and S. epidennidis in Sorbarod biofilm models. Therefore, in 
order to establish biofilm structures on Sorbarods, a complex medium (brain heart 
infusion broth), was used. After establishing biofilms on Sorbarods, the filters were 
sacrificed. Biofilm cells and eluate cells were challenged with cefalexin, ciprofloxacin 
and roxithromycin antibiotics in order to determine their corresponding minimum
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inhibitory concentrations. These values will be used to calculate in-use sub-MICs of the 
antibiotics in order to investigate the effects of these sub-MICs on virulence factors 
expressed in biofilms.
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Chapter 4
Studies of whole cell protein and exoprotein profiles of various 
cells and supernatants obtained from biofilms of 
Staphylococcus au reu s NCTC 11962 challenged with 
subinhibitory concentration of selected antibiotics
4.1 Introduction
Numerous proteins are expressed by Staphylococcus aureus. Some of these 
proteins are intracellular and others are secreted proteins. The composition and amount of 
these proteins vary according to the growth phase and external factors. Williams et al.,
(1999), have shown that cellular proteins of attached S. aureus vary with growth phase 
and that protein content (39 total protein per cell measured by fluorescence) was less than 
that in planktonic bacteria (74 total protein per cell measured by fluorescence) of the 
same species and strain. In the late exponential phase to early stationary phase, S. aureus 
makes a switch in protein production from surface proteins to extracellular proteins. This 
switch is regulated by quorum sensing (Arvidson, 2004). During infection, the bacteria 
change the expression of their enzymes and proteins to help in tissue invasion and spread 
(McGavin et a l , 1997). Furthermore, when exposed to sub-inhibitory concentrations of 
antibiotics, staphylococci respond by inducing genotypic and / or phenotypic changes 
(Gemmell, 1995). These changes will result in reducing the production of some proteins 
or increasing the production of others (Gemmell, 1995; Stevens et al., 2007). Sub- 
inhibitory cerulenin has been found to inhibit some staphylococcal exoproteins by 
blocking their transcription (Adhikari and Novick, 2005). At a concentration of 90% MIC
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of linezolid, overall exoprotein secretion of S. aureus was reduced (Bernardo et al.,
2004). This resulted in significant changes in the exoprotein patterns analysed by SDS- 
PAGE. When compared to erythromycin, erythromycin induced less evident changes in 
protein patterns (Bernardo et al., 2004). Toxic Shock Syndrome Toxin 1 (TSST-1) 
production in seven TSST-1 producing strains was reduced to below detection limit when 
cells were treated with clindamycin or lincomycin at 1/4 of MIC (Dickgiesser and 
Wallach, 1987).
Thus, in the following sections, whole cell protein profiles of biofilm cells and 
eluate cells and exoprotein profile of S. aureus NCTC 11962 in the presence of 1/16 MIC 
of selected antibiotics (cefalexin, ciprofloxacin and roxithromycin) and in their absence 
(control) were analyzed. The aim was to examine any alterations in protein profiles due to 
exposure to these antibiotics.
4.2 Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS- 
PAGE) for studying protein profiles.
SDS-PAGE is a widely used technique in biochemistry, genetics and molecular 
biology to analyse proteins and nucleic acids. Whole cell protein profile obtained by 
SDS-PAGE analysis has been shown to be able to establish the source of Salmonella 
typhimurium, which can be useful in tracing outbreak strains (Khan et al, 1996). SDS- 
PAGE analysis of whole cell polypeptide has also been used to identify staphylococcal 
species (Clinck and Pennington, 1987). However, Pennington et al (1991) were not able 
to identify coagulase-negative staphylococci by their polypeptide profiles alone. The 
SDS-PAGE technique has been used widely to identify new proteins (Su and Wong, 
1995; De Rossi et al, 1997; Munson et al, 1998) or to track and study changes in 
exoprotein or cellular protein profiles when the bacteria were exposed to different
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conditions (environmental or mutational) (De Rossi et a l , 1997; Karlsson and Arvidson, 
2002; Bernardo et al, 2004; Adhikari and Novick, 2005; Koszczol et a l , 2006). 
Moreover, SDS-PAGE has been frequently used in following the progress of purification 
steps of proteins or assessing their purity (Blomster-Hautamaa et a l, 1986; Su and Wong, 
1995; Munson et al., 1998; Masadeh, 2005; He et al, 2006; Burkhard and Wilks, 2007).
In this technique, proteins are denatured with anionic surfactant, SDS, to be 
unfolded, linearized and to form soluble negatively charged complex. In general, about 
1.4g SDS binds to lg protein, which will give approximately uniform charge/mass ratio 
(Smith, 1984). After denaturing the proteins, they are applied to a gel of polyacrylamide 
and a current is applied where the migration of proteins through the gel is proportional to 
the size of protein (Smith, 1984). Polyacrylamide gels are formed from the 
polymerization of acrylamide and N,N'-methylene-bis-acrylamide (a cross-linking agent). 
The polymerization is initiated by the addition of ammonium persulfate and N,N,N',N',- 
tetramethylethylenediamine (TEMED). The resulting gel is a neutral, hydrophilic, three- 
dimensional sieve-like matrix of long hydrocarbons cross-linked by methylene groups 
(Boyer, 2000). Since the proteins after SDS denaturing have the same charge/mass ratio, 
mobility of the proteins in the gel is a function of pore size of the gel matrix. This 
mobility is proportional to the molecular weight of the protein. The pore size of a gel 
depends on the amount of acrylamide and bis-acrylamide present. Higher concentrations 
give gels with smaller pore sizes allowing the analysis of lower molecular weight 
biomolecules. In contrast, lower concentrations of acrylamide give gels with large pores 
allowing analysis of higher molecular weight biomolecules (Boyer, 2000). Laemmli's 
gels (Laemmli, 1970), are discontinuous gels, that is, they are composed of two different 
gels (stacking gel and separating gel). These gels differ in their pH and pore size. In 
stacking gel, all proteins will migrate together in a high speed in the form of a stacked
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zone. Once they reach the separating gel, with different gel composition and higher pH, 
the mobility of proteins will be reduced and separation of proteins based on their 
molecular weight will commence.
In this project, the gel system used through the study was of slab shape. Slab gels 
offer the advantage that more than one sample can be analysed at the same time for 
comparative study. Besides, all samples are analyzed in a matrix and environment that is 
identical in composition. The buffers used for the gel system were prepared according to 
Laemmli’s method (Laemmli, 1970).
4.3 Experimental approach
4.3.1 Preparation of TSST-1 standard for SDS-PAGE analysis
Toxic Shock Syndrome Toxin 1 (TSST-1; Sigma) powder was reconstituted with 
distilled water to form lmg mL'1 solution. Equal volumes of this standard and sample 
buffer (described in Chapter 2) were mixed together and heated at 90°C for 5 minutes. 
The prepared standard was distributed in small aliquots and stored at -20°C for 
subsequent use.
4.3.2 Confirmation of TSST-1 production by Staphylococcus aureus NCTC 11962 
using SDS-PAGE.
In order to confirm the production of TSST-1 from S. aureus NCTC 11962, SDS- 
PAGE analysis of the extracellular proteins produced by these bacteria was done. The 
extracellular protein profile of a TSST-1 producing strain (NCTC 11962) was compared 
with the extracellular protein profile of non-producing strain (ATCC 27659) which was 
used as a control. The membrane-over-agar method was used to assess production of 
TSST-1 by the bacteria (Parsonnet et al., 1987; Daghistani et a l, 2000; Braga et al.,
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2005; Kansal et al., 2007). In this method, circular sheets of Visking dialysis tubing 
(Medicell International Ltd, UK) of 12 to 14 kDa molecular weight cut off, were cut to fit 
Petri dishes. The sheets were sterilized by autoclaving at 121°C, 15psi for 15 minutes. 
The sterile circles were transferred aseptically and laid on brain heart infusion agar plates. 
Two plates were prepared, one for each strain. The sheets were inoculated with bacteria 
by spreading 0.1 mL of mid-exponential phase bacterial suspension on the sheets and 
were incubated at 37°C. After 24hrs, bacterial growth was harvested from the membrane 
by washing the membrane with 1.5mL sterile normal saline and collecting it in 
microtubes. The collected suspensions were centrifuged at 13000 rpm (Genfuge 24D, 
Progen, Mexborough, UK) at 4°C for 15 minutes. Protein concentration in the supernatant 
solution of each strain was determined by BCA assay (described in Chapter 2). SDS- 
PAGE analysis was performed for the two strain's supernatants (Chapter 2). Equal 
amounts of proteins were loaded on previously prepared polyacrylamide gels and 
constant current was applied using (Mini PROTEAN 3 system, Bio-Rad, Hercules, CA, 
USA). When the dye front was about to reach the bottom of the gel, the gels were 
removed and silver stained (Chapter 2).
4.3.2.1 Results and discussion
Figure 4.1 shows exoprotein profile of TSST-1 producing S. aureus NCTC 11962 
lane 3 and TSST-1 non-producing S. aureus ATCC 27659 lane 2. When compared with 
TSST-1 standard band (molecular weight 22kDa), there is a clear band in lane 3 
indicating the presence of TSST-1 in the exoproteins of S. aureus NCTC 11962, while in 
lane 2 no band corresponding to TSST-1 was obtained. These results confirm the 
production of TSST-1 by S. aureus NCTC 11962.
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Figure 4.1: SDS-PAGE for exoproteins obtained by membrane-over-agar method. 
Lane 1: TSST-1 standard (Sigma) (1 jig well1); lane 2, exoprotein profile of S. 
aureus 27659 non-TSST-1 producing strain; lane 3, exoprotein profile of S. aureus 
NCTC 11962 TSST-1 producing strain. Protein loaded (8pg well'1) for sample wells.
4.3.3 Preparing and testing whole cell proteins and exoproteins by SDS-PAGE
Cell pellets of biofilm cells or eluate cells obtained from Sorbarod biofilms 
exposed to 1/16 MIC of the three antibiotics and a control (prepared as described in 
Chapter 2), were suspended in a buffer composed of 50mM Tris-HCl buffer containing 
protease enzymes inhibitors; lmM Phenylmethylsulphonyl fluoride (PMSF) and 0.5mM 
Na-Tosyl-L-lysine chloromethyl ketone (TLCK). Protease inhibitors were added to 
prevent proteolysis and degradation of proteins from protease enzymes that will be 
released after cell disruption. The volume of the buffer added was twice the volume of the 
pellet. The cells were disrupted mechanically on ice using an hand held homogeniser 
(Ultra Turrax T8, S8N-5G, IKA Labotechnic, Staufer, Germany) as was mentioned in 
Chapter 2. Cell lysate was distributed in microtubes and clarified by centrifugation at
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13000 rpm (Genfuge 24D, Progen, Mexborough, UK) for 15 minutes at 4°C. Protein 
concentration in the solution was determined by BCA assay (Chapter 2).
For extracellular protein preparation, eluate supernatants were treated with 
trichloroacetic acid to precipitate the proteins as was mentioned in Chapter 2. After 
washing the precipitated proteins and drying them under nitrogen, the precipitate was 
dissolved in buffer (50mM Tris-HCl buffer containing ImM PMSF and 0.5mM TLCK). 
Protein concentration was determined by BCA assay. The clear protein solutions obtained 
from cells or eluate supernatants were mixed with sample buffer (described in Chapter 2) 
in 1:1 ratio and then heated at 90°C for 5 minutes. After the samples cooled down to room 
temperature, they were applied into the wells of previously prepared gels using special 
tips (Gel saver II tips, Fisherbrand, UK). 5 to 20pL of the samples was applied so that 
equal amounts of proteins were loaded in all sample wells. SDS-PAGE standard marker 
(3pL) (Serva Electrophoresis, Germany) was applied in a separate well. The gels were 
run under constant current (30mA) until the dye front reached 2-5mm from the bottom of 
the gel. The gels were removed and silver stained (Chapter 2).
4.3.4 SDS-PAGE protein markers
The SDS-PAGE protein marker (Serva Electrophoresis GmbH, Heidelberg, 
Germany) used in this study was ready made, composed of recombinant proteins in the 
range 10 to 150kDa). The molecular weights (kDa) of the marker proteins were (10, 20, 
30, 40, 60, 80, 100, and 150). In order to estimate molecular weights of protein bands in 
SDS-PAGE gel, protein markers were run with each gel to reduce gel to gel variation. 
After running the markers, their Rf values were calculated (Table 4.1) and a calibration 
curve was plotted versus their corresponding molecular weights (Figure 4.2).
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4.3.5 Results and discussion
Some distinct variations in protein profiles were observed in biofilm and eluate 
cells in addition to extracellular proteins when biofilms of S. aureus NCTC 11962 were 
exposed to sub-MIC of cefalexin (0.5pg mL"1), ciprofloxacin (0.05 pg mL'1) and 
roxithromycin (0.0625 pg mL'1). Gel analysis has been performed by visually inspecting 
the gels and comparing protein profiles of treated gels to those of untreated (control 
biofilms). Repression of some proteins, over / under expression of others or production of 
new proteins were observed during analysis of the gels. For the purpose of simplicity, 
only protein bands showing variations from the control were recorded.
Figure 4.3 shows SDS-PAGE gel and Table 4.2 presents summary of findings for 
treated biofilm cells and control. A new protein (32kDa) was expressed in biofilm cells 
exposed to cefalexin and roxithromycin but not ciprofloxacin. This protein was not 
apparent in control biofilm cells. On the other hand, a 25kDa protein which was 
expressed in control biofilm cells was less expressed in ciprofloxacin treated biofilm cells 
(appearing as a light band). Similarly, the expression of a 45kDa protein was very low in 
biofilm cells exposed to roxithromycin when compared to control or other treatments.
Table 4.2: Data analysis of protein profiles obtained from biofilm cells exposed to 
sub-MIC cefalexin, ciprofloxacin or roxithromycin and control. Protein molecular 
weights (Mr) were estimated from a calibration curve of protein markers run on the 
same gel. Data presented here shows proteins on which variations have happened 
compared to control. P: present; A: absent; N: novel protein.
Protein Mr 
(kDa)
Control Cefalexin Ciprofloxacin Roxithromycin
25 P P Light band P
32 A P(N) A P (N)
45 P P P Light band
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Figure 4.3: SDS-PAGE analysis of biofilm cells. Lane 1, protein markers from 10 to 
150kDa; lane 2: TSST-1 standard; lane 3: untreated biofilm cells (control); lane 4: 
biofilm cells exposed to 1/16 MIC of ciprofloxacin; lane 5: biofilm cells exposed to 
1/16 MIC of roxithromycin; lane 6: biofilm cells exposed to 1/16 MIC of cefalexin. 
Arrows indicate novel protein (N) at 32kDa, light band at 25kDa and light band at 
45kDa. (Protein loading 8pg well'1).
Figure 4.4 and Table 4.3 shows SDS-PAGE analysis for eluate cells exposed to 
antibiotics and control. A 27kDa protein was suppressed in eluates exposed to sub-MIC 
roxithromycin, although it was expressed when the cells were exposed to other 
antibiotics. On the other hand, a 34kDa protein was over expressed by eluate cells 
exposed to cefalexin. The protein band was darker than those corresponding to the control 
and the other treatments. Similarly, 82.5kDa proteins were less produced when cells were 
exposed to cefalexin and roxithromycin, but not ciprofloxacin. Moreover, 95kDa novel 
protein appeared in cells treated with ciprofloxacin when compared to other treatments 
and control.
107
Table 4.3: Data 
sub-MIC cefale: 
weights (Mr) we 
same gel. Data 
P: present; A: a
analysis of protein profiles obtained from eluate cells exposed to 
rin, ciprofloxacin or roxithromycin and control. Protein molecular 
re estimated from a calibration curve of protein markers run on the 
jresented here shows proteins on which variations have happened, 
jsent; N: novel protein.
Protein Mr 
(kDa)
Control Cefalexin Ciprofloxacin Roxithromycin
27 P P P A
34 P P (strong band) P P
82.5 P P (light band) P P (light band)
95 A A P(N) A
H |  1
27(A)
2 3
kDa
150
100
W<N>
s a s  / *
i l M P so
82.5 SO
40
■ SO
MM 20
10
4 5 8
Figure 4.4: SDS-PAGE analysis of eluate cells. Lane 1: TSST-1 standard; lane 2: 
eluate cells exposed to 1/16 MIC of cefalexin; lane 3: eluate cells exposed to 1/16 
MIC of roxithromycin; lane 4: eluate cells exposed to 1/16 MIC of ciprofloxacin; 
lane 5: untreated eluate cells (control); lane 6: protein markers from 10 to 150kDa. 
Arrows indicate novel protein (N), absent protein (A), strong band at 34kDa and 
protein band at 82.5kDa. (Protein loading 8pg well'1).
Figure 4.5 and Table 4.4 show results of SDS-PAGE analysis for eluate 
supernatants challenged with antibiotics and control. Two proteins (29kDa and 46kDa) 
were absent from eluate supernatants of biofilms exposed to cefalexin at sub-MIC level, 
but were apparent when exposed to ciprofloxacin or roxithromycin and control. On the 
other hand, a new protein, 28kDa, appeared in the protein profile of cells exposed to 
cefalexin when compared to the control and other treatments. A 49kDa protein was not
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detected in the eluate supernatants when biofilms were perfused with sub-MIC of 
roxithromycin, but not the other antibiotics. The three treatments caused reduction in the 
expression of proteins with 22kDa when compared to that of the control.
Table 4.4: Data analysis of protein profiles obtained from eluate supernatants of 
biofilms which are exposed to sub-MIC cefalexin, ciprofloxacin or roxithromycin 
and control. Protein molecular weights (Mr) are estimated from a calibration curve 
of protein markers run on the same gel. Data presented here shows proteins on 
which variations have happened. P: present; A: absent; N: novel protein.
Protein Mr
(kDa)
Control Cefalexin Ciprofloxacin Roxithromycin
22 P P (light band) P (light band) P (light band)
28 A P(N) A A
29 P A P P
46 P A P P
49 P P P A
tcDa
1&D
100
30
60
40
30
20
10
1 2  3 4
Figure 4.5: SDS-PAGE analysis of eluate supernatants. Lane 1: eluate supernatants 
exposed to sub-MIC of cefalexin; lane 2: eluate supernatants exposed to sub-MIC of 
roxithromycin; lane 3: eluate supernatants exposed to sub-MIC of ciprofloxacin; 
lane 4: untreated eluate supernatants (control); lane 5: protein markers from 10 to 
150kDa; lane 6: TSST-1 standard. Arrows indicate novel protein (N), absent protein 
(A) and strong band at 22kDa. (Protein loading 8jjg well'1).
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Variations in the pattern of protein profiles of secreted proteins or whole cell 
proteins obtained from biofilm cells or eluate cells after exposure to subinhibitory 
concentrations of cefalexin, ciprofloxacin or roxithromycin are apparent. In whole cell 
protein profiles, some proteins were not expressed in the control, but appeared after 
exposure to an antibiotic. Other proteins disappeared after exposure to antibiotics. These 
results indicate that exposure to subinhibitory levels of antibiotics induces series of 
complex internal reactions in the cell leading to cellular changes. Such changes could be 
phenotypic, genotypic or in the pathogenicity of the bacterium.
Although SDS-PAGE analysis has earned its reputation as a standard method for 
protein measurement and analysis, the information it provides is not considered 
definitive. Since proteins are analysed based on only one dimension or factor (molecular 
weight), several proteins that share the same molecular weight will migrate at the same 
rate forming one single band. Thus, for protein identification purposes, other parameters 
should be considered, such as isoelectric point (by 2D-PAGE analysis) or protein 
sequencing (mass spectroscopic analysis). Therefore, 2D-PAGE analysis was undertaken 
for whole cell proteins and exoproteins.
4.4 Two-Dimensional polyacrylamide gel electrophoresis (2D-PAGE)
2D-PAGE is a powerful technique that is used for the separation of proteins in 
complex mixtures. This method employs separation of denatured proteins according to 
two different parameters; isoelectric point (pi) by isoelectric focusing in the first 
dimension, and size by SDS-PAGE in the second dimension. Consequently, this 
technique can separate thousands of proteins simultaneously and provides information 
about protein isoelectric point and molecular weight, where each spot on the gel 
corresponds to a single protein species (Smith, 1984). In the isoelectric focusing step, a
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pH gradient is formed in a gel tube or strip by electrophoresis of synthetic 
polyelectrolytes called ampholytes. Ampholytes are low molecular weight polymers with 
a wide range of isoelectric points. They are available in different pH ranges (pH 5 to 7, 6 
to 8, 3.5 to 10, etc.) (Boyer, 2000).
The net charge on a protein is pH dependent. When the pH is below pi of a 
protein, the protein will be positively charged and will migrate toward the negatively 
charged cathode. At a pH above the pi of the protein, it will be negatively charged and 
will move toward the anode. When the pH is identical to the pi, the protein will have a 
zero net charge and will not migrate. Thus, when a protein sample is loaded onto a pH 
gradient strip or tube and a current is applied, proteins in the sample will migrate until 
each one reaches a region where its net charge is zero, and then it will stop migration. 
Therefore, when a current is applied, all molecules of a protein located anywhere in the 
gradient, will migrate toward the region corresponding to their isoelectric point and will 
stop there, forming a sharp band. In other words, they will 'focus' at their isoelectric point 
(Boyer, 2000).
In the original technique introduced by O’Farrell in 1975, the first dimension 
(isoelectric focusing) was performed in narrow tubes of polyacrylamide gel containing 
carrier ampholyte (O'Farrell, 1975). After setting gel tubes, carrier ampholytes were 
allowed to migrate throughout the gel by voltage application to form pH gradient. Later, 
immobilised pH gradient (IPG) strips were introduced in which pH gradients groups were 
covalently linked to the matrix (Bjellqvist et ah, 1982). These immobilized IPG strips 
overcome the problems encountered with the older carrier ampholyte-generated pH 
gradients such as pH gradient instability and irreproducibility, in addition to the higher 
loading capacity and improved resolution (Bjellqvist et al., 1982).
I l l
After running the first dimension, the sample gel tube or strip is transferred to a 
SDS-PAGE slab and electrophoresis is performed in the second dimension to separate 
proteins based on their molecular weights.
4.4.1 Experimental approach
4.4.1.1 Preparing and testing whole cell proteins and exoproteins by 2D-PAGE
Cell pellets of biofilm cells or eluate cells obtained from Sorbarod biofilms 
exposed to 1/16 MIC of the three antibiotics and a control (prepared as described in 
Chapter 2) were suspended in lysis buffer. The volume of lysis buffer added was about 
twice the pellets’ volume. Protease enzymes inhibitors were added to a final 
concentration of ImM Phenylmethylsulphonyl fluoride (PMSF) and 0.5mM Na-Tosyl-L- 
lysine chloromethyl ketone (TLCK). The cells were disrupted mechanically on ice using 
hand held homogeniser (Ultra Turrax T8, S8N-5G, IKA Labotechnic, Staufer, Germany) 
as mentioned in Chapter 2. Cell lysate was distributed in microtubes and clarified by 
centrifugation at 13000 rpm (Genfuge 24D, Progen, Mexborough, UK) for 15 minutes at 
4°C. Protein concentration in the solution was determined by BCA assay (Chapter 2).
For extracellular protein preparation, the proteins precipitated from eluate 
supernatants, which were washed and dried (as described in Chapter 2), were dissolved in 
about lmL lysis buffer. Protease inhibitors were added and protein concentration was 
determined by BCA assay. Aliquots from the prepared samples in lysis buffer were mixed 
with certain volumes of rehydration buffer (containing DTT and bromophenol blue, 
described in Chapter 2) so as the final volume of the sample would be 125pL. Equal 
amounts of proteins were prepared for each group of samples under testing. Each sample 
was used separately to rehydrate IPG strip (Immobiline dry strip pH 3-10NL, 7cm, GE 
Healthcare, Sweden). After rehydrating IPG strips, the first dimension was run under high
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program m able voltage supplied by (M o d e l E P S -3 5 0 1 X L , A m ersham  Biosciences, 
Sweden; Chapter 2) and the second dim ension was run using (M in i P R O T E A N  3 system, 
B io -R ad , Hercules, C A , U S A ; C hapter 2 ). T he  gels were s ilver stained.
4.4.1.2 Results a n d  discussion
The objective o f  applying S D S -P A G E  and 2 D -P A G E  to w ho le  cell proteins and  
extracellu lar proteins, was to detect proteins that m ight be responsible for any changes in  
virulence o f S. aureus b io film s w hen exposed to s u b -M IC  o f  antibiotics. S D S -P A G E  
analysis o f  these proteins when b io film s were exposed to cefalex in , c ip ro floxac in  and  
roxithrom ycin  has shown that distinct variations in  protein profiles occurred as a result o f  
such exposure. Som e novel proteins, w h ich  were not expressed in  untreated cells, 
appeared in  some o f  the treated ones, others w ere over-expressed or disappeared in  the 
treated ones. Th is  in  turn was reflected on the secreted proteins, w h ich  m ay suggest a ro le  
in  the expression and activ ity  o f secreted viru lence factors. Therefore, in  order to further  
investigate these alterations in  protein profiles, 2 D -P A G E  was perform ed fo r the three  
treatments and control.
The estim ation o f  m olecular weights and isoelectric points o f  proteins analysed on  
2D -gels  w ere based on calibration curves constructed fro m  tw o-d im ensiona l 
electrophoresis protein markers (Figure 2 .7  and 2 .8 , page 5 4  and 55, C hapter 2 ). T o  
estimate isoelectric point (p i) for protein spots detected on the gels, R f  value o f  the first 
dim ension was com puted and interpolated on p i calibration curve (F igure 2 .7 , C hapter 2 ). 
S im ila rly , R f  values o f  the second dim ension w ere calculated and interpolated on the 
protein markers calibration curve (m olecu lar weights against R f  values) in  order to 
estimate m olecular weights o f  the protein spots separated on 2D -gels . I f  the value o f  
calculated R f  was outside the calibration  range, extrapolation was perform ed. D u e  to
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presence o f  some uncertainty in  cases o f  extrapolation, spots extrapolated w ere  m arked to 
indicate this event.
2D -gels  w ere inspected v isua lly  and com pared w ith  each other. Protein  profiles o f  
control samples (b io film  cells, eluate cells and eluate supernatant) w ere com pared w ith  
antib iotic treated corresponding samples. K ey  proteins that w ere  observed in  control 
samples and treated ones w ere iden tified  by estim ating their p i  and m olecu lar w eight. 
Each protein spot was given a num ber that is unique to this spot, w hether it  was observed  
on control gel or treated one. N o v e l proteins (those that appear in  treated sam ple, but not 
in  the control) or disappearing proteins w ere identified  b y  estim ating their p i and  
m olecular w eight. For each treated gel, new  proteins w ere g iven a lphabetical letters for  
identification . These letters were g iven serially  fo r each gel, i.e  the le tte r is not unique for  
each protein.
Figures 4 .6 , 4 .7 , 4 .8  and 4 .9  show 2D -g e ls  for b io film  cells challenged w ith  sub- 
M IC  o f  antibiotics and control b io film  cells. Tables 4 .5 , 4 .6 , 4 .7  and 4 .8  show estim ated  
m olecular weights and isoelectric points o f  the visualised proteins and the ir status (novel 
proteins or disappeared ones). Exposure o f  S. aureus N C T C  11962  b io film s  to 1 /16  o f  
M IC  levels o f cefalexin  (0 .5 |ig  m L '1), c ip ro floxacin  (0 .0 5 |ig  m L '1) and rox ith rom ycin  
(0 .0 62 5 p g  m L '1) resulted in  several changes in  protein profiles o f  cells and extracellu lar  
proteins w hen com pared to those o f  untreated b io film s (contro l). T w o  new  proteins w ith  
m olecular w eight 3 1 .5 k D a  (p i 6 .58  and 6 .3 ) (Tab le  4 .6 ; F igure  4 .7 , spots F  and J 
respectively) appeared in  b io film  cells exposed to cefalex in . These proteins are m ost 
lik e ly  the same proteins observed in  S D S -P A G E  gels (protein  band at 3 2 k D a ) o f b io film s  
treated w ith  same antibiotic (Figure 4 .3 , lane 6 ). S im ila rly , tw o  new  proteins w ith  same 
m olecular w eight 3 2 k D a  and (p i 6 .4  and 5 .2 ) (Tab le  4 .8 ; F igure  4 .9 , spots E  and I )  
respectively, appeared in  2D -gels  o f  b io film s  exposed to rox ith rom ycin .
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F ig u re  4 .6: 2 D -P A G E  analysis  o f u n tre a te d  b io film  cells (c o n tro l). P ro te in  spots 
w e re  n u m b e re d  fo r  id e n tif ic a tio n  (T a b le  4 .5 ). P ro te in  lo a d in g  (3 0 p g ).T h is  im ag e  was  
com bined  fro m  tw o  im ages fo r  c la r ity  in  p resen ta tio n .
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P ro te in  lo ad in g  (30p g).
115
Non linear pH range from 3 to 10
-C
‘53
£
uc
ooocd
-oaj
73a<uon
Si 6765&>
76 -- 7871,’:
52
5050» 46 41« 66 35
79
Si
53
54
56. 51 44 3973 Vetto 45 4240 56 ^
*lh * 1 to 51
74 S2 M j
to%  45 H 26
44
75: fS *S to * 2560
so N
6?
23 20 14 22-
so
10
1113 U
5 D B
Figure 4.8: 2D-PAGE analysis of biofilm cells exposed to sub-MIC ciprofloxacin. 
Protein spots were numbered for identification. Missing numbers correspond to 
missing proteins. Newly appearing proteins were given alphabetical letters (Table
4.7). Protein loading (30pg).
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Figure 4.9: 2D-PAGE analysis of biofilm cells exposed to sub-MIC roxithromycin. 
Protein spots are numbered for identification. Missing numbers correspond to 
missing proteins. Newly appearing proteins are given alphabetical letters (Table
4.8). Protein loading (30pg). This image was combined from two images for clarity 
in presentation.
116
Table 4.5: 2D-PAGE analysis of biofilm cells (control). Spots are
identified by a number. Molecular weight (Mr) and isoelectric
point (pi) are estimated from their corresponding Rf values.
Extrapolated values are marked with (*).
Spot Estimated Estimated Spot Estimated Estimated
ID Mr (kDa) pi ID Mr (kDa) pi
1 85.9 10* 44 44.5 5.13
2 21.9 9.1 * 45 41.5 5.13
3 43.3 8.9* 46 51 5.1
4 27 8.6* 47 28.1 4.96
5 27 8.3 * 48 23.8 4.96
6 41 8.3 * 49 20.5 4.96
7 21 7.54 50 60.4 4.93
8 28 7.26 51 43.5 4.93
9 22.5 7.23 52 62.5 4.85
10 73.4 7.15 53 41.5 4.85
11 61.5 7.15 54 82.8 4.74
12 24.8 7.06 55 51.5 4.72
13 61.5 7.04 56 47.5 4.7
14 28 7.00 57 34 4.7
15 61.5 6.95 58 26 4.7
16 89 6.86 59 56 4.54
17 44.5 6.86 60 21.9 4.65
18 41.9 6.86 61 38.7 4.5
19 29 6.86 62 34 4.5
20 28.3 6.86 63 29.5 4.5
21 26.8 6.86 64 26 4.48
22 24.8 6.86 65 17.8 4.35
23 28.3 6.75 66 50.5 4.3
24 20.3 6.63 67 74.5 4.25
25 28.2 6.56 68 72 4.25
26 27.8 6.43 69 67.4 4.25
27 59.5 6.24 70 55.3 4.25
28 24.5 6.16 71 51.5 4.25
29 58 6.12 72 51 4.25
30 20 6.12 73 41.5 4.25
31 35 5.9 74 34 4.25
32 58.5 5.77 75 24 4.12
33 42 5.73 76 57.5 4.08
34 23.5 5.6 77 18 3.95
35 35 5.57 78 20.4 3.85
36 42 5.53 79 37 3.85
37 26 5.43 80 20.4 3.84
38 48 5.33 81 74.5 3.82
39 43.5 5.33 82 34 3.82
40 36 5.33 83 30.5 3.6*
41 51 5.25 84 27 3.6*
42 36 5.2 85 22.4 3.6*
43 28.5 5.2
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Table 4.6: 2D-PAGE analysis of biofilm cells exposed to sub-MIC 
of cefalexin compared to those of control. Newly appearing spots 
(proteins) are given alphabetical letters. Disappearing spots are 
given their corresponding numbers as they appear in control gel. 
Molecular weight (Mr) and isoelectric point (pi) are estimated 
from their corresponding Rf values. Extrapolated values are 
marked with (*).___________________________________________
Novel P 
control)
roteins (compared to Disappearing spots (compared 
to control)
Spot
ID
Estimated 
Mr (kDa)
Estimated
pi
Spot
ID
Estimated 
Mr (kDa)
Estimated
pi
A 18 7.75 * 3 43.3 8.9 *
B 28 7.45 19 30.8 6.86
C 28 7.28 21 26.8 6.86
D 30.5 6.64 26 27.8 6.43
E 34.3 6.58 42 36 5.2
F 31.5 6.58 77 18 3.95
G 42 6.4 78 20.4 3.85
H 59.5 6.3 84 27 3.5 *
I 34.3 6.3
J 31.5 6.3
K 42 6.13
L 47.5 5.77
M 47.5 5.6
N 47.5 5.53
O 74 4.85
P 81.5 4.7
0 26.5 4.27
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Table 4.7: 2D-PAGE analysis of biofilm cells exposed to sub-MIC 
of ciprofloxacin compared to those of control. Newly appearing 
spots (proteins) are given alphabetical letters. Disappearing spots 
are given their corresponding numbers as they appear in control 
gel. Molecular weight (Mr) and isoelectric point (pi) are estimated 
from their corresponding Rf values. Extrapolated values are 
marked with (*).___________________________________________
Novel P 
control)
roteins (compared to Disappearing spots (compared 
to control)
Spot
ID
Estimated 
Mr (kDa)
Estimated
pi
Spot
ID
Estimated 
Mr (kDa)
Estimated
pi
A 41 8 * 3 43.3 8.9 *
B 28 7.85 * 12 24.8 7.06
C 41.5 7.75 * 21 26.8 6.86
D 28 7.54 25 28.2 6.56
E 73.4 7.04 27 59.5 6.24
F 30.5 6.86 77 18 3.95
G 22.5 6.86 78 20.4 3.85
H 27.8 5.53
I 35 5.36
J 30.5 5.3
K 33.5 5.2
L 33.5 4.9
M 30.5 4.9
N 20 4.5
0 24.1 3.1 *
P 22 3.1 *
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Table 4.8: 2D-PAGE analysis of biofilm cells exposed to sub-MIC of 
roxithromycin compared to those of control. Newly appearing spots 
(proteins) are given alphabetical letters. Disappearing spots are 
given their corresponding numbers as they appear in control gel. 
Molecular weight (Mr) and isoelectric point (pi) are estimated from 
their corresponding Rf values. Extrapolated values are marked with
(*).________________________________________________________
Newly appearing spo 
(compared to contro
ts
)
Disappc
control)
jaring spots (compared to
Spot
ID
Estimated 
Mr (kDa)
Estimated
pi
Spot
ID
Estimated 
Mr (kDa)
Estimated
pi
A 42 7.65 3 43.3 8.9 *
B 29.5 7.33 10 73.4 7.15
C 61.5 7.04 15 61.5 6.95
D 41.8 6.9 16 89 6.86
E 32 6.4 17 44.5 6.86
F 42 6.3 18 41.9 6.86
G 42 6 19 30.8 6.86
H 27 5.5 20 28.3 6.86
I 32 5.2 21 26.8 6.86
J 72 4.85 23 28.3 6.75
K 75.5 4.8 25 28.2 6.56
L 42 4.6 42 36 5.2
43 28.5 5.2
65 17.8 4.35
77 18 3.95
78 20.4 3.85
79 37 3.85
These proteins explain the appearance of new band at 32kDa (Figure 4.3, lane 5) 
in SDS-PAGE gels for biofilms exposed to similar conditions. A basic protein (pi 8.9, Mr 
43.3kDa) disappeared from biofilm cells exposed to any of the three treatments when 
compared to control (spot 3). Similarly, a 26.8kDa protein (pi 6.86; spot 21; Tables 4.6,
4.7 and 4.8; Figures 4.7, 4.8 and 4.9), which was observed in control biofilm cells, was 
not detected in the gels of treated biofilm cells. Several neutral proteins (pi range 7.15 to 
6.75) disappeared from cells exposed to roxithromycin (spots 10, 15 to 21 and 23) when 
compared to control. Six protein spots (spots number, 41, 46, 51, 44, 45, 53) 
corresponding to (51kDa (pi 5.25), 51kDa (pi 5.1), 43.5kDa (pi 4.93), 44.5kDa (pi 5.13), 
41.5kDa (pi 5.13), 41.5kDa (pi 4.85), respectively) were observed on 2D-gels of biofilm
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cells are more or less, matching those of protein A (minor shifts could be attributed to 
manual calculations or gel to gel variation). Protein A is a cell-associated protein 
expressed on S. aureus  surface and is known to be one of its virulence factors (Mascellino 
et al., 1989; Jendeberg et al., 1996; Hartleib et al., 2000). In 2D-PAGE analysis, protein 
A appears as multiple spots (52.6kDa (pi 5.12), 49.2 kDa (pi 4.9), 43.5kDa (pi 4.91), 
42.4kDa (pi 5.11), 41.7kDa (5.03), 41.5kDa (4.92)) (http://www.expasv.org/swiss- 
2dpage/ac=P99134). These protein spots were observed in biofilm cells (control) and 
antibiotic-exposed cells. Some antibiotics have been found to inhibit protein A expression 
(Gemmell, 1995). However, in this study none of the three antibiotics at 1/16 of MIC was 
able to inhibit the production of this protein. A protein with Mr 27 kDa and pi 8.6 (spot 4) 
appearing in 2D-gels is most probably TSST-1 precursor. TSST-1 precursor is known to 
be produced intracellularly with a molecular weight of 26.3kDa and theoretical pi 8.8 
(Blomster-Hautamaa et al., 1986; http://www.expasy.org). Before its release, a 40 
aminoacid signal peptide is cleaved to give the mature toxin. This protein spot (spot 4) 
appeared in all biofilm cells (control) and treated ones (Figures 4.6 to 4.9). A spot 
representing protein with molecular weight of 22.5kDa and isoelectric point 7.23 (spot 9) 
approximates to TSST-1 (theoretical Mr 22kDa, pi 7.0; Blomster-Hautamaa et al., 1986; 
Reiser et al., 1983).
Comparison of 2D-PAGE profiles of eluate cells, of control and antibiotic- 
exposed cells, indicated marked differences among them. Two proteins having the same 
molecular weight (52.5kDa) (pi 5.77 and 5.68), although absent in control gels (Figure 
4.10) were apparent in cefalexin treated cells (Figure 4.11, Table 4.10, spots F and I 
respectively). Similarly, two new proteins with the same molecular weight (52.5kDa) 
appeared in gels of roxithromycin treatment. The isoelectric points of these proteins were
6.1 and 5.9 (spots F and H, respectively) (Figure 4.13, Table 4.12). Roxithromycin
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resulted in the disappearance of a bright protein spot from eluate cells (spot 34, 
corresponding to 27kDa, pi 5.25), which was reflected on SDS-PAGE gel of the same 
cells (Figure 4.4, lane 3). In gels of control and cefalexin treatment, five spots out of six 
were believed to roughly correspond to those of protein A, (spots 35, 51, 52, 40, 36) 
which represent (50kDa, pi 5.17; 44kDa, pi 4.85; 41kDa, pi 4.85; 41kDa, pi 5.1; 41kDa, 
pi 5.17). The sixth spot could be overlapping or underestimated due to the very close 
molecular weights and isoelectric points of these spots. These spots also appeared in 
eluate cells of ciprofloxacin and roxithromycin treated cells in addition to the sixth spot 
of protein A, spot D (48kDa, pi 4.8) in ciprofloxacin gel and spot M (48kDa, pi 4.85) in 
roxithromycin gel. Spot 2, (26kDa and pi 8.7), which matches that of TSST-1 precursor 
(26.3kDa, pi 8.8), was observed in all eluate cells whether treated or control. Also spot 14 
(22.8kDa and pi 6.95) representing TSST-1, appeared in all gels of eluate supernatants. 
Several other proteins disappeared and many others appeared due to exposing eluate cells 
to sub-MIC of antibiotics (Figures 4.11 to 4.13, Tables 4.10 to 4.12).
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Figure 4.10: 2D-PAGE analysis of untreated eluate cells (control). Protein spots 
were numbered for identification (Table 4.9). Protein loading (30pg).
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Figure 4.11: 2D-PAGE analysis of eluate cells exposed to sub-MIC cefalexin. Protein 
spots were numbered for identification. Missing numbers correspond to missing 
proteins. Novel proteins were given alphabetical numbers (Table 4.10). Protein 
loading (30pg).
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Figure 4.12: 2D-PAGE analysis of eluate cells exposed to sub-MIC ciprofloxacin. 
Protein spots are numbered for identification. Missing numbers correspond to 
missing proteins. Novel proteins are given alphabetical numbers (Table 4.11). 
Protein loading (30pg).
123
Non linear pH 3 to 10
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Figure 4.13: 2D-PAGE analysis of eluate cells exposed to sub-MIC roxithromycin. 
Protein spots are numbered for identification. Missing numbers correspond to 
missing proteins. Novel proteins are given alphabetical numbers (Table 4.12). 
Protein loading (30pg)
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Table 4.9: 2D-PAGE analysis of eluate cells (control). Spots were 
identified by a number. Molecular weight (Mr) and isoelectric 
point (pi) are estimated from their corresponding Rf values. 
Extrapolated values are marked with (*).
Spot Estimated Estimated Spot Estimated Estimated
ID Mr (kDa) pi ID Mr (kDa) pi
1 18.5 9.3 * 36 41 5.17
2 26 8.7 * 37 35.3 5.12
3 26 8.5 * 38 22.8 5.1
4 38.5 8.4 * 39 19.5 5.1
5 38.5 8 * 40 41 5.1
6 36.3 7.8 * 41 84 5
7 26 7.53 42 72 5
8 38.5 7.44 43 63.8 5
9 26 7.37 44 61 5
10 18.5 7.33 45 31.5 4.9
11 58.5 7.2 46 29.3 4.9
12 26 7.2 47 25.3 4.9
13 58.5 6.95 48 19.5 4.9
14 22.8 6.95 49 57 4.85
15 58.5 6.87 50 51.8 4.85
16 22.8 6.83 51 44 4.85
17 19.3 6.43 52 41 4.85
18 58.5 6.04 53 36.5 4.8
19 22.8 6.04 54 32.5 4.75
20 19 6.04 55 25.3 4.7
21 32.5 5.87 56 39.3 4.52
22 58.5 5.8 57 28 4.52
23 51.8 5.8 58 73 4.43
24 41 5.77 59 72 4.43
25 23.3 5.63 60 69 4.43
26 41 5.57 61 55.5 4.43
27 32.5 5.57 62 55 4.43
28 25.5 5.57 63 50 4.43
29 61 5.48 64 56.5 4.17
30 61.5 5.48 65 20 4.13
31 50 5.4 66 38.5 4.07
32 41 5.4 67 33 4.07
33 32.5 5.4 68 73 4.03
34 27.3 5.25 69 22.5 3.6*
35 50 5.17
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Table 4.10: 2D-PAGE analysis of eluate cells exposed to sub-MIC 
of cefalexin compared to those of control. Newly appearing spots 
(proteins) are given alphabetical letters. Disappearing spots are 
given their corresponding numbers as they appear in control gel. 
Molecular weight (Mr) and isoelectric point (pi) are estimated 
from their corresponding Rf values.__________________________
Newly appearing spots 
(compared to control)
Disappearing spots (compared 
to control)
Spot
ID
Estimated 
Mr (kDa)
Estimated
pi
Spot
ID
Estimated
Mr (kDa)
Estimated
pi
A 39.5 6.95 58 70.5 4.43
B 33.3 6.86 66 38.5 4.07
C 41.3 6.4
D 41.3 6.04
E 24 6.04
F 52.5 5.77
G 32.6 5.73
H 24 5.73
I 52.5 5.68
J 56.5 5.58
K 23 5.58
L 24 5.53
Table 4.11: 2D-PAGE analysis of eluate cells exposed to sub-MIC 
of ciprofloxacin compared to those of control. Newly appearing 
spots (proteins) are given alphabetical letters. Disappearing spots 
are given their corresponding numbers as they appear in control 
gel. Molecular weight (Mr) and isoelectric point (pi) are estimated 
from their corresponding Rf values.__________________________
Newly appearing spots 
(compared to control)
Disappearing spots (compared 
to control)
Spot
ID
Estimated 
Mr (kDa)
Estimated
pi
Spot
ID
Estimated 
Mr (kDa)
Estimated
pi
A 41.3 6.95 23 51.8 5.8
B 58.6 6.23 37 35.5 5.07
C 41.3 6.04
D 48 4.8
126
Table 4.12: 2D-PAGE analysis of eluate cells exposed to sub-MIC 
of roxithromycin compared to those of control. Newly appearing 
spots (proteins) are given alphabetical letters. Disappearing spots 
are given their corresponding numbers they appear in control gel. 
Molecular weights (Mr) and isoelectric points (pi) are estimated 
from their corresponding Rf values. Extrapolated values are 
marked with (*).___________________________________________
Newly appearing spots 
(compared to control)
Disappearing spots (compared 
to control)
Spot
ID
Estimated 
Mr (kDa)
Estimated
pi
Spot
ID
Estimated 
Mr (kDa)
Estimated
pi
A 58.5 7.46 9 26 7.37
B 36.3 7.13 23 51.8 5.8
C 39.5 6.95 34 27 5.25
D 41.3 6.15 37 35.3 5.07
E 58.5 6.15 58 73 4.43
F 52.5 6.1 69 22.5 3.6*
G 41.3 5.92
H 52.5 5.92
I 58.5 5.76
J 31 5.6
K 49.5 5.43
L 44 5.33
M 48 4.85
Exposure of biofilms to subinhibitory concentrations of cefalexin, ciprofloxacin 
and roxithromycin, resulted in distinct alterations in the pattern of secreted protein 
profiles, which were consistent with those observed in SDS-PAGE gels. Exposure of 
biofilms to cefalexin at sub-MIC levels resulted in the disappearance of a 29kDa protein 
(pi 8.37) from eluate supernatants (spots 5, Figure 4.15, Table 4.14). This protein was 
present in the supernatants of control biofilms and those exposed to the other treatments. 
The disappearance of this 29kDa protein was consistent with the disappearance of a band 
in SDS-PAGE at similar molecular weight (Figure 4.5, lane 1). Moreover, at 46kDa, two 
protein spots with pis 5.2 and 5.34 were not apparent when compared to control (spots 22 
and 20). The disappearance of these two spots explains the disappearance of a band at 
46kDa in SDS-PAGE (Figure 4.5, lane 1). Two new proteins having same molecular 
weight (28.4kDa, pi 6.4 and 5.32) were secreted / produced when biofilms were exposed
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to cefalexin at sub-MIC (spots C and G respectively, Figure 4.15, Table 4.14). These 
proteins were responsible for the presence of a new band at molecular weight 28kDa in 
SDS-PAGE gels of supernatants exposed to similar conditions (Figure 4.5, lane 1). A 
49kDa protein with isoelectric point 6.25 (spot 13) disappeared from supernatants 
exposed to sub-MIC of roxithromycin (Figure 4.17, Table 4.16). This protein is the same 
one which disappeared from SDS-PAGE gel (Figure 4.5, lane 2). Two protein spots (10 
and 21) disappeared from supernatants exposed to cefalexin (Figure 4.15, Table 4.14) and 
ciprofloxacin (Figure 4.16, Table 4.15), but not roxithromycin. A group of alkaline 
proteins disappeared from supernatants exposed to sub-MIC of cefalexin (pi range 8 to 
8.75) (spots 1, 2, 4, 5, 7 and 8) and at the same time, several acidic proteins appeared (pi 
range 6.09 to 3.75; spots E to R). Several proteins disappeared and new ones appeared in 
samples treated with antibiotics when compared with control (Tables 4.14, 4.15 and 
4.16). ). Spot 9 represents TSST-1 (Mr 22kDa and pi 7.25) which is secreted after its 
cleavage from precursor. This toxin was observed in all 2D-PAGE gels of treated and 
control supernatant preparations.
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Figure 4.14: 2D-PAGE analysis of untreated eluate supernatants (control). Protein 
spots are numbered for identification. Protein loading (25pg).
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Figure 4.15: 2D-PAGE analysis of eluate supernatants exposed to sub-MIC 
cefalexin. Protein spots are numbered for identification. Missing numbers 
correspond to missing proteins. Novel proteins are given alphabetical letters (Table 
4.14). Protein loading (25pg).
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Figure 4.16: 2D-PAGE analysis of eluate supernatants exposed to sub-MIC 
ciprofloxacin. Protein spots are numbered for identification. Missing numbers 
correspond to missing proteins. Novel proteins are given alphabetical letters (Table 
4.15). Protein loading (25pg).
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Figure 4.17: 2D-PAGE analysis of eluate supernatants exposed to sub-MIC 
roxithromycin. Protein spots are numbered for identification. Missing numbers 
correspond to missing proteins. Novel proteins are given alphabetical letters (Table 
4.16). Protein loading (25pg).
130
Table 4.13: 2D-PAGE analysis of eluate supernatant (control).
Spots were identified by a number. Molecular weight (Mr) and
isoelectric point (pi) are estimated from their corresponding Rf
values. ixtrapolatec values are marked witth (*).
Spot Estimated Estimated Spot Estimated Estimated
ID Mr (kDa) pi ID Mr (kDa) pi
1 21.5 8.75* 25 42.5 5.03
2 20 8.65* 26 36 5.03
3 33 8.5 * 27 25 5
4 31 8.5 * 28 20 5
5 29 8.37* 29 74.5 4.94
6 26.5 8.27* 30 64 4.94
7 58.5 8 * 31 49.3 4.84
8 40.6 8 * 32 47 4.84
9 22.8 7.25 33 27.5 4.84
10 60 6.68 34 24.8 4.84
11 31.5 6.68 35 54.8 4.77
12 24 6.54 36 21.2 4.77
13 49.3 6.25 37 17.5 4.77
14 62 6.11 38 26.5 4.70
15 27.5 6.11 39 73.3 4.57
16 59.3 5.8 40 42.5 4.57
17 45 5.51 41 68.4 4.5
18 35 5.51 42 57 4.5
19 27.5 5.48 43 24 4.45
20 46 5.34 44 38.5 4.18
21 32 5.24 45 35.3 4.18
22 46 5.2 46 32 3.97
23 23.5 5.16 47 18 3.75
24 21 5.16 48 21.6 3.75
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Table 4.14: 2D-PAGE analysis of eluate supernatants exposed to 
sub-MIC of cefalexin compared to those of control. Newly 
appearing spots (proteins) are given alphabetical letters. 
Disappearing spots are given their corresponding numbers as they 
appear in control gel. Molecular weight (Mr) and isoelectric point 
(pi) are estimated from their corresponding Rf values. 
Extrapolated values are marked with (*).______________________
Newly appearing spots 
(compared to control)
Disappearing spots (compared 
to control)
Spot Estimated Estimated Spot Estimated Estimated
ID Mr (kDa) pi ID Mr (kDa) pi
A 42 7.25 1 21.5 8.75 *
B 34 7.27 2 20 8.65 *
C 28.4 6.4 4 31 8.5 *
D 34.5 6.15 5 29 8.37 *
E 23 6.09 7 58.5 8 *
F 51.7 5.56 8 40.6 8 *
G 28.4 5.32 10 60 6.68
H 51.7 5.05 20 46 5.34
I 21.7 5.05 21 32 5.24
J 36 4.88 22 46 5.2
K 40.8 4.4
L 33.7 4.3
M 31 4.21
N 18 4.15
O 22.2 4.04
P 21.4 4.204
Q 47.5 3.81
R 75 3.75
Table 4.15: 2D-PAGE analysis of eluate supernatants exposed to 
sub-MIC of ciprofloxacin compared to those of control. Newly 
appearing spots (proteins) are given alphabetical letters. 
Disappearing spots are given their corresponding numbers as they 
appear in control gel. Molecular weight (Mr) and isoelectric point 
(pi) are estimated from their corresponding Rf values.
Newly appearing spots 
(compared to control)
Disappearing spots (compared 
to control)
Spot
ID
Estimated
Mr (kDa)
Estimated
pi
Spot
ID
Estimated
Mr (kDa)
Estimated
pi
A 62.5 5.72 10 60 6.68
B 19.8 5.14 21 32 5.24
C 35.3 4.88 24 21 5.16
D 36 4.76 33 27.5 4.84
34 24.8 4.84
37 17.5 4.77
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Table 4.16: 2D-PAGE analysis of eluate supernatants exposed to 
sub-MIC of roxithromycin compared to those of control. Newly 
appearing spots (proteins) are given alphabetical letters. 
Disappearing spots are given their corresponding numbers as they 
appear in control gel. Molecular weight (Mr) and isoelectric point 
(pi) are estimated from their corresponding Rf values. 
Extrapolated values are marked with (*).______________________
Newly appearing spots 
(compared to control)
Disappearing spots (compared 
to control)
Spot Estimated Estimated Spot Estimated Estimated
ID Mr (kDa) pi ID Mr (kDa) pi
A 40.6 7.69 * 13 49.3 6.25
B 22 7.69* 14 62 6.11
C 32 7.3
D 40.6 7.15
E 19 4.44
The results obtained from SDS-PAGE and 2D-PAGE analysis showed that marked 
differences in protein profiles of whole cell proteins and secreted proteins exist among 
biofilms treated with sub-MIC of different antibiotics on one hand and among treated 
biofilms and control on the other hand. While many proteins were common between 
treated and control cells or supernatant samples, others appeared to be novel (proteins that 
were detected in treated samples, but not in control ones). Moreover, some proteins 
disappeared from cells or supernatants following exposure to subinhibitory levels of 
antibiotics.
Since most virulence factors expressed by S. a u r e u s  (whether cell associated or 
secreted) are proteins in nature, then the observed alterations in protein profiles due to 
exposure to sub-MIC of antibiotics may reflect alterations in virulence factor production. 
It is suggested that this will lead to variations in bacterial pathogenicity. It has been found 
that protein profile alterations induced by exposure to sub-MIC of antibiotics that act by 
inhibiting protein synthesis, such as lincosamides and linezolid, were caused by 
alterations in virulence factors rather than alterations in ribosomal protein or non toxic 
proteins (Gemmell, 1995; Herbert et al., 2001; Bernardo et al., 2004). One of the reasons
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could be that toxin production in S. au r e u s  is controlled by membrane associated 
ribosomes that are more prone to attack by a small number of antibiotics that reach them 
than cytoplasmic ribosomes, which are concerned with structural and cell maintenance 
proteins (Gemmell, 1995). The other reason is that, these protein synthesis inhibitor 
antibiotics act by differential inhibition of the synthesis of one or more of the regulatory 
proteins (Herbert et al., 2001). This will result in inhibition of synthesis of some 
virulence factors and the increase in production of the others (Herbert et al., 2001).
Variation in vimlence factor production could be a result of alterations at 
transcriptional level, translational level or alterations in metabolic pathways. For 
example, subinhibitory concentrations of nafcillin (a p-lactam antibiotic) induced 
transcription and prolonged mRNA for Panton-Valentine leukocidin, a-toxin and TSST-1 
in S. aureus  (Stevens et al., 2007). In contrast, linezolid and clindamycin repressed 
translation rather than transcription of those toxin genes (Stevens et al, 2007).
Toxic Shock Syndrome Toxin 1 is a vimlence factor secreted by some strains of 
S. aureus. In this study, TSST-1 was observed in order to investigate the effect of 
subinhibitory concentrations of antibiotics on its production. TSST-1 precursor was 
observed in biofilm and eluate cells of biofilms exposed to sub-MIC of cefalexin, 
ciprofloxacin and roxithromycin and controls. Furthermore, TSST-1 was detected in 
biofilm and eluate cells and eluate supernatants of those treated and control biofilms. The 
information obtained from electrophoresis indicated the presence of TSST-1 in 
extracellular secretions of biofilms exposed to the antibiotics, but cannot indicate whether 
the biological activity of the toxin was altered by exposing biofilms to sub-MIC of 
antibiotics or not. Therefore, in order to obtain such data, TSST-1 has to be purified from 
eluate supernatants of biofilms that were challenged with treatments and control, in order 
to observe its altered biological activity, if any. This study will be discussed in Chapter 6.
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In addition, in order to have a better picture of the effect of sub-MIC on secreted 
virulence factors, these virulence factors should be evaluated individually. Thus, the next 
chapters will deal with some selected virulence factors.
4.5 Conclusion
The aim of this chapter was to investigate the effect of sub-MIC of cefalexin, 
ciprofloxacin and roxithromycin on S. a u reus  proteins: whole cell and secreted proteins. 
Distinct alterations in protein profiles were detected by SDS-PAGE, which were 
confirmed and more detailed by 2D-PAGE. These shifts in protein profiles are believed to 
be caused in part by alterations in virulence factor expression whether cell associated or 
secreted. Hence, selected virulence factors will be further studied to investigate the effect 
of antibiotic exposure on their production. Furthermore, TSST-1 precursor was detected 
in the cells exposed to sub-MIC antibiotics and mature TSST-1 was detected in bacterial 
cells and secretions. Whether the amount of TSST-1 secreted or its biological activity was 
affected by the exposure to antibiotic or not will be investigated later.
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Chapter 5
Effect of subinhibitory concentration of selected antibiotics on 
some virulence factors of S taph ylococcu s au reu s  NCTC 11962 
biofilms
5.1 Introduction
The pathogenicity of S. a ureus  depends on its ability to produce numerous 
virulence factors, such as secreted toxins and enzymes, cell wall associated proteins and 
polysaccharides. These factors may be considered as accessory gene products that are not 
required for growth and cell division under normal conditions, but to enable 
microorganisms to adapt to special environmental conditions and to adhere to and invade 
the host tissues (Herbert et al., 2001).
The clinical efficacy of antibiotics does not depend solely on their ability to 
produce a bactericidal or bacteriostatic effect on infecting bacteria, but also upon their 
action on bacterial virulence factor production or release (Bernardo et al., 2004). In 
general, antibiotics can enhance the release of some virulence factors and down regulate 
the synthesis and release of others depending on the type of antibiotic (Gemmell, 1995; 
Stevens et al., 2007). Therefore, the antibiotic-induced regulation of virulence factors 
could either worsen or attenuate the disease (Bernardo et al., 2004).
As discussed earlier in Chapter 1, the production of staphylococcal virulence 
factors is regulated through a quorum sensing system. As cell density increases during the 
post-exponential phase, S. aureus  switches its virulence factor production from cell 
associated factors to secreted ones (Ji et al., 1995; Arvidson, 2004). This switch is 
modulated by global regulators. The most important regulators are the a g r  (accessory 
gene regulator) and the sar  (staphylococcal accessory regulator) discussed in Chapter 1.
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Several studies have investigated the effect o f antibiotics at s u b -M IC  levels on the 
production o f virulence factors. S u b -M IC  n a fc illin  has been found to induce the  
production o f  Panton valentine leukocid in , toxic  shock syndrom e tox in  1 and alpha tox in . 
O n the other hand, c lindam ycin  and lin e zo lid  s ignificantly  suppressed the production o f  
these toxins (Stevens et al, 2 007). S u b -M IC s  o f  cefodizim e dow n to 1 /32  M IC  have been  
found to inh ib it the adhesiveness o f E. coli to hum an epith e lia l cells. A lso  s u b -M IC s  o f  
this antibiotic have been found to reduce haem agglutination and hydrophobicity  o f  E. coli 
(Braga et al, 2 000). S u b -M IC  lin ezo lid  im paired  the production o f  D N ase  and increased  
the susceptibility o f  Streptococcus p y o g e n e s  to phagocytosis (G e m m e ll and Ford, 2 0 0 2 ). 
A t 1/2 to 1/8 M IC  o f  am ikacin and 1/2 to 1 /16 M IC  o f  c ip ro floxac in , E. coli cells changed  
from  hydrophobic state to hydrophilic  state and c ip ro floxacin  at 1/2 M IC  was the m ost 
effective  in  reducing the bacterial adherence capability  (W o jn ic z  and Jankow ski, 2 0 0 7 ).
In  this chapter, the effect o f exposing S. aureus  N C T C  11962  b io film s  to 1 /16  
M IC  o f  cefalexin , c ipro floxacin  and rox ith rom ycin  on the production o f  coagulase, T o x ic  
Shock Syndrom e T o x in  1 and protease w il l  be investigated. In  addition, the ab ility  o f  S. 
aureus  to form  b io film  in  presence o f antibiotics at s u b -M IC  levels w il l  be evaluated.
5.2 Coagulase
Coagulase belongs to a group o f  proteins that b ind specifica lly  to fib rinogen, 
called the fibrinogen b inding proteins (Boden and F lock, 1989; P a lm a et al., 2 0 0 1 ). I t  is a 
predom inantly extracellu lar protein that binds to prothrom bin  fo rm in g  a com plex  
com pound called staphylothrom bin that has throm bin -like  activ ity , w h ich  converts  
fibrinogen into fib rin  (K aw abata  et al, 1986). A  fraction o f the coagulase is bound to the 
bacterial cell. This bound form  o f  coagulase was earlier confused w ith  the c lum ping  
factor, until it was genetically  proved otherwise (M c D e v itt  et al, 1992). Coagulase is
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considered one o f  the most re liab le  determ inants fo r the id en tifica tio n  and classification
o f  staphylococci and it is considered a v iru lence factor in  its ow n  righ t (S aw ai et al., 
1997). T he  role that coagulase plays as a viru lence factor appears in  som e, but not a ll o f  
the infectious processes induced by S. aureus. For exam ple, the in vitro adherence o f  
coagulase defective S. aureus  mutants to either rat fibrinogen or p la te le t-fib rin  clots was 
not altered w hen com pared to the parental bacteria (M o re illo n  et al, 1995). A t  the same 
tim e no difference has been noticed in  the in fec tiv ity  betw een coagulase-deficient 
mutants and the w ild  type cells in  a rat endocarditis m odel (M o re illo n  et al, 1995). In  
another study, addition o f  h ighly p u rified  coagulase to coagulase-deficient m utants o f  S. 
a ureus  has no enhancement effect on the v iru lence o f this m utant, w h ile  the addition  o f  
concentrated culture filtrate  o f  the parent bacteria to the coagulase defic ient m utant, 
enhanced its virulence rem arkably (Hasegaw a et al., 1983). B y  studying S. a u reus 
N ew m an  strain and its coagulase negative m utant, coagulase has been found to p lay  some 
ro le in  the attachment o f  S. aureus  to purified -fib rinogen-coated  surface, but has no  
significant role in  the attachment to plasm a-coated surfaces (D ick in so n  et al., 1995). 
M e ie r  et al, (20 01 ) transferred the c lum ping  factor gene and coagulase gene to the less 
v iru lent bacterium , Streptococcus gordonii, w hich  was able to express the ir gene 
products. Coagulase positive transform ants w ere neither m ore adherent to p la te le t-fib rin  
clots nor m ore in fective in  the rat endocarditis m odel than the parent, w h ile  c lum ping  
factor transformants were m ore adherent and m ore in fective than the parental bacteria. O n  
the other hand, coagulase has been found to p lay  a significant ro le  as a v iru lence factor in  
other models. A  study in  mouse m astitis m odel has shown that a -hem o lys in -neg ative  
single m utant and coagulase-negative single m utant have lo w e r v iru lence com pared to 
w ild  type (Jonsson et al., 1985). Furtherm ore, double m utant S. a u r e u s  has shown a 
dram atic decrease in  virulence, such that on ly  m inor changes w ere observed after
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microscopic inspection of the mouse infected tissue (Jonsson et al, 1985). Moreover, in a 
murine blood-borne staphylococcal pneumonia model, a significant correlation existed 
between coagulase titre and the number of bacteria recovered from lung tissue (Sawai et 
al, 1997). When a coagulase-deficient strain was used to infect the lungs, a reduced 
number of viable bacteria were isolated from the lungs when compared with the parental 
strain (Sawai et al, 1997). These findings suggest that coagulase is a virulence 
determinant in S. au r e u s .
Coagulase is mainly synthesized in the exponential growth phase in contrast to 
other extracellular proteins, which are produced in post-exponential phase. The regulation 
of coagulase expression is modulated both positively and negatively by the a g r  locus 
(Lebeau et al, 1994). Many researchers have studied the effect of subinhibitory 
concentrations of different antibiotics on coagulase as one of the virulence factors. At 1/2 
MIC, 1/4 MIC and 1/8 MIC, linezolid (which inhibits bacterial translation) reduced the 
production of coagulase by 16, 8 and 4 times, respectively, when compared to control, an 
effect that was attributed to the inhibition of protein synthesis (Gemmell and Ford, 2002). 
The effect of sub-MIC silver sulphadiazine (a topical antibacterial agent) on coagulase 
production by two strains of S. aureus  has been investigated. In one strain, the detection 
of coagulase in supernatants was delayed for 21 hours with no effect on the amount 
secreted. However, the production and timing of coagulase in the other strain was not 
affected (Edwards-Jones and Foster, 2002). No effect of sub-MIC clindamycin has been 
detected on coagulase production from S. aureus, although the production of many other 
exoproteins was reduced (Herbert et al, 2001).
In this section, the production of coagulase in eluate supernatants of S. au r e u s  
NCTC11962 biofilms exposed to 1/16 MIC of cefalexin, ciprofloxacin and roxithromycin 
will be investigated and compared to untreated biofilms.
139
5.2.1 Experimental approach
5.2.1.1 Preparation o f  eluate supernatants
Four S. aureus  biofilms were established on Sorbarods (as described in Chapter 2) 
at the same time and under exactly the same conditions. The dimensions and weights of 
Sorbarods were selected to have less than 0.1% relative standard deviation. The filters 
were inoculated with 3mL of mid-exponential phase of same inoculum culture grown in 
BHI. In order to avoid minor variations in prepared media composition, the filters were 
perfused from the same brain heart infusion medium preparation except that, each filter 
was perfused with BHI containing sub-MIC of one of the selected antibiotics. One filter 
unit was perfused with BHI without antibiotic, as a control. After reaching steady state, 
after 48 hours, eluates were collected and supernatants were obtained as was described 
earlier in Chapter 2. Supernatants were stored immediately at -20°C until required for 
subsequent analysis.
5.2.1.2 D e t e r m i n a t i o n  o f  c o a g u l a s e  titre
In order to determine coagulase activity in a quantitative fashion, the titre of 
soluble coagulase in culture supernatants was determined. In this method, serial dilutions 
of supernatants were prepared and mixed with plasma. After incubation, the reciprocal of 
the highest dilution showing visible plasma coagulation was taken as the titre (Edward- 
Jones and Foster, 2002; Gemmell and Ford, 2002; Yanagihara et al., 2006).
In this study, eluate supernatants of control biofilm and of biofilms exposed to 
sub-MIC of cefalexin, ciprofloxacin and roxithromycin were applied in triplicate to 96- 
well round bottom microtiter plate. The supernatants were serially diluted and equal 
volumes of citrated rabbit plasma were applied as was described in section 2.9.1 Chapter
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2. After 4 hours incubation at 37°C, the plates were visualized against a black background 
and the titre for each treatment was recorded. The test was repeated three times.
5.2.1.3 Statistical analysis
Statistical difference among the results obtained by the treatments and control 
were examined by one way analysis of variance (ANOVA), followed by Tukey multiple 
intergroup comparison. P values <0.05 were considered significant. Since these tests are 
based on two assumptions, normal distribution of the results and equal variance, these 
assumptions were checked first. Normality of results was tested using Anderson-Darling 
test (p >0.05). Equal variance was tested using Bartlett's test (p >0.05). All calculations 
were carried out using Minitab 15 software.
5.2.2 Results and discussion
Figure 5.1 exhibits the results of coagulase titres for different treatments and 
Table 5.1 gives the statistical analysis of the results. The results were normally distributed 
(Anderson-Darling p = 0.431, p >0.05) with equal variance (Bartlett's p = 0.095, p >0.05). 
The production of coagulase in eluate supernatants exposed to roxithromycin is the least 
when compared to other treatments and control. Although it is not significant compared 
to other treatments, it is significantly less than that of control (p <0.05). This result agrees 
with the work of others. Moneib et al. (1993), who have shown that sub-MICs of new 
macrolides (azithromycin, clarithromycin and roxithromycin) suppress the production of 
coagulase from S. aureus, although erythromycin has no effect. In another study, protein 
synthesis inhibitors (chloramphenicol, gentamicin and tetracycline) at sub-MIC levels 
reduced the production of coagulase (Doss et al., 1993). However, sub-MIC clindamycin 
had no significant effect on coagulase production in spite of the fact that other
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exoproteins were reduced (Herbert et al, 2001). On the other hand, coagulase production 
in eluate supernatants exposed to sub-MIC ciprofloxacin and cefalexin were not 
significantly different from each other or from the control (Figure 5.1 and Table 5.1). 
These results support the results obtained by Doss et al, (1993). In their work, they have 
found that subinhibitory concentration of methicillin (a p-lactam antibiotic), has no effect 
on coagulase production, which agrees with the results obtained with cefalexin. Similarly, 
enoxacin and ciprofloxacin at sub-MIC have been shown not to affect the production of 
coagulase (Doss et al, 1993). This confirms the result obtained from eluate supernatants 
exposed to ciprofloxacin.
Figure 5.1: Coagulase titre of eluate supernatants exposed to sub-MIC ciprofloxacin 
(cipro), cefalexin (cefalex), roxithromycin (Rox) and control. Error bars represent 
standard deviation for each treatment, where n=4.
Table 5.1: Statistical analysis of coagulase titre using Tukey 
multiple intergroup comparison. Treatments that are significantly 
different are given different letters. Treatments that are 
significantly similar are given the same letter.
Control Roxithromycin Cefalexin Ciprofloxacin
A B AB AB
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5.3 Biofilm assay
B io film  assay or testing the a b ility  o f  staphylococci to fo rm  b io film  in vitro has 
been proposed as a useful m arker fo r the viru lence o f  the bacteria (D aven p o rt et cil., 1986; 
D eighton  and B alkau, 1990). In  this test, bacteria are a llo w ed  to g row  in  polystyrene  
m icro tite r plate w ells. A fte r the incubation period, the plate is washed and stained. 
O ptica l density o f  the solubilized stain is measured and is found to be proportional to the 
am ount o f  adherent b io film s that absorbed the stain.
The b io film  assay has been used w id e ly  to detect the a b ility  o f  bacteria to fo rm  
b io film  in  com parative studies (D jo rd jev ic  et al., 2002; K ap lan  and M u lk s , 200 5 ; Jin et 
al., 2 00 6 ) or to quantify the amounts o f  b io film  produced betw een d iffe rent strains or 
grow th conditions (Stepanovic et ciL, 2000; Stepanovic et al ., 2 00 1 ; M itra k u l et al., 2005; 
M oh am ed  et al., 2007). M oreo ver, the b io film  assay has been shown to be convenient and 
useful in  screening fo r enteroaggregative E. coli, based on the optical density o f  the 
stained b io film s (W ak im o to  et al., 2 004).
In  this section, the ab ility  o f  S. au r e u s  to form  b io film  in  the presence o f  several 
subinhibitory concentrations o f  antibiotics w il l  be quantified and com pared w ith  that o f  
control.
5.3.1 Experimental approach
The m ethod used by Stepanovic et al. (2 0 0 0 ) and the ir c riteria  fo r the evaluation  
o f b io film  form ation has been adopted in  this study. Serial d ilutions o f  antibiotics in  B H I  
w ere placed in  trip licate in  9 6 -w e ll m icro tite r plates, so that w hen the bacterial 
suspension was added, the concentration o f  antibiotics cover the range o f  9 0 %  M IC  to 
0 .35 %  M IC  (procedure details described in  Chapter 2, section 2 .9 .2 .2 ). A  positive control 
was prepared using broth alone w ith o u t antib iotic. A  m id -exponentia l phase S. a ureus
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culture (adjusted to 0.5 McFarland) was used to inoculate all the wells. Negative controls 
were prepared by adding broth to eight wells without inoculation. After 24hr incubation 
at 37°C, the plate was washed and stained (as described in Chapter 2). After solubilizing 
the dye, the plate was placed on ELISA reader and optical density (562nm) of the wells 
was recorded.
5.3.2 Data analysis
For comparative analysis of the results, adherence capability of the bacteria was 
classified into four categories: non-adherent, weakly adherent, moderately adherent and 
strongly adherent (Stepanovic et al, 2000). Optical density cut-off (ODc) for the 
microtiter plate test was defined as three standard deviations above the mean OD of the 
negative control. Table 5.2 shows the classification of adherence capability of the 
bacteria.
Table 5.2: Classificat 
(optical density), ODc
ion and criteria of adherence capabilities, OD 
'optical density cutoff) (Stepanovic et ah,  2000)
Classification Criteria
Non-adherent OD less than or equal to ODc
Weakly adherent OD more than ODc and less than 2 fold ODc
Moderately adherent OD more than 2 fold ODc and less than 4 fold ODc
Strongly adherent OD more than 4 fold ODc
5.3.3 Results and discussion
Tables 5.3 and 5.4 show OD results of positive and negative controls and those in 
the presence of antibiotics, respectively. From Table 5.3, one may observe the OD cut off 
equals 3 x 0.0095 + 0.1099 = 0.1384. Thus, the criteria mentioned in Table 5.2 can be 
defined and re-written in numerical values (Table 5.5). Accordingly, the ability of S. 
aureus  to form biofilm in the absence and presence of sub-MIC of antibiotics is classified
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as in Table 5.6. These results show that the ability of untreated bacteria to produce 
biofilm in microtiter plate is weak. The same was noticed when the bacteria were treated 
with ciprofloxacin in the range of 90% MIC to 0.35% MIC. This indicates that 
ciprofloxacin has neither inhibitory nor stimulatory effect on biofilm formation under the 
experimental conditions applied in this study. Similar results were obtained by Perez- 
Geraldo et al. (1994), when 12 strains of S. epidermidis bacteria were exposed to 1/2, 1/4, 
1/8 and 1/16 MIC of three fluoroquinolone antibiotics (ciprofloxacin, ofloxacin and 
sparfloxacin). Compared to control, none of these antibiotics modified bacterial 
adherence to microtiter plate. Moreover, Rupp and Hamer (1998) reached the same 
conclusion when sub-MIC ofloxacin, a fluoroquinolone, produced no significant effect on 
biofilm production of two strains of S. epidennidis. When the cells were grown in the 
presence of roxithromycin in the range of 45% MIC to 0.35% MIC, biofilm formation 
was similar to that of the control (weak) (Table 5.6). At 90% MIC roxithromycin, the 
bacteria lost its ability to produce biofilm (Table 5.6). These results agree with the 
findings of Rachid et al., (2000). In their study, some protein synthesis inhibitors, 
chloramphenicol, clindamycin and gentamicin produced no effect on ica operon 
expression when used at 1/70 to 1/2 MIC. Therefore, biofilm formation was not affected. 
On the other hand, other protein synthesis inhibitors, quinupristin-dalfopristin and 
tetracycline have strongly induced biofilm formation of S. epidennidis through enhancing 
ica expression at these sub-MICs (Rachid et al., 2000). The ica operon is known to 
encode the enzymes involved in biosynthesis of polysaccharide intercellular adhesin 
(PIA) (Heilmann et al., 1996). However, when concentrations above 1/2 MIC were 
applied, biofilm formation was inhibited (Rachid et al., 2000), which agrees with the 
observed effect of roxithromycin at 90% MIC.
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Cefalexin induced biofilm formation in the range of 2.81% to 45% sub-MIC, 
while its effect on biofilm formation at lower sub-MIC, 1.41%, 0.7% and 0.35% MIC and 
at 90% MIC was not significant (Table 5.6). These findings are comparable to those 
obtained by Dunne (1990). In his study, cefamandole, a cephalosporin antibiotic, resulted 
in variable biofilm densities when coagulase-negative staphylococci were grown in 
different sub-MICs in microtiter plates. Twelve percent of the strains exhibited both 
increased and decreased densities dependant upon the sub-MIC used, 42% of strains had 
increased biofilm density, while 38% of strains had reduced biofilm density (Dunne, 
1990). However, treating two strains of S. epidermidis with sub-MIC cefazolin, another 
cephalosporin drug, resulted in significant decrease in biofilm formation (Rupp and 
Hamer, 1998).
Table 5.3: OD results at 562nm for positive and negative 
controls in microtiter plate.
Parameter Positive control 
(OD 562nm)
Negative control 
(OD 562nm)
Average 0.1532 0.1099
Standard deviation 0.0146 0.0095
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Table 5.4: OD i 
plates after bein
*esults at 562nm for stained biofilms in microtiter 
g exposed to sub-MICs of different antibiotics.
% MIC OD at 562nm, average (standard deviation)
Cefalexin Ciprofloxacin Roxithromycin
90% 0.211 (0.0227) 0.206 (0.0094) 0.093 (0.0036)
45% 0.431 (0.0159) 0.189 (0.0089) 0.158 (0.0038)
22.5% 0.521 (0.0390) 0.162 (0.0019) 0.189 (0.0148)
11.25% 0.330 (0.0089) 0.149 (0.0079) 0.170 (0.0101)
5.63% 0.310(0.0146) 0.145 (0.0053) 0.180 (0.0262)
2.81% 0.283 (0.0080) 0.159 (0.0184) 0.174 (0.0170)
1.41% 0.231 (0.0062) 0.139 (0.0084) 0.177 (0.0168)
0.70% 0.223 (0.0040) 0.152 (0.0103) 0.174 (0.0242)
0.35% 0.209 (0.0497) 0.161 (0.0339) 0.176 (0.0233)
Table 5.5: classification and criteria of S. aureus adherence 
capabilities in numerical values.
Classification Criteria
Non-adherent OD less than or equal 0.1384
Weakly adherent OD more than 0.1384 and less than 0.2768
Moderately adherent OD more than 0.2768 and less than 0.5536
Strongly adherent OD more than 0.5536
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Table 5.6: Classification of the ability of S. aureus to form biofilm 
in microtiter plate based on criteria in Table 5.5.
% MIC Biofilm formation classification
Cefalexin Ciprofloxacin Roxithromycin
90% Weak Weak Non
45% Moderate Weak Weak
22.5% Moderate Weak Weak
11.25% Moderate Weak Weak
5.63% Moderate Weak Weak
2.81% Moderate Weak Weak
1.41% Weak Weak Weak
0.70% Weak Weak Weak
0.35% Weak Weak Weak
5.4 Production of Toxic Shock Syndrome Toxin 1
As was discussed earlier in Chapter 1, TSST-1 is a superantigen that is considered 
the major causative agent of toxic shock syndrome cases. TSST-1 isolated from toxic 
shock syndrome patients was isolated from S. aureus (Todd et al., 1978; Bohach et ah, 
1990). Only some strains of S. aureus produce TSST-1 (Reeves et aL, 1984). Orden et al.
(1992) have shown that some strains of coagulase-negative staphylococci isolated from 
mastitis affecting some animals, produced TSST-1. However, Parsonnet et al. (1987), 
observed that none of the 111 coagulase-negative strains isolated from new and used 
tampons and from the genital tract of toxic shock patients, produced TSST-1. TSST-1 
production, as most other S. aureus secreted virulence factors, is regulated via agr and sar 
loci. TSST-1 production occurs in the post-exponential phase when a critical cell mass is 
attained (Sarafian and Morse, 1987). However, Wong and Bergdoll (1990), observed that 
the maximal rate of TSST-1 synthesis was during mid to late-exponential phase. The fact
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that TSST-1 production occurs during mid to late exponential phase suggests that nutrient 
limitation could play a role in its production. Although it is known that nutrient deprived 
batch culture cells are typical in the stationary phase, several studies have shown that 
reductions in specific nutrients takes place before the onset of stationary phase (Brown et 
al, 1990). In general, bacteria respond to nutrient limitation by the so-called stringent 
response (Godfrey et al, 2002; Jain et a l, 2006). Under conditions of nutritional and 
metabolic stresses, bacteria synthesize an unusual guanosine nucleotide termed GDP 3'- 
diphosphate or GTP 3'-diphosphate (referred to together as (p)ppGpp or 'magic spot') 
(Cashel, 1974; Cashel, 1975). The accumulation of (p)ppGpp in the cells will turn on the 
stringent response. The transcription of stable RNA, such as tRNA and rRNA, will be 
repressed and the expression of genes involved in the survival of cells under stringent 
conditions will be upregulated (Chatterji and Ojha, 2001). (p)ppGpp has been found to be 
involved in various physiological aspects such as quorum sensing, antibiotic production, 
biofilm formation and virulence (Jain et a l, 2006). In one study, biotin limitation resulted 
in 50 to 200 fold increase of intracellular toxins of Clostridium difficile (Karlsson et a l , 
1999). However, in another study, Bacillus anthracis stringent response was responsible 
for sporulation but not toxin production and virulence (Schaik et a l, 2007). Although 
(p)ppGpp has been found in staphylococci (Cassels et a l, 1995), its role in toxin 
production needs to be elucidated.
On the other hand, S. aureus has been found to respond to environmental stress 
through a 6 factor (described in Chapter 1). However, the role of gb factor was found not 
to be vital for starvation survival (Chan et al, 1998).
Production of TSST-1 is affected by the surrounding environment (Wong and 
Bergdoll, 1990). Aeration has an enhancing effect on TSST-1 yield up to a limit where 
excessive aeration has an inhibitory effect. Carbon dioxide has a stimulatory effect on
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toxin production (Wong and Bergdoll, 1990). Furthermore, antimicrobials have different 
effects on the synthesis of TSST-1, depending on the type and concentration of the 
antibiotic in addition to the bacterial strain (Reeves et al, 1984; Dickgiesser and Wallach, 
1987; Gemmell, 1995; Stevens et al., 2007).
Several methods have been used for the detection or quantitation of TSST-1 in 
culture supernatants or biological media. One of the methods is optimal sensitivity plate 
(OSP) developed by Robbins et al. (1974). It is based on immunodiffusion technique, 
which is performed in Petri dishes filled with agar of specific type and concentration. The 
sample containing toxin and antisera specific for the toxin are added separately to wells in 
the agar. After incubation, lines of precipitation indicate presence of toxin. OSP is used 
mainly to detect presence of toxin in culture supernatants (Robbins et a l , 1974; De 
Buyser et a l, 1987; Daghistani et a l, 2000). Enzyme linked immunosorbent assay 
(ELISA) technique as such or modified have been used widely to detect and quantitate 
TSST-1 in culture supernatants (Rosten et al, 1987; Daghistani et a l, 2000), in vaginal 
washings (Rosten et al, 1987) and in human serum or plasma (Miwa et al., 1994; Miwa 
et al., 2000). The principle of one of the ELISA techniques, is to fix specific antibodies to 
a surface (microtiter wells) and the sample containing the antigens is added so that 
antigen-antibody interaction occurs. An enzyme conjugated to another antibody is added 
so that a complex is formed between the antigen and the conjugated antibody. Later, a 
substrate which can be converted by the enzyme to a detectable, measurable compound is 
added (Wells et al., 1987; Rosten et a l, 1987).
The reversed passive latex agglutination method (RPLA) was first reported as a 
method for the detection of TSST-1 by Igarashi et al. (1986). Before that it was used in 
Japan for the detection of staphylococcal enterotoxins since it proved to be more sensitive 
than immunodiffusion method (Igarashi et a l, 1986). In this method soluble antigen
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(TSST-1 in this case) reacts with its specific antibody that is attached to non-reactive 
latex particles where the agglutination reaction occurs (Igarashi et al., 1986). Since in 
standard agglutination, soluble antibody reacts with a particulate antigen, the term 
(reversed) is used for RPLA. Also, since the latex particles attached to antibody are inert, 
they are passive, therefore, the method is named Reversed Passive Latex Agglutination.
Takeuchi et al. (1998), used RPLA to quantitate the production of TSST-1 from 
isolates from mastatic cow's milk and farm bulk milk. In addition, RPLA was used to 
screen for the production of Staphylococcus enterotoxins in a food poisoning outbreak 
(Wei and Chiou, 2002). Moreover, some health authorities use or recommend the use of 
RPLA test to screen for certain pathogenic toxins (Akhtar, 2005; Feng, 2001).
5.4.1 Detection and quantitation of TSST-1
The amount of TSST-1 present in eluate supernatants of biofilms exposed to sub- 
MIC antibiotics was determined semiquantitatively by measuring the titre of the toxin in 
the supernatants (using RPLA kit as was described in Chapter 2), and then multiplying 
the titre by the detection limit of the anti-TSST-1 antibody.
In order to determine the limit of detection of the antibody suspension in this 
RPLA kit, it has to be titrated against purified TSST-1 standard (Sigma) with known 
concentration. To do so, 25jliL TSST-1 standard (Sigma) (lmg mL'1) was serially double 
diluted with RPLA diluent in 96-well V-shaped bottom microtiter plate. The 
concentrations were in the range of 0.25ng mL'1 to 5xl05ng mL'1. 25 pL of latex 
suspension sensitised with specific rabbit IgG antibody against staphylococcal TSST-1 
was added to all dilutions and mixed. The plates were covered and incubated at room 
temperature on a vibration free surface. After 24hr, the lowest concentration of TSST-1 
that produced agglutination was recorded.
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5.4.2 Results and discussion
The limit of detection of latex suspension sensitized with specific antibody was 
found to be 0.5ng mL'1. Accordingly, the concentration of TSST-1 present in each eluate 
supernatant was calculated. Table 5.7 shows the results of titre for eluate supernatants 
exposed to sub-MIC antibiotics and the corresponding concentration of TSST-1.
Table 5.7: TSST-1 titre and concentration in eluate 
supernatants of biofilms exposed to sub-MIC 
antibiotics.
Treatment Titre Estimated concentration 
(ng mL'1)
Control 4096 0.5x4096=2048
Roxithromycin 4096 0.5x4096=2048
Cefalexin 1024 0.5x1024=512
Ciprofloxacin 2048 0.5x2048=1024
The amount of TSST-1 released in supernatants exposed to roxithromycin (protein 
synthesis inhibitor) is similar to that released in control supernatants, indicating that 
roxithromycin at 1/16 MIC has no effect on TSST-1 release. Several workers have 
studied the effect of protein synthesis inhibitors on TSST-1 production. Herbert et aL, 
(2001) found that sub-MIC clindamycin inhibits TSST-1 and other exoprotein synthesis 
through blocking gene transcription. This blocking is believed to be a result of differential 
inhibition of the translation of a regulatory protein. In another study (Dickgiesser and 
Wallach, 1987), 1/4 MIC of clindamycin, erythromycin and lincomycin completely 
inhibited TSST-1 production. At 1/16 MIC these antibiotics, in addition to kanamycin, 
significantly but variably reduced TSST-1 production. However, concentrations at 1/16 
MIC or lower of tetracycline have no effect on TSST-1 production, although 1/4 MIC 
reduced its synthesis (Dickgiesser and Wallach, 1987). These results indicate that the 
effect of protein synthesis inhibitors antibiotics on TSST-1 production depends on the
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concentration and type of antibiotic used. This could explain why roxithromycin has no 
effect on TSST-1 production at 1/16 MIC. Eluate supernatant, which was exposed to 
ciprofloxacin, produced smaller amounts of TSST-1 than did the control. However, 
cefalexin resulted in the production of the smallest amount of TSST-1 (Table 5.7). The 
effect of (3-lactams on TSST-1 production is variable. Ampicillin at concentrations up to 
lOmg L'1 has no effect on TSST-1 production (Schlievert and Kelly, 1984). Flucloxacillin 
at 2 to 10 times MIC was able to inhibit TSST-1 production in the exponential growth 
phase (van Langevelde et al., 1997). Addition of nafcillin ((3-lactam) at sub-MIC levels to 
mid-exponential phase MRS A and MSS A, prolonged gene transcription of TSST-1. This 
resulted in prolonged and increased toxin production. However, high concentrations of 
nafcillin decreased toxin production although mRNA expression remained prolonged 
(Stevens et al., 2007).
5.5 Proteases
Four types of extracellular proteases are known to be produced by S. aureus: these 
include the serine proteases (V8 protease and related enzyme expressed by Spl operon) 
(Reed et al., 2001), the cysteine protease (Rice et ah, 2001), the metalloprotease 
(aureolysin) (Banbula et al., 1998), and the thiol proteases including protease II and 
staphopain (Chan and Foster, 1998). These proteases are secreted as proenzymes, which 
are proteolytically cleaved to produce the mature enzymes (Chan and Foster, 1998; 
Lindsay and Foster, 1999). Proteases are activated by inter-dependent proteolytic activity. 
The proform of serine protease is inactive and is cleaved to the active form by a 
mechanism that involves aureolysin specific process (Drapeau, 1978; Nickerson et al., 
2007). The proenzyme of cysteine protease seems to be active and is cleaved by serine 
protease (Rice et al., 2001).
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The production of proteases takes place mainly in the late exponential phase to 
post exponential phase. Their production is positively regulated by the agr locus and 
down regulated by sarA (Lindsay and Foster, 1999).
Staphylococcal proteases perform several functions that contribute to the 
organisms’ pathogenicity. Serine proteases were believed to be potentially involved in 
neutrophilic inflammation in chronic sinusitis (Sachse et al., 2006). In addition, some 
proteases have been found to degrade a number of important host proteins, including 
elastin (Potempa et al., 1988), the heavy chains of all human immunoglobulin classes 
(Prokesova et al., 1992) and human proteinase inhibitor (Potempa et al., 1986). 
Moreover, certain proteases have been shown to degrade bacterial surface proteins such 
as protein A, fibronectin binding protein and clumping factor (Karlsson et al., 2001). 
Combined, these activities of proteases have been implicated in the spread of the 
pathogen by a mechanism in which the microorganism becomes less adherent (McGavin 
et al., 1997). In addition, proteases are thought to down regulate the virulence of S. 
aureus to aid in its colonization in certain in vivo niches such as skin and nares (Lindsay 
and Foster, 1999).
The effect of subinhibitory concentrations of antimicrobials on proteases as part of 
the virulence factors, has been investigated by several researchers. The inhibitory effect 
of cerulenin at sub-MIC level on exoprotein production has been found to be at the 
transcription level. Subinhibitory concentrations of cerulenin have a strong effect on 
some of the genes encoding serine proteases and on genes encoding a-hemolysin, but 
have a minimal effect on other genes encoding other serine proteases (Adhikari and 
Novick, 2005). Subinhibitory concentrations of silver sulphadiazine reduced the 
production of metalloprotease significantly in one S. aureus strain, but not in another
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strain. At the same time, total protease secreted remained constant due to the increase in 
thiol protease and serine protease production (Edward-Jones and Foster, 2002).
In this study, the presence of protease will be detected and quantified by two 
methods (Zymography and azocasein assay) to investigate the effect of sub-MIC 
antibiotics on its production.
5.5.1 Experimental approach
5.5.1.1 Zymography
Zymography is an electrophoretic technique to detect for proteolytic activity in 
polyacrylamide gels. In this technique, developed by Heussen and Dowdle (1980), a large 
protein substrate such as gelatin or casein is copolymerized with separating gel during 
casting. The enzymes are applied to migrate and separate under non-reducing denaturing 
conditions (by sodium dodecyl sulfate). SDS is removed by a detergent, which will refold 
the enzyme and restore its activity. After incubation in a suitable buffer system, the gels 
are protein stained to visualise the activity of the enzymes, which is demonstrated by 
areas free from stain. These areas indicate degradation of the protein substrate by the 
enzyme. This method has the advantage of detecting proteolytic activity and separating 
the enzymes based on molecular weight which provides useful qualitative information 
about the species of the enzyme. In addition, zymography has been used as described or 
with some modifications to assess proteolytic activity quantitatively (Kleiner and Stetler- 
Stevenson, 1994; Le et al., 1999; Chu et a i, 2004).
In this study, eluate supernatants of the control and treated biofilms were mixed 
4:1 with sample buffer (5x) (described in section 2.9.3 in Chapter 2). Proteinase K (lmg 
mL'1) solution was used as a positive control for proteolytic activity after mixing it with 
sample buffer (5x). Aliquots (22|iL) of the samples and positive control were applied into
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the wells of stacking gel (0.75mm). Electrophoresis was performed in mini Protean 3 
system (Biorad, USA). After processing the gel (washing and incubation, as described in 
Chapter 2), it was stained and then destained to visualize proteolytic activity (Chapter 2).
5.5.1.2 Azocasein assay
Azocasein is a chemically modified protein composed of casein (milk protein) 
attached to orange azo-dye compound, sulphanilamide. Proteolysis releases acid soluble 
azopeptide resulting in orange-red colour that can be measured spectrophotometrically 
(Miedzobrodzki et a l , 2002). The intensity of the colour is proportional to the activity of 
proteases. In this method, total proteolytic activity is determined by dissolving the sample 
containing the enzyme into buffered azocasein solution and incubating it at 37°C for a 
specific time to allow for the proteolytic reaction to proceed. After stopping the reaction 
and separating the unreacted protein, the absorbance of the supernatant is measured 
spectrophotometrically (Brock et a l, 1982; Miedzobrodzki et al., 2002). One unit of 
activity is defined as an increase in the absorbance by 0.001 after lhr incubation 
(Edward-Jones and Foster, 2002). Thiol, serine and metalloprotease activity can be 
determined by the addition of appropriate inhibitors and subtracting the activity from the 
total one (Edward-Jones and Foster, 2002). Serine protease activity may be inhibited by 
the addition of phenyl methyl sulphonyl fluoride (PMSF, 12.5mM); thiol protease activity 
may be inhibited by the addition of iodoacetic acid (12.5mM) and metalloprotease 
activity may be inhibited by the addition of ethylenediamine tetraacetic acid (EDTA, 
12.5mM).
In this work, 50jliL of eluate supernatants of control biofilm and those exposed to 
sub-MIC antibiotics (prepared in section 5.2.1.1) were added to incubation mixture and 
incubated for 3 hours (procedure details described in Chapter 2). After stopping the
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reaction and separating the unreacted protein, the absorbance at 365nm was measured. An 
aliquot (50pL) of BHI treated in the same way was used as a blank.
5.5.2 Results and discussion
After inspecting the zymogram (data not shown), no colourless bands in the gel 
corresponding to the treated eluates or control eluates have been observed, indicating the 
absence of protease activity. A clear colourless band corresponding to the proteinase K 
(positive control) appeared indicating the activity of the enzyme and the validity of the 
test. In order to confirm these results, an azocasein assay was conducted. Absorbencies of 
zero values were obtained for all eluate samples (treated and control biofilms) indicating 
absence of proteolytic activity (data not shown).
The above results indicate that under the mentioned conditions, protease activity 
was absent in the eluate supernatants of S. aureus NCTC 11962, whether untreated or 
exposed to sub-MICs of cefalexin, ciprofloxacin or roxithromycin. Similar results have 
been obtained with other workers. S. aureus (67 strains) isolated from skin lesions of 
patients with atopic dermatitis were shown to exhibit variable proteolytic activities 
(Miedzobrodzki et al., 2002). Although eleven strains exhibited high activity, six strains 
gave no detectable activity when tested by azocasein assay (incubation for 3 hours). 
Similarly, 6 strains exhibited zero activity when tested by a qualitative method (casein 
agar plate), where the plate was incubated with the sample for 24hr. Interestingly, when 
the agar plates were incubated with the sample for a longer time (72hr), four strains out of 
the six strains exhibited proteolytic activity. This indicates that the non-active strains 
could have proteolytic activity that is below the detection threshold (Miedzobrodzki et 
al., 2002). In another study (Karlsson and Arvidson, 2002), 92 strains from infected 
human soft tissue were tested for proteolytic activity. Twenty one strains produced
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proteolysis on casein agar plates, and the remaining 71 strains appeared to be protease­
negative. Some strains from the protease-negative and protease-positive ones were 
screened for protease genes. All the screened strains were found to contain the major 
protease genes. A significant correlation was noticed between the level of protease 
mRNA and the zone of proteolysis on casein agar plates. In addition, an inverse 
correlation has been observed between the levels of sarA mRNA and protease mRNA. 
Further analysis has shown that protease genes are intact and their expression is down 
regulated in most S. aureus clinical strains. This was attributed to high o B-dependent sarA 
at least under specific in vitro growth conditions (Karlsson and Arvidson, 2002).
Therefore, the absence of proteolytic activity in S. aureus NCTC 11962 under the 
specified conditions, could be a consequence of elevated level of protease gene repressors 
that were not affected or down regulated by the presence of antibiotics.
5.6 Conclusion
The exposure of S. aureus NCTC 11962 to sub-MICs of antibiotics resulted in some 
moderation of its normal virulence factor expression depending on the type of antibiotic 
applied. This strain was found to be protease-negative and exposing its biofilms to 
antibiotic did not induce protease production or down regulate protease repressors under 
the specified testing conditions. 1/16 MIC of roxithromycin significantly reduced the 
production of coagulase when compared to control. This could imply that the use of 
roxithromycin in treating staphylococcal infections will decrease its virulence. On the 
other hand, the use of cefalexin at different sub-MICs resulted in variable effects on 
biofilm formation. At certain range of sub-MICs, cefalexin induced biofilm formation. 
This indicates that there should be proper usage of cefalexin to treat staphylococcal 
infections, otherwise, improper usage of such antibiotics may have the unintended
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consequence of promoting biofilm formation, thus, worsening the infection. There is a 
discrepancy in the effect of p-lactam (cefalexin) on production of TSST-1 and those 
obtained with Stevens et al. (2007). In this study, cefalexin at 1/16 MIC has reduced the 
production of TSST-1, while TSST-1 production increased at different sub-MICs after 12 
and 24 hrs when nafcillin was used. This discrepancy could be attributed to differences 
between the two drugs (nafcillin is a penicillin derivative, while cefalexin is a 
cephalosporin). Also, in Stevens et al. work (2007), the bacteria were in batch culture and 
they were exposed to the antibiotics at mid-exponential phase, which is known to be 
particularly sensitive to P-lactam activity. By contrast, in this study, the bacteria were 
grown in biofilm and were exposed to the antibiotic from the start of biofilm formation.
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Chapter 6
Purification of Toxic Shock Syndrome Toxin 1 from eluate 
supernatants challenged with sub-MIC of selected antibiotics 
and an assay of its biological activity using a mouse splenocyte 
model.
6.1 Introduction
The tst gene encoding TSST-1 is located in a mobile genetic material in the 
staphylococcal chromosome called the pathogenicity island (Lindsay et al., 1998). As 
discussed earlier, tst gene expresses TSST-1 precursor (a 234 aminoacid protein), which 
has a 40 aminoacid N-terminal signal peptide (Blomster-Hautamaa et al., 1986). The 
secretion of staphylococcal exoproteins including TSST-1 is not fully elucidated although 
secretory protein export in Escherichia coli and Bacillus subtilis is well described. 
Therefore, since most the components of exoprotein transport pathways of these 
organisms are conserved in S. aureus, knowledge from E. coli and B. subtilis was used to 
fill the current knowledge gaps in S. aureus (Sibbald et al., 2006). It is believed that 
TSST-1 is transported via the general secretory (Sec) pathway, since it contains a signal 
peptide (Alksne et al., 2000). Upon emergence of the nascent TSST-1 precursor from the 
ribosome, the signal peptide is recognized by chaperones or targeting factors in order to 
target the preprotein to the cytoplasmic membrane (Sibbald et al., 2006). At the 
membrane, the precursor will be directed to the translocation machinery. The 
translocation machinery of S. aureus is composed of several (Sec) proteins. The precursor 
will undergo several interactions with specific Sec proteins modulated by ATP binding
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and release. These interactions will lead to conformational changes that will promote the 
insertion of the precursor into the membrane embedded translocation channel and its 
subsequent release to the extracytoplasmic compartment. During or shortly after 
translocation, the signal peptide is cleaved by a signal peptidase leaving the protein in the 
unfolded state. By the aid of a folding catalyst (in case of S. aureus it is believed to be the 
lipoprotein PrsA and the membrane protein DsbA), the protein is folded rapidly into its 
native and protease resistant conformation. The mature protein is then secreted from the 
cell wall as it has no cell wall retention signal (Sibbald et al., 2006).
Since the synthesis and secretion of TSST-1 involve numerous complicated steps, 
it is assumed that the presence of sub-MIC antibiotics may interfere with one or more of 
these steps resulting in attenuated TSST-1. Therefore, the first objective of this chapter is 
to purify TSST-1 from eluate supernatants of control biofilms and from biofilms exposed 
to sub-MIC antibiotics, and to compare the biological activity of the purified toxins from 
treated biofilms with that of control. The second objective is to test the proliferative 
activity of eluate supernatants (the control and treated eluates) as such and to compare the 
results with those obtained from purified TSST-1.
6.2 TSST-1 purification steps
The method used by Reiser et al (1983) was used with some modifications in this 
study to purify TSST-1 from eluate supernatants taken from control biofilm and biofilms 
exposed to sub-MIC of antibiotics. This method has been used by others or modified to 
purify TSST-1 and other toxins (Reiser et al., 1984; Micusan et al., 1986, Su and Wong, 
1995; Munson et al, 1998).
S. aureus NCTC 11962 biofilms were established on Sorbarod units as described 
in Chapter 2. After inoculating the Sorbarods with mid-exponential phase bacterial cells,
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the filters were perfused with BHI media in the case of control biofilm or BHI with sub- 
MIC of antibiotic. In each case three Sorbarod units were used. Once steady state was 
achieved (after seven hours), eluate was collected and stored at -20°C. The collection of 
eluate continued until 48hrs. In order to prepare cell free eluate, the frozen eluates were 
thawed and centrifuged at 13000 rpm at 4°C using cooled continuous centrifuge 
(Contifuge 17RS Heraeus Sepatech, Osterode, Germany). Eluates were pumped to the 
centrifuge using peristaltic pump (Autoclude, model V, England) set at 15% feeding rate. 
Centrifugation was repeated twice. Eluate supernatant (~3L) was collected to be used in 
the next step.
All buffer systems used during purification steps were prepared from distilled then 
deionised water (Nanopure Diamond, Barnstead, USA). The preparation of buffers was 
described in Chapter 2. All buffers were filtered through a 0.45pm membrane filter.
6.2.1 Batch adsorption using Amberlite CG50 (Sigma)
Amberlite CG50 is a weakly acidic cation exchanger which was used to adsorb 
proteins from the supernatants. Since it is a weak cation, high salt concentration may 
interfere with its function. Therefore, eluate supernatants should be diluted before 
applying them on the cation exchanger. In order to determine the suitable dilution factor, 
a mini scale trial was performed. In this trial, eluate supernatants were diluted in different 
proportions in water (1:1, 1:2, 1:3, 1:4, 1:5) and their pHs were adjusted to 5.6 by HC1. A 
quantity of Amberlite CG50 proportionate to the volume of supernatant to be used was 
prepared as described in Chapter 2. The cation exchanger was added to the diluted 
supernatants and mixed by magnetic stirrer for 30 minutes. After the resin settled down, 
the supernatant was removed and Amberlite was packed in a 5mL syringe. Several 
syringes were prepared, one for each dilution. The resin was washed with water and the
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adsorbed proteins were eluted with 0.5M sodium phosphate buffer with 0.5M NaCl pH
6.2 by slowly dripping a volume of buffer proportionate to the amount of Amberlite. The 
eluted buffer was collected. Proteins in the eluted buffer and the remaining solutions 
(solutions from which protein was adsorbed) were precipitated by trichloroacetic acid, 
washed, dried and reconstituted with lysis buffer as described in Chapter 2. 2D-PAGE 
analysis was performed to portions taken from the eluted buffer (Figure 6.1 A) and to 
portions taken from the remaining solutions (Figure 6. IB). The dilution that resulted in 
complete disappearance of TSST-1 from the remaining solution and produced highest 
protein spot in the eluted buffer was selected. The best dilution factor was found to be 
four.
The collected eluate supernatants (3L) were diluted four times in water and the pH 
was adjusted to 5.6 using 5M HC1. Amberlite resin was prepared as was described in 
Chapter 2. The swollen resin was added to the diluted eluate supernatant and stirred using 
(IKA RW16 basic stirrer, IKA labortechnik, Germany) for 2.5 hours at speed 5. The resin 
was left to settle down for 30 minutes and the supernatant was discarded. The resin with 
adsorbed protein was transferred to an XK 26/40 (GE Healthcare) column and washed 
with water (500mL) at flow rate 120mL hr'1. The adsorbed proteins were eluted from the 
column by 2L of 0.5M sodium phosphate buffer with 0.5M NaCl pH 6.2 at a flow rate of 
120mL min'1. The flow rate was maintained by a two-piston pump (P-500, Pharmacia, 
Sweden) connected to the solvent reservoir. The eluted protein was collected and filtered 
under vacuum through a 10pm membrane filter (47mm polycarbonate membrane filter, 
Nuclepore Corporation, USA) to be ready for the next step of processing.
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Figure 6.1: 2D-PAGE gels for the mini trial where eluate was diluted four times. (A): 
proteins eluted from Amberlite CG50 after being adsorbed on the resin. The arrow 
shows TSST-1 spot and (B): proteins in the solution remaining after batch 
adsorption where the arrow shows that TSST-1 disappeared (adsorbed onto the 
resin). Protein loading 25pg.
6.2.2 Concentrating the protein solution
Several methods can be used to concentrate protein solutions, such as precipitation 
(salting out), dialysis, gel filtration and ultrafiltration. In this study, ultrafiltration through 
a lOkDa molecular weight cut-off membrane was used. In ultrafiltration, a solution 
containing proteins and molecules with different molecular weights and sizes is forced 
through a membrane with a certain pore cut-off. Small molecules (such as water and low 
molecular weight solutes) can pass through the membrane with the ultrafiltrate, while
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large molecules are retained in the retentate and concentrated relative to the starting 
solution (Scopes, 2002).
The eluted protein solution (2L) was forced through a regenerated cellulose 
ultrafiltration membrane device (Pellicon XL device, Millipore, USA) using a peristaltic 
pump (Masterflex, Cole Parmer Instrument Company, USA). The solution was circulated 
through the membrane until the volume was reduced to 50mL. In order to replace the 
buffer system of the protein solution and simultaneously remove excess low molecular 
weight solutes, dialysis was performed (Scopes, 2002). The concentrated protein solution 
was transferred to dialysis tubing (12 to 14kDa) molecular weight cut-off (Visking 
dialysis tubing, Medicell International Ltd, UK). Dialysis tubing was previously washed 
and prepared according to manufacturer's instructions. Dialysis was performed by four 
changes of 5mM phosphate buffer pH 5.6 for 24hr at 4°C.
6.2.3 Ion exchange chromatography using CM-Sepharose CL 6B
A chromatography column (XK 26/40; GE Healthcare) containing CM-Sepharose 
CL 6B ion exchanger was prepared, washed and equilibrated as was discussed in Chapter
2. The entire dialysed protein sample solution (~50mL) was introduced to the column. 
The outlet of the column was connected to a monitor set at 280nm (Single path monitor 
UV-1 optical unit and Single path monitor UV-1 Control unit, Pharmacia, Sweden). The 
effluent from the monitor was collected in 20mL fractions by a fraction collector (LKB 
Bromma, model 2070, Ultrorac n, Sweden). The resin was washed by pumping 500mL 
water at flow rate 120mL hr'1. The toxin was eluted from the column by applying three 
different buffers. The buffers were delivered to the column in succession using two 
pumps (P-500) controlled via Gradient programmer (GP-250, Pharmacia, Sweden). The 
buffers percolated into the column at a flow rate 60mL hr'1 according to the following
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order: 500mL of 5mM sodium phosphate buffer pH 6.0, 2250mL of 0.03M sodium 
phosphate buffer pH 6.0 and 1 lOOmL of 0.045M sodium phosphate buffer pH 6.4.
Proteins eluting in the effluent were estimated by measuring the absorbance of the 
collected fractions at 280nm (Figure 6.2) using UV/Vis spectrophotometer (Genesys 
10UV, Thermo Spectronic, New York, USA).
Figure 6.2: An example of ion exchange chromatogram on CM-Sepharose CL 6B for 
control supernatants. Fractions (20mL) were collected and absorbance at 280nm 
was measured. Arrows indicate fraction (Fr) number at the apex of the peak.
In order to determine the fractions containing TSST-1, SDS-PAGE analysis was 
performed on aliquots taken from the fractions corresponding to peaks. Figure (6.3) 
shows SDS-PAGE gel of the fractions forming the peaks. Fraction 147 was found to 
contain TSST-1, therefore, fractions forming this peak (fractions 146 to 149) were 
collected, mixed and dialysed against 40% w/v polyethylene glycol (PEG) 20000 at 4°C 
for 24hr in order to concentrate TSST-1.
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Figure 6.3: SDS-PAGE analysis of the fractions corresponding to the eluted peaks 
from CM-Sepharose CL 6B (Figure 6.2). Lane 1, SDS-PAGE protein marker; lane 2, 
fraction 181; lane 3, fraction 157; lane 4, fraction 153; lane 5, fraction 151; lane 6, 
fraction 147; lane 7, fraction 143; lane 8, fraction 72; lane 9, TSST-1 standard. 
Volume applied: maximum well capacity (23pL).
At this stage, TSST-1 was not detected in fractions eluted from supernatants 
exposed to roxithromycin. This could be related to reduced column efficiency and loss of 
resolution since the exposed roxithromycin supernatant was purified last.
6.2.4 Gel Liltration using Sephacryl S 200HR
The concentrated toxin (~3mL) from the previous step was filtered through a 
0.45pm nylon membrane filter. The sample was injected into a column of Sephacryl S 
200HR (XK 26/100) through sample application valve (V-7, Pharmacia, Sweden). The 
column was previously packed, washed and equilibrated with 0.05M phosphate buffer 
pH6.8 containing 1M NaCl (described in Chapter 2). The toxin was eluted from the 
column by applying 600mL of 0.05M sodium phosphate buffer pH 6.8 containing 1M 
NaCl at a flow rate of 60mL hr"1 and the eluted effluent was collected in 5mL fractions. 
Aliquots from the fractions were tested spectrophotometrically at 280nm (Genesys 10UV, 
Thermo Spectronic, New York, USA). Figure 6.4 shows fractions eluted from gel 
filtration column (Sephacryl S 200HR). Fractions from the eluted peaks were analysed by
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SDS-PAGE to identify those containing TSST-1 (Figure 6.5). Fractions containing TSST- 
1 were combined together and dialysed at 4°C against 5mM phosphate buffer pH 6.8 
using Visking dialysis tubing (Medicell International Ltd, UK) (12 to 14kDa) molecular 
weight cut-off. The purified toxin was distributed in small tubes and stored at -20°C for 
subsequent use.
Figure 6.4: An example of gel filtration chromatogram on Sephacryl S 200HR 
(Sigma) for control supernatants, (5mL) fractions were collected and absorbance at 
280nm was measured. Arrows indicate fraction (Fr) number.
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Figure 6.5: SDS-PAGE analysis of fractions eluted from gel filtration column 
(Sephacryl S200 HR; Figure 6.4). Lane 1, TSST-1 standard (sigma); lane 2, SDS- 
PAGE marker; lane 3, fraction 37; lane 4, fraction 65; lane 5, fraction 67; lane 6, 
fraction 71; lane 7, fraction 73; lane 8, fraction 76; lane 9, fraction 86. Volume 
applied: the maximum well capacity (23pL well'1)
6.3 Testing the biological activity of TSST-1 in vitro
TSST-1 biological activity can be evaluated in vivo and in vitro based on its 
activity as a superantigen. In vivo studies may include studying the lethal effect of TSST- 
1 in rabbits (Reeves et al, 1986; Kum et al., 1993) or mice (Stiles et a!., 1995), changes 
in blood chemistries of infected rabbits (Bonventre et al., 1993), cytokine release 
(interleukins, tumour necrosis factors, interferons) (Stiles et al., 1995). In vitro studies of 
TSST-1 involve studying the production of cytokines by human lymphocytes (Micusan et 
al., 1986; Parsonnet and Gillis, 1988; Akatsuka et al., 1994; Krakauer and Stiles, 1999; 
Imanishi et al., 2003), rabbit lymphocytes (Ikejima et al., 1988), murine lymphocytes 
(Micusan et al., 1986) and bovine lymphocytes (Yokomizo et al., 1995) in addition to 
studying the proliferative effect of TSST-1 on different types of lymphocytes whether 
from human or animal origin (Calvano et al., 1984; Yokomizo et al., 1995; Krakauer and 
Stiles, 1999; Gampfer et al., 2002).
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As discussed in Chapter 1, TSST-1 as a superantigen, has a mitogenic effect on T- 
lymphocytes. It binds to major histocompatibility complex II (MHC II) of the antigen 
presenting cell (APC) outside the conventional binding site and the complex binds to 
specific Vp element of the T-lymphocyte outside the binding groove. This binding will 
stimulate T-lymphocytes to proliferate and triggers the release of cytokines from APCs 
and lymphocytes (Dinges et al., 2000; Lee and Bohach, 2004). Therefore, the presence of 
APCs is important for the superantigenic activity of TSST-1. See et al. (1992), have 
shown that TSST-1 was not able to produce interleukin-1 or tumor necrosis factor when 
lymphocytes or monocytes were exposed to it separately. However, a 1:1 mixture of these 
cells resulted in significant production of these cytokines (See et al., 1992). Similarly, 
presence of macrophages has been proven to be necessary for the proliferation of 
lymphocytes in mouse and human systems (Poindexter and Schlievert, 1985). These 
properties (proliferative effect of TSST-1 on lymphocytes and provoking the release of 
cytokines) were used to measure the activity of TSST-1 in vivo and in vitro under 
different conditions (Calvano et al., 1984; Blanco et al., 1990; Bonventre et al., 1993; 
Kum et al., 1993; Stiles et al., 1995; Krakauer and Stiles, 1999). On the other hand, 
although TSST-1 has a lethal effect on animals and humans, it was shown not to possess 
cytotoxic activity on eukaryotic cells (Deresiewicz et al, 1994).
In this project, the proliferative effect of TSST-1 purified from eluate supernatants 
and the proliferative effect of eluate supernatants exposed to different treatments and 
control will be studied on freshly prepared mouse splenocytes.
6.3.1 Mouse splenectomy
Adult female Swiss mice (six to nine weeks old) were obtained from a colony 
maintained by Ninewells Hospital, Dundee, after being freshly sacrificed by cervical
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dislocation. The mouse was then laid on its right side on a clean chopping board, which 
was disinfected with 70% alcohol. The mouse skin was wetted with 70% alcohol. The 
dissection tools were sterilized by autoclaving. The skin was cut midway on the mouse’s 
left side. The peritoneum was carefully lifted with small forceps and cut to expose the 
spleen. The spleen was excised from the abdomen and mesenteries by a scalpel and then 
placed in a sterile Petri dish (5cm, Sterilin) containing about 5mL sterile Dulbecco's 
phosphate buffered saline pH 7.2 (D-PBS) (NaCl (8.0g), KC1 (0.2g), KH2P04 (0.2g), 
Na2HP04 (1.15g) and water up to 1L, sterilized by autoclaving).
6.3.2 Preparing single cell suspension of splenocytes
For each experiment, two spleens were excised. Each was treated separately to 
extract splenocytes, but in the final two washes, splenocytes were combined.
Two sterile 5mL syringe needles were bent at right angles using the protective cap 
of the needle. One needle was used to hold the spleen to the dish, the other one was used 
to make an incision in the spleen capsule and to express cells from the spleen. A sterile 
Pasteur pipette was used to break up the cells clumps by repeated aspiration and blowing 
of cell suspension. Then the whole dish contents were passed through sterile 70pm mesh 
(Cell strainer BD Falcon, BD Biosciences, USA). The filtrate was collected in sterile 
50mL tube. The mesh containing the retained clumps and spleen remains was placed in 
petri dish containing fresh 5mL PBS. The rubber end of a sterile 3mL syringe plunger 
was used to break up clumps and to gently squeeze cells from the spleen against the cell 
strainer. This was performed until only white connective tissue was left from the spleen 
fragments.
The contents of the dish were passed through the 70pm mesh and added to the 
previous splenocyte suspension. The dish was washed twice with 2mL of fresh D-PBS
171
and the washings were added to the suspension. The suspension was transferred to a 
15mL conical centrifuge tube and the cells were pelleted by centrifugation at 4000 rpm 
for 2min (IEC Centra-4B Centrifuge, International Equipment Company, USA). The 
supernatant was discarded. The pellet was loosened by flicking the ends of the tube and 
lmL of sterile red blood cells (RBC) lysis buffer was added to it (RBC lysis buffer: 
0.83% ammonium chloride in 0.01 M Tris-HCl buffer, pH 7.2, filter sterilized; Czajgucki 
et al., 2007) and then incubated at room temperature for 5 min. The activity of lysis 
buffer was terminated by adding chilled D-PBS up to 15mL. The suspension was 
centrifuged at 4000 rpm for 2min (IEC Centra-4B Centrifuge, International Equipment 
Company, USA) and the supernatant was discarded. In order to lyse the residual red 
blood cells, the procedure was repeated twice. Later the cells of the two spleens were 
combined together and washed twice with sterile tissue culture medium. Tissue culture 
medium was composed of sterile RPMI 1640 with L-glutamine and sodium bicarbonate 
(Sigma) containing sterile 5% Foetal bovine serum (Biowhittaker Lonza-Belgium) and 
sterile RPMI 1640 Vitamins solution (lOOx) (Sigma), lOOpig mL'1 streptomycin as 
sulphate (Sigma) (stock solution prepared and filter sterilized), 100 U mL'1 penicillin G as 
sodium salt (Sigma) (stock solution prepared and filter sterilised).
Washing the cells was done by adding 10 mL of tissue culture medium to the 
cells, swirling the tube gently, pelleting the cells by centrifuge and discarding the 
supernatant. In the second wash after adding the lOmL medium, the suspension was 
passed through glass wool packed into a 3mL syringe previously sterilised by 
autoclaving, to remove the cell debris of the lysed RBCs (cell debris will attach to glass 
wool while splenocytes do not) (Czajgucki et al., 2007). The suspension was centrifuged 
and the supernatant discarded. After washing, the cells were transferred to a 50mL sterile 
tube and suspended in 30mL tissue culture medium.
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6.3.3 Adjustment of splenocytes density (cells m L1)
Trypan Blue exclusion assay was used to adjust cell density to 5xl06 cell mL'1 
(Blanco et al., 1990). The cells were mixed gently in the tube and 50pL aliquot was 
mixed with 50pL Trypan Blue (0.4% w/v) (Sigma). The Trypan blue-cell suspension 
mixture was applied to a haemocytometer (Neubauer improved) where the mixture spread 
by capillary action under the glass cover and filled the whole chamber. Viable cells 
exclude Trypan blue dye, whereas dead cells take up the dye and attain dark blue colour 
(Micusan et al., 1986; Lyu and Park, 2006). Viable cells were counted in each of the four 
primary squares of haemocytometer chamber using lOOx magnification, and the sum of 
viable cells in the four primary squares was calculated. Cell density (cells mL'1) in the 
suspension was calculated using the following formula:
D= Nx5000 (equation 6.1)
Where D: Cell density; N: total number of cells in the 4 primary squares and 5000 is the 
result of calculating the volume of suspension retained in 4 primary squares (each with 
1mm2 area x 0.1 mm depth) and the dilution of the suspension in 1:1 ratio with Trypan 
blue. According to the resulting cell density, the suspension was diluted by adding fresh 
tissue culture medium to obtain cell concentration of 5xl06 cells mL'1.
6.3.4 Proliferation assay using MTS/PMS method
MTS is a tetrazolium salt (3-(4,5-dimethylthiazol-2-yl)-5-(3-caboxymethoxy 
phenyl)-2-(4-sulfophenyl)-2H-tetrazolium, salt. PMS (phenazine methosulfate) is an 
electron coupling reagent (Cory et al., 1991). The MTS/PMS assay is a colourimetric 
method for determining the number of viable cells in proliferation assays. It is widely 
used in research for in vitro cell growth assays in human, animal and algal cells (Capasso 
et al., 2003; Ganguly et al., 2006; Pi et al., 2006).
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Viable cells are metabolically active and produce reducing agents such as NADH 
or NADPH. These compounds pass their electrons to an electron coupling reagent (PMS), 
which reduces the tetrazolium compound MTS into a soluble intensely coloured formazan 
product, whose optical density can be determined in the range 450 to 540nm, optimum 
wavelength 490nm (Cory et al., 1991; Goodwin et al., 1995; Chen et al., 2002; Anon,
2005). Dead cells cannot reduce tetrazolium products, therefore formazan compound 
production is proportional to the number of viable cells in culture.
When MTS/PMS is compared to other microculture tetrazolium salts assays like 
XTT (2,3 -  bis (2-methoxy- 4-nitro-5-sulfophenyl)-5-[(phenylamino) carbonyl]-2H- 
tetrazolium hydroxide) and MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium 
bromide); MTS/PMS and XTT/PMS were shown to have the advantage of forming 
soluble formazan product which eliminates possible errors in the steps of solubilisation 
required in MTT assay (Cory et al., 1991). On the other hand, XTT/PMS mixture shows 
instability in some solutions, which results in poor assay precision. This instability was 
not encountered in MTS/PMS assay (Goodwin et al., 1995).
Being a non-radioactive assay, MTS/PMS has the advantage over tritiated 
thymidine incorporation in that it is safe and does not require scintillation cocktails or 
disposal of radioactive waste. In a study by Zolnai et al. (1998), to determine mitogen- 
induced lymphocyte proliferation in cell culture, the results of MTS/PMS showed good 
correlation with tritiated thymidine incorporation assay.
6.3.4.1 Purified TSST-1 proliferation assay
The concentration of purified TSST-1 from biofilm eluate supernatants of 
cefalexin and ciprofloxacin treatments and a control was determined by the Bradford 
assay method (described in Chapter 2). The concentrations were 4.6, 4.3 and 4.7jig mL'1
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respectively. Purified TSST-1 from the treatments and control was diluted into tissue 
culture medium to a concentration of 2000ng mL'1. Ten fold serial dilutions were done to 
each purified toxin in tissue culture medium to give 200, 20, 2, 0.2 ng mL"1 in addition to 
the stock which is 2000ng mL'1. Aliquots of 100pL were taken from each toxin 
concentration of each treatment and distributed in sterile 96-well flat-bottom tissue 
culture plate (Fisher Scientific, England). Each concentration was applied in triplicate.
Phytohemagglutinin PHA-P (Lectin from Phaseolus vulgaris (red kidney beans) 
containing buffer salts and NaCl) (Sigma) was used as mitogen positive control. 5mg of 
the lyophilised PHA-P powder was dissolved in 5mL sterile water. A stock solution of 
80pg mL'1 was prepared by dilution in tissue culture medium. Aliquots of 100pL from 
the stock were distributed in three wells in a 96-well flat-bottom tissue culture plate. 
Double serial dilution was done by adding lOOpL aliquots from the stock to other wells 
containing lOOpL fresh medium in triplicates. The solution was mixed and lOOpL 
transferred to other wells containing fresh medium. The process was repeated until a 
concentration range from 80 to lOpg mL'1 was obtained where the last lOOpL taken from 
the last wells after mixing were discarded. In order to make negative control, lOOpL of 
fresh medium were added to new wells. Aliquots (lOOpL) of 5xl06 splenocytes were 
added to all the wells so that, the final concentration of TSST-1 in the wells ranged from 
1000 to O.lng mL'1, whereas the final concentration of PHA-P in the wells ranged from 
40 to 5pg mL'1. Splenocytes (lOOpL) were also added to the negative control wells. 
Accordingly, the concentration of cells present in all the wells was 5xl05 cells well'1. The 
plates were covered and incubated at 37°C, 5% CCL incubator (Heraeus Instruments, 
Model B5060 EK/CCL, Germany) for 48 hours. After the incubation period, 40pL of 
MTS/PMS dye mixture (Cell Titer 96 Aqueous Non Radioactive Cell proliferation assay, 
Promega, USA) (prepared by adding lmL of PMS solution into 20mL MTS solution) was
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added to all wells and incubated for 4 hours at 37°C, 5% CO2 according to manufacturer's 
recommendation.
In order to measure the optical density of formazan product converted by viable 
splenocytes from tetrazolium salts, the plates were mixed gently for 30 seconds and 
optical density (OD) was measured at 450nm using ELISA reader (Rosys Anthos ht III- 
Anthos Labtec Instruments, Salzburg). OD of the negative control was subtracted from 
those of samples and PHA-P. The concentration of PHA-P which produced the highest 
response (OD value) was selected and its average value was considered 100% response. 
OD results of the samples were calculated as percentage response from PHA-P. The 
results were expressed as mean ± standard deviation (SD) and plotted versus 
concentration of the mitogen (toxin or PHA).
6.3.4.2 Statistical analysis
Statistical difference among the results obtained by the treatments and control 
were examined by one way analysis of variance (ANOVA), followed by Tukey multiple 
intergroup comparison. P values < 0.05 were considered significant. Normal distribution 
of the results and equal variance were checked using Bartlett's test (p> 0.05) and 
Anderson-Darling test (p > 0.05). All calculations were carried out using Minitab 15 
software.
6.3.4.3 Results and discussion
Figure 6.6 shows the proliferative effect of the positive control mitogen, 
phytohemagglutinin (PHA-P). After 48 hr incubation with mouse splenocytes, the lOjug 
mL"1 concentration produced the highest response. This indicates the presence of an 
optimal concentration for the mitogen to produce the highest response. The response (OD
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450nm) of splenocytes at this concentration was considered as 100% response. This 
behaviour is consistent with that obtained with concanavalin A (a positive mitogen) when 
used in splenocyte proliferation assay (Lyu and Park, 2006), where an optimal dose 
produced the highest proliferation above which a reduction in proliferation happened.
Figure 6.7 shows the proliferative effect of TSST-1 purified from eluate 
supernatants exposed to sub-MIC cefalexin and ciprofloxacin and control. In the three 
cases, the proliferative effect of the toxin increases in a dose dependent manner until a 
peak (optimum concentration) is reached, after which the response is decreased. This 
proliferative effect of TSST-1 is supported by the work of others as follows: the increase 
in splenocyte proliferation as a result of increase in the toxin concentration was obtained 
by Bon ventre et al. (1993), who studied the toxicity of recombinant TSST-1 and mutant 
toxins on mouse splenocytes at concentration range from 0.1 to lOOng mL'1, as the toxin 
concentration increases, tritiated thymidine incorporation increased. In another study, 
TSST-1 purified from periplasmic space of E. coli after cloning the TSST-1 gene in it, 
exhibited an increase in mitogenic activity on mouse splenocytes at concentrations 
ranging from 1 to 500ng mL' 1 (Blanco et al., 1990). Similarly, the mitogenic effect of 
TSST-1 on peripheral blood mononuclear cells (PBMC) has been shown to be dose 
dependent (Kum et al., 1993).
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Figure 6.6: Proliferative effect of the mitogen PHA-P on mouse splenocyte. 
MTS/PMS assay was performed and optical density (OD at 450nm) was plotted 
against different concentrations of PHA-P. Error bars indicate ± standard 
deviations from the mean (n=3).
Figure 6.7: Proliferative effect of purified TSST-1 from biofilm eluates of control, 
cefalexin (cefa) and ciprofloxacin (cipro) on mouse splenocyte. Optical density (OD) 
at 450nm was measured and OD of negative control was subtracted. OD of the 
samples was calculated as percentage from OD of PHA-P. Error bars indicate ± 
standard deviations from the mean (n=3).
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At the concentration range from 0.1 to lOOng mL'1, TSST-1 purified from control biofilm 
eluates or from treated biofilm eluates was found to possess comparable proliferative 
effect at each concentration level (Table 6.1). There is no significant difference among 
the two treatments and control at 95% confidence level (Table 6.1). At lOOOng mL"1, the 
reduction in response was higher for TSST-1 purified from supernatants exposed to 
ciprofloxacin.
Table 6.1: Tukey's multiple 
of the proliferative effect of 
control, cefalexin treated an 
on mouse splenocytes. Stat 
between treatments. Treatr 
given same letter. Treatmen 
from the others was given dil
»roup analysis (95% confidence) 
TSST-1 purified from eluates of 
d ciprofloxacin treated biofilms 
istical analysis was performed 
nents with similar effect were 
t which is significantly different 
ferent letter.
TSST-1 
Cone, 
ng mL' 1
Control Cefalexin Ciprofloxacin
0.1 A A A
1 A A A
1 0 A A A
1 0 0 A A A
1 0 0 0 A A B
6.3.4.4 Eluate supernatants proliferation assay
Eluate supernatants of ciprofloxacin, cefalexin and roxithromycin treatments and 
control were diluted in ten fold serial dilutions with tissue culture medium to obtain final 
dilution in the range of 5xl0"2 to 5xlO"5. A dilution of 1/2 was excluded from the study 
due to high interference of BHI medium present in eluate supernatants on the MTS/PMS 
OD values. Aliquots (90pL) of tissue culture medium were placed in the wells of 96-well
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flat-bottom tissue culture plate. Eluate supernatants (IOjiL) of each treatment and control 
were placed in the wells in triplicates. The contents were mixed and 10 pL were 
transferred to the next wells containing 90 pL tissue culture medium. The process was 
repeated until lxlO’4 dilution of eluate supernatant in tissue culture medium was obtained. 
Splenocyte suspension (90pL of 5 x 106cells mL'1) was added to all wells. A negative 
control was prepared as was described earlier. PHA-P was prepared at a concentration 
which gave the highest response in the previous experiment (lOpg mL"1). The plates were 
covered and incubated at 37°C, 5% CCL. After 48hrs, 36pL of MTS/PMS dye mixture 
was added to all wells and incubated for 4 hours at 37°C, 5 %  CO2. The plates were mixed 
gently for 30 seconds and optical density (OD) was measured at 450nm using an ELISA 
reader. The OD of the negative control was subtracted from those of samples and PHA-P. 
OD results of the samples were calculated as percentage response from PHA-P. The 
results were expressed as mean ± standard deviation (SD) and plotted versus the dilution.
6.3.4.5 Results a n d  discussion
Figure 6 .8  shows the proliferation of mouse splenocytes when incubated with 
different dilutions of eluate supernatants of control biofilms and biofilms exposed to sub- 
MIC antibiotics. The highest response was obtained at 5xlO"3 dilution and as the dilution 
increased the response decreased indicating that the response is dose dependent. However 
at the lowest dilution (5xl0"2), which is the highest concentration of mitogens, the 
response was the lowest indicating the presence of an optimal mitogenic effect after 
which the response declines. As mentioned earlier, 1/2 dilution was excluded from the 
study due to high interference from BHI on the OD of MTS/PMS dye. These results are 
consistent with those obtained with purified TSST-1, as after an optimal concentration, 
reduction to proliferation appeared.
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Figure 6.8: Proliferative effect of eluate supernatants exposed to cefalexin (Cefa), 
ciprofloxacin (Cipro) and roxithromycin (Rox) on mouse splenocytes. The activity 
was calculated as a percentage from PHA-P activity, assuming the activity of PHA-P 
to be 100%. Error bars indicate ± standard deviations from the mean (n=3).
At high dilutions (5x1 O'4 and 5x10'5) there was no significant difference in the 
proliferative effect among the treated and control eluates (Table 6.2). At 5x10'3 dilution, 
the effect of cefalexin treated eluate was significantly different from control eluates 
(p<0.05), although it was not significantly different from ciprofloxacin or roxithromycin 
treated eluates. At 5xlO'2 dilution, the proliferative effect of cefalexin treated eluates was 
significantly different from the control and other treatments. The concentration of TSST-1 
in eluate supernatants was estimated earlier (Chapter 5, section 5.4.2), accordingly, the 
concentration of TSST-1 in the diluted supernatants is calculated (Table 6.3).
From tables 6.2 and 6.3, it is noticeable that cefalexin at 5x10' and 5x10'“ dilution 
has more significant mitogenic effect than the control although TSST-1 concentration in it 
is almost quarter that in the control supernatant. The same can be said about ciprofloxacin 
where the content of TSST-1 is half that in control, but still its mitogenic effect is
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comparable to that of control. This effect could imply that either TSST-1 in cefalexin 
treated supernatants is more potent than that in control supernatant or that another factor 
in the eluate is potentiating the mitogenic effect of cefalexin treated supernatant and that 
its effect is more pronounced at lower dilutions (5xl0'3 and 5xl0'2). The first explanation 
can be ruled out because it has been shown in Table 6.1 that TSST-1 biological activity is 
the same whether it was purified from control or treated eluates. Thus, the second 
explanation which is the presence of other factors that contribute to the mitogenic activity 
is more valid.
Although it is inaccurate to compare the values of responses obtained from eluate 
supernatants with those obtained from purified toxins due to the fact that the two 
experiments were performed in different days using different splenocyte suspensions, it is 
obvious that by comparing the responses of purified TSST-1 of any treatment with those 
of corresponding eluate supernatants containing equivalent concentration of TSST-1, the 
response resulting from eluate supernatant is higher (higher values of OD%) (Figure 6.7 
and Figure 6 .8 ). This increase in mitogenic effect of eluate supernatants when compared 
to that of purified toxin can be justified by two reasons: as was mentioned earlier, S. 
aureus  NCTC 11962, produces enterotoxin A. This toxin has superantigenic activity and 
therefore, has proliferative effect on lymphocytes (Lee and Bohach, 2004). It acts by 
binding to specific family of Vp chains that are different from those that bind to TSST-1 
(Davison et a l , 2000). The other reason is that purified TSST-1 has passed through 
several steps of purification and concentration, hence, its biological activity could have 
been affected by these steps.
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Table 6.2: Tukey's multiple group analysis (95% confidence) of the 
proliferative effect of eluate supernatants of control, cefalexin treated and 
ciprofloxacin treated biofilms on mouse splenocytes. Statistical analysis was 
performed between treatments. Treatments with similar effect were given 
same letter, treatment which is significantly different from the others was 
given different letter.
Eluate
supernatant
Dilution
Control Cefalexin Ciprofloxacin Roxithromycin
5x10" AB D B AC
5xl0'J BC A AB AC
5x1 O'4 A A A A
5x1 O'3 A A A A
Table 6.3: Estimated concentration of TSST-1 (ng mL'1) in eluate 
supernatants exposed to different treatments at different dilution ratios.
Eluate
supernatant
Dilution
Control Cefalexin Ciprofloxacin Roxithromycin
5x10" 102.40 25.60 51.20 102.40
5x10" 10.24 2.56 5.12 10.24
5x1 O'4 1 .0 2 0.26 0.51 1 .0 2
5x10° 0 . 1 0 0.03 0.05 0 . 1 0
6.4 Conclusion
The production and secretion of TSST-1 from S. a ureus  involves multiple steps 
that require the interaction and involvement of several enzymes and regulatory proteins. It 
was postulated therefore, that exposing S. a u reus  biofilm to sub-MIC antibiotic could 
have an impact on some of these steps resulting in the secretion of a protein with altered 
biological activity. In this study, TSST-1 was purified from eluate supernatants of 
biofilms exposed to sub-MIC of antibiotics and control. The biological activity of TSST-1 
was tested by comparing the proliferative effect of different concentrations of the purified
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toxins on mouse splenocytes. In addition, the proliferative activity of crude eluate 
supernatants exposed to sub-MIC was tested also by comparing the activity at different 
dilutions. In both cases, the proliferation of splenocytes was dose dependent up to a 
maximum after which the effect was reduced. There was no significant difference in the 
proliferative activity among purified TSST-1 from control and treated eluates at different 
concentrations of TSST-1 up to the optimum concentration, indicating that 1/16 MIC of 
cefalexin or ciprofloxacin has no significant impact on the stages involved in the 
synthesis of TSST-1 that would lead to altered activity. On the other hand, the 
proliferative activity of crude eluate supernatants exposed to cefalexin at the optimum 
concentration was higher than that of control. In addition, the proliferative activity of 
crude eluate supernatants was higher than that of purified toxins exposed to same 
treatment. These effects were attributed to the presence of another mitogenic agent, 
enterotoxin A, produced by this strain that could have been affected by the presence of 
cefalexin more than the presence of other antibiotics. Moreover, the possible effect of 
purification stages on reducing the activity of purified toxins can not be ruled out.
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Chapter 7
General Discussion
The fact that staphylococci are common colonizers of human skin and mucous 
membranes, makes them important pathogens in causing infections once these barriers are 
disrupted. Staphylococcus aureus  infections are difficult to manage, often need weeks of 
antimicrobial chemotherapy (Higashi and Sullam, 2006). The ability of staphylococci to 
form biofilms on both native tissue and abiotic surfaces inside the body comprises a 
challenge that faces clinicians. Biofilm structures are recognized for their high resistance 
to chemotherapy and the bacteria released from these biofilms cause metastatic infections 
that will complicate the diagnosis of the actual site of infection. If biofilm infections are 
not treated aggressively, the infections can recur, hence, in most cases, successful cure 
requires surgical removal of the biofilm.
The nutritional requirements of S. aureus  are relatively complex when compared 
to the nutritional requirements of other bacteria, such as Escherichia coli and 
P s e u d o m o n a s  aeruginosa. While the later is ubiquitous in nature, the natural habitat of 
the staphylococci is limited to animal skin and mucosal membranes or as contaminants in 
food. Therefore, whilst simple sources of organic carbon, iron, magnesium and other 
basic ions are satisfactory to support the growth and biofilm formation of both E. coli and 
Ps. aeruginosa  (Al-Hmoud, 2002; Masadeh, 2005) this is not the case with S. a u r e u s , 
where several amino-acids were found to be required in order to support growth (Chapter
3). Moreover, as was exhibited in Chapter 3, even more complex media, such as brain 
heart infusion media, were required by the bacteria to form biofilm structures.
S. aureus  is known to express numerous virulence factors that help the bacterium 
to invade and infect the body, to evade host defence mechanisms and to adapt to different 
and potentially hostile environments. These factors have made S. a u r e u s  among the five
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most common isolates in clinical microbiology laboratories (Higashi and Sullam, 2006). 
Virulence factors of S. aureus  have attracted many researchers to study the mechanism 
and role of these factors in infection and spread of microorganism (Hienz et al., 1996; 
Lee et al., 2002; Mack et al., 2004; Shannon et al., 2005; Fitzgerald et al., 2006). Besides, 
many studies (Lebeau et al., 1994; Chan et al., 1998; Bischoff et al., 2001; Dunman et al., 
2001; Lyon et al., 2002; Valle et al., 2003; Boisset et al., 2007) have been conducted to 
identify regulatory pathways for these factors and the agents that have an impact on their 
production or regulation.
7.1 Encountering sub-MICs of antibiotics in clinical settings
Clinically, microorganisms can encounter sub-minimal concentrations of 
antibiotics on several occasions. Pharmacokinetic factors, such as absorption of the drug 
from site of application, distribution into diverse tissues, metabolism and clearance of the 
drug could lead to gradients in the concentration of the drug in the body tissues. In 
addition, pharmacological factors, such as drug-drug or drug-food interactions, certain 
health and clinical conditions of the patient, or direct effect of the microorganism, 
whether pathogenic or normal flora, especially by releasing antibiotic inactivating 
enzymes (Baquero, 2001), would create an environment in which bacteria as planktonic 
or biofim phenotypes will face sub-inhibitory levels of antibiotics.
Understanding the clinical importance of sub-MIC of antibiotics, it was the aim of 
this thesis to study the effect that subinhibitory concentrations of selected antibiotics 
would have on the virulence factors expressed by S. au r e u s  biofilms. The selected 
antibiotics were of three different antibacterial groups, cefalexin (a cephalosporin that 
inhibits cell wall synthesis), ciprofloxacin (a fluoroquinolone that inhibits bacterial DNA 
replication) and roxithromycin (a macrolide that inhibits protein synthesis).
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7.2 Protein profile shifts may reflect alterations in bacterial virulence
Allowing S. a ureus  NCTC 11962 to grow and build a biofilm in the presence of 
1/16 MIC of the antibiotics resulted in remarkable shifts in protein profiles of biofilm 
cells, eluate cells and in the secreted proteins (eluate supernatants) (Chapter 4). Some 
novel proteins appeared in SDS-PAGE and 2D-PAGE gels and others disappeared when 
compared to control protein profiles (Figures 4.3 to 4.17 and Tables 4.2 to 4.16). Protein 
shifts could be attributed to changes in virulence or strategic shifts by the organism to 
make changes in structural proteins and enzymes that are required for cell viability and 
maintenance. Changes in protein profiles of eluate supernatants were found to be 
accompanied by changes in some of the studied virulence factors. For example, 
roxithromycin at sub-MIC resulted in reduction of coagulase production when compared 
to control (Chapter 5, Figure 5.1). Toxic Shock Syndrome Toxin 1 production was altered 
when the biofilms were exposed to cefalexin and ciprofloxacin (Chapter 5, section 5.4). 
In another experiment (Chapter 5, section 5.3), the formation of biofilms on microtiter 
plates was enhanced in the presence of a range of sub-MICs of cefalexin. Taken together, 
these alterations in secreted virulence factors (coagulase, TSST-1 and exopolysaccharide 
material) will result in the appearance of different protein profiles from those secreted 
from control cells, in addition to the fact that variations in virulence should reflect 
intracellular changes in some regulatory proteins or effector agents. Such changes will be 
observed as different protein patterns on electrophoresis gels.
7.3 Effect of subinhibitory concentrations of antibiotics on virulence
It is well recognized that the efficacy of antibiotics does not depend exclusively 
on their bacteriostatic or bactericidal effect on the bacteria, but also on reducing or 
inhibiting their virulence. In some clinical situations where the released toxins cause
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severe progression of the disease, antimicrobials which inhibit toxin production are the 
preferred treatments (Micek et al., 2005). In addition, since the possibility of 
subinhibitory concentrations of antibiotics in clinical situations is high, much work has 
been conducted to explore the effect of sub-MIC on bacterial virulence. Much work has 
been conducted and is ongoing in the study of the effect of subinhibitory concentrations 
of antibiotics on the virulence of different microorganisms (Dickgiesser and Wallach, 
1987; Gemmell and Ford, 2002; Bernardo et al., 2004; Adhikari and Novick, 2005; 
Spreer et al., 2007; Yanagihara et al., 2008). Most of the work has been done for 
microorganisms in the planktonic state (Sonstein and Burnham, 1993; Wu et al., 2002; 
Dal Sasso et al., 2003; Galice et al., 2006; Koszczol et al., 2006). However, very little 
work has been conducted to evaluate the effect of sub-MICs on the secreted virulence 
factors from biofilms (Masadeh, 2005).
Proteases are one of the types of virulence factors produced by most strains of S. 
aureus. They act on bacterial proteins, as part of the protein processing steps, or degrade 
them as a tactic by which the pathogenic bacteria change their status from invasion to 
colonization. In addition, some proteases act on host proteins to help the pathogenic 
bacteria in invading the body tissues. However, the production of excreted proteases from 
S. aureus  NCTC 11962 was not detected in the eluate supernatants (whether treated or 
control) when tested by both azocasein assay and zymography under the prescribed 
experimental conditions used in this project (Chapter 5, section 5.5.1). However, this does 
not conclude the complete absence of proteases in this organism. Karlsson and Arvidson 
(2002) found that all the clinical strains of S. aureus  that were screened for protease 
activity including those that were thought to be protease negative, contain the major genes 
that encode proteases. Therefore, the variation in protease secretion was attributed to the 
degree of protease gene expression, which could be regulated by several factors including
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the presence of protease gene repressors. Thus, based on this explanation, it can be 
concluded that the presence of sub-MICs of antibiotics did not induce protease gene 
expression in the experiments conducted in this project.
The production of coagulase is used to classify staphylococci as either coagulase 
positive or coagulase negative. S. au r e u s  is almost the only coagulase positive 
Staphylococcus  spp. isolated from human specimens (Mack et al., 2006). Coagulase is 
believed to be a virulence factor (Jonsson et al., 1985; Sawai et al., 1997). When S. 
aureus  biofilms were exposed to sub-MICs of the antibiotics, the bacterial response was 
variable with regard to coagulase production according to the challenging antibiotic 
(Chapter 5, section 5.2.1). Roxithromycin produced a significant reduction in coagulase 
activity (Chapter 5, section 5.2.2). This effect is predicted based upon the mechanism of 
action of this macrolide. Roxithromycin is a general protein synthesis inhibitor. It acts by 
inhibiting ribosome assembly, early dissociation of tRNA and blocking the progression of 
the polypeptide chain. Therefore, it would be reasonable to suggest that sub-MIC 
roxithromycin was able to inhibit one or more of the steps involved in coagulase 
synthesis. On the other hand, based on the mode of action of ciprofloxacin and cefalexin, 
it is expected that they do not have a direct effect on coagulase synthesis, thus, its 
production was comparable to that of untreated biofilm.
Another important virulence determinant in microorganisms is the ability to 
adhere and form biofilms. In general, what determines the effect of exposing bacteria to 
sub-MIC of antibiotics, in terms of their ability to adhere and to form biofilms, is the 
bacterial type and strain and concentration of the antibiotic (Shibl, 1985; Fonseca et al., 
2004; Majtan et al., 2007; Stamer et al., 2008). For example, sub-MICs of cefotaxime 
have been found to significantly induce biofilm formation and exopolysaccharide 
production in Salmonella typhimurium,  while sub-MICs of ciprofloxacin and gentamicin
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have reduced biofilm formation and exopolysaccharide production (Majtan et al., 2007). 
In another study, sub-MICs of gentamicin have been found to have no effect on biofilm 
formation of H a e m o p h i l u s  influenzae, while sub-MIC azithromycin has significantly 
decreased biomass and maximal thickness of these biofilms (Starner et al., 2008). 
Fonseca et al., (2004), have shown that piperacillin / tazobactam significantly decrease 
the adhesion of all strains of P s e u d o m o n a s  aeruginosa  used in their study. The reason 
was linked to the effect of sub-MICs of the antibiotic on other virulence factors of the 
organism, such as altering cell surface hydrophobicity, inhibition of motility and possible 
effects on surface adhesins (Fonseca et al., 2004). The adherence of F u s o b a c t e r i u m  
nucleatum,  a colonizer in dental biofilm, has been found to be reduced when exposed to 
sub-MICs of penicillin, chlorhexidine, triclosan, and metronidazole. The reduction was 
attributed to surface adhesins, as the hydrophobicity of the microbe was not altered 
(Okamoto et al., 2002).
The ability of S. aureus  to form biofilms in polystyrene microtiter plate wells was 
tested in the presence of sub-MICs of the selected antibiotics and in controls (Chapter 5, 
section 5.3.1). The results exhibit that cefalexin, in the range of 2.81% to 45% MIC has a 
stimulatory or potentiating effect on bacterial adhesion and biofilm formation, while 
ciprofloxacin and roxithromycin do not exhibit such an effect (Chapter 5, section 5.3.3). 
Cefalexin is a cell wall synthesis inhibitor. Therefore, it can be assumed that its effect at 
sub-MIC could have affected the cell surface of the bacteria in favour of increased 
hydrophobicity, that has led to increased adherence. A similar increase in hydrophobicity 
was found in Staphylococcus epidennidis  when studied in a continuous ambulatory 
peritoneal dialysis in vitro model (Hanlon et al., 2004). The adherence of the organism to 
the surface of catheters and its colonization and formation of a biofilm has been linked to 
this increase in hydrophobicity (Hanlon et al., 2004). The other explanation for the
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stimulatory effect of cefalexin on biofilm formation is that, cefalexin could exhibit an 
indirect induction of biofilm formation through stimulation of a-toxin production, a-toxin 
has been found to be an essential compound for cellular interaction in the second phase of 
biofilm formation (Caiazza and O'Toole, 2003). p-lactams at subinhibitory concentrations 
have been found to induce a-toxin production (Gemmell, 1995; Ohlsen et al., 1998; 
Stevens et al., 2007). Therefore, cefalexin stimulatory effect on biofilm formation could 
be attributed to a-toxin induction. Biofilm enhancing effect of p-lactams in staphylococci 
have been shown in some studies (Dunne, 1990; Frank et al., 2007) and their inhibitory 
effect on biofilm formation has been shown in other studies (Dunne, 1990; Rupp and 
Hamer, 1998). These variations could be ascribed to the type of p-lactam used, its 
concentration and the bacterial strain. On the other hand, protein synthesis inhibitors have 
variable effects on biofilm formation in staphylococci: some induce biofilm formation 
and others inhibit it (Rachid et al., 2000; Frank et al., 2007).
Biofilm production at different sub-MICs of roxithromycin was comparable to 
that of control (Chapter 5, section 5.3.3). This suggests that sub-MICs of roxithromycin 
were neither stimulatory (potentiating) nor inhibitory, except at 90% MIC, where no 
biofilm was formed. Since roxithromycin is a protein synthesis inhibitor, this could imply 
that none of the effector agents that are synthesized and involved in biofilm production 
were inhibited by roxithromycin in the range 0.35% to 45% MIC. Therefore, biofilm 
formation was not inhibited. At 90% MIC the inhibition of biofilm formation could be a 
result of inhibiting regulatory proteins required for biofilm formation. On the other hand, 
it can also be postulated that none of the repressors to biofilm formation were inhibited by 
roxithromycin (0.35% to 90% MIC), therefore, biofilm formation was not induced.
Sub-MIC ciprofloxacin did not affect biofilm formation in S. a u r e u s  (Chapter 5, 
section 5.3.3). Although this was true for other fluoroquinolones at sub-MICs when S.
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epidemiidis  was exposed to them (Perez-Geraldo et al., 1994; Rupp and Hamer, 1998), 
however, fluoroquinolones were found to have an inhibitory effect when P. a eruginosa 
was exposed to them (Yassien et al., 1995). Similarly, sub-MICs of ciprofloxacin have 
resulted in a reduction in the number of bacteria attached to epithelial cells, where the 
reason was attributed to a reduction in the hydrophobicity of the bacteria (Wojnicz and 
Jankowski, 2007). These results indicate that the effect of sub-MICs of antibiotics on 
microorganisms is species and strain dependent.
7.4 Effect of sub-MIC of antibiotics on TSST-1 production and 
biological activity
As was discussed earlier, sub-MIC of antibiotics have variable effects on the 
production of bacterial virulence factors. For TSST-1, one of the aims of this thesis was 
to study the effect of 1/16 MIC of selected antibiotics on the production and biological 
activity of TSST-1 released from biofilms. In the literature, after identifying the 
biological activity of TSST-1 in the early stages after its discovery (Calvano et al., 1984; 
Micusan et al., 1986; Uchiyama et al., 1987; Parsonnet and Gillis, 1988) TSST-1 
biological activity studies have been continued in order to study the mechanism of host 
response under different variables (See et al., 1992; Akatsuka et al., 1994; Davison et al., 
2000; Brandt et al., 2002), to identify TSST-1 structural domains or regions role and 
activity (Murray et al., 1996; Wahlsten and Ramakrishnan, 1998) and to conduct 
structure-function analysis mainly by studying TSST-1 mutants (Blanco et al., 1990; 
Bonventre et al., 1993; Stiles et al., 1995). However, no previous or current studies have 
been conducted to observe the effect of sub-MICs of antibiotics on the biological activity 
of TSST-1 released from biofilms of S. a u reus  when exposed to these antibiotics.
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TSST-1 was extracted and purified from eluate supernatants of biofilms that were 
exposed to 1/16 MIC of antibiotics and control (Chapter 6 , section 6.2). The proliferative 
activity of TSST-1 was evaluated on mouse splenocytes (Chapter 6 , section 6.3). Ten-fold 
serial dilutions were prepared from each purified toxin and the proliferative activities 
were compared for a concentration range from 0.1 to lOOOng mL'1. It was found that 
TSST-1 is active in this range, but with an optimal activity at lOOng mL' 1 (Chapter 6 , 
Figure 6.7). The presence of optimal activity for mitogens was also noticed when 
phytohaemagglutinin-P (PHA-P) was tested (Chapter 6 , Figure 6 .6 ), where lOpg mL' 1 
was the optimum concentration above which a reduction in the response was obtained. In 
another study, concanavalin A produced similar effects when applied to splenocytes (Lyu 
and Park, 2006). Similar findings have been obtained by Gampfer et al., (2002). In their 
study, the optimal proliferative response of human peripheral mononuclear cells to TSST- 
1 in the range of 1 to 500ng mL' 1 in one experiment and of 0.01 to 1000 ng mL' 1 in 
another experiment was at lOOng mL'1. After that a reduction in response was observed. 
As shown in Figure 6.7 and Table 6.1, at each concentration level, there is no significant 
difference in the response of splenocytes to TSST-1 purified from control or from eluate 
supernatants exposed to treatments, except the one at lOOOng mL'1. This indicates that 
exposing S. a ureus  biofilms to 1/16 MIC of cefalexin or ciprofloxacin has no effect on the 
proliferative activity of the toxin.
On the other hand, the proliferative activity of ten fold serial dilutions of crude 
eluate supernatants of the control and treated ones, resulted in a similar pattern of 
responses, where the response was dose dependent and has an optimum after which a 
reduction was observed (Chapter 6 , Figure 6 .8). In addition, an interesting response was 
observed when the proliferative activity of TSST-1 purified from eluate supernatants was 
compared with the proliferative activity of crude eluate supernatants exposed to sub-MIC
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antibiotics at equivalent TSST-1 concentrations (Figures 6.7 and 6 .8 ). Although it would 
be reasonable to accept that toxin purification and concentration steps might have some 
negative effect in terms of proliferative activity. However, the remarkable difference in 
activity (Figures 6.7 and 6 .8 ) in terms of OD % from PHA-P, could be attributed to a 
mitogenic agent present in the crude eluate supernatant, but of course, not in the purified 
TSST-1.
S. aureus  NCTC 11962 produces enterotoxin A. This toxin is known to have 
superantigenic activity (Lee and Bohach, 2004). It acts in a similar way to TSST-1 by 
binding to the T-cell receptor. While TSST-1 stimulates V(32 and VP5.1, enterotoxin A 
stimulates a family of VP chains known as (Vp 5.2/3) (Saloga et al, 1996; Davison et al,
2000). Enterotoxin A has a molecular weight of 27.5kDa and has been reported to have 
multiple isoelectric points (8.1, 7.68, 7.26, 6.64; Schantz et al., 1972). The two major 
forms obtained by Reynolds et al. (1988), were pi 8.1 and 7.08. By referring back to 
eluate supernatant 2D-gels (Chapter 4; Figures: 4.14, 4.15, 4.16, 4.17; Tables: 4.13, 4.14, 
4.15, 4.16) a spot appearing at Mr 26.5kDa and pi 8.27 (spot 6 ) is most probably 
enterotoxin A. Therefore, the presence of another mitogenic agent in crude eluate 
supernatants may explain the higher response of splenocytes to crude eluates than to 
equivalent concentrations of purified TSST-1. However, due to time considerations, a 
decision was taken not to further investigate this toxin during this project.
Generally, it is recognized that protein synthesis inhibitors inhibit the production 
of TSST-1 and other exoproteins (Schlievert and Kelly, 1984; Dickgiesser and Wallach, 
1987; Herbert et al., 2001). However, roxithromycin at 1/16 MIC has no effect on the 
production of TSST-1 from S. aureus  biofilm exposed to it (Chapter 5, section 5.4). One 
of the reasons that could explain the discrepancy in results could be attributed to the mode 
of action of this macrolide on TSST-1, as it is known that there are several mechanisms of
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action of protein synthesis inhibitors. The other reason could be the concentration of 
antibiotic used in this thesis. For example, tetracycline at 1/4 MIC reduced the synthesis 
of TSST-1, while 1/16 MIC has no effect (Dickgiesser and Wallach, 1987). Therefore, the 
inhibitory effect of roxithromycin on TSST-1 production can not be ruled out at higher 
concentrations.
1/16 MIC of Ciprofloxacin resulted in reduction to TSST-1 production from 
biofilms exposed to it. This effect was also demonstrated by Parsonnet et al., (1994) 
where they showed that fluoroquinolones, clindamycin and rifampin suppress TSST-1 
production up to 90%.
Cefalexin was found to reduce the production of TSST-1 from S. a u r e u s  biofilms 
when exposed to 1/16 MIC of cefalexin (Chapter 5, Table 5.7). However, in the literature 
the effect of p-lactams on TSST-1 production is variable. For example ampicillin, even at 
relatively high concentrations has no effect on TSST-1 production (Schlievert and Kelly, 
1984), while sub-MIC nafcillin increased toxin production (Parsonnet et al., 1994; 
Stevens et al., 2007). This effect was suggested to be related to the action of nafcillin on 
the cell wall resulting in increased cell wall permeability and rupture releasing the toxin 
outside the cell (Parsonnet et al., 1994).
It is clear from studying the biological activity of purified TSST-1 (Chapter 6 ) 
that cefalexin at 1/16 MIC does not cause any alteration in the synthesis of the toxin that 
would lead to biological malfunctioning. This was found in Chapter 6 where the 
biological activity of purified toxins from biofilms exposed to sub-MIC cefalexin was not 
altered. At the same time, the amount of TSST-1 produced was reduced (Chapter 5, Table 
5.7), which means that cefalexin has either caused a blockage in the TSST-1 synthesis 
pathway or an inhibition to its maturation and release from the cell. P-lactams are small 
molecules that can pass through the cell wall. Therefore, they have access to the inside of
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the cell where the premature toxin is present. It is well known that P-lactams are 
analogues of the D-alanyl-D-alanine residue of the peptidoglycan of the cell wall, thus 
inhibiting the action of transpeptidases. In S. aureus, the signal peptidase enzyme acts on 
TSST-1 precursor to cleave the 40 amino-acid signal peptide, a step that occurs during or 
immediately after translocation across the cytoplasmic membrane (Sibbald et al., 2006; 
Figure 7.1).
Figure 7.1: Synthesis and secretion of TSST-1 and the postulated inhibitory effect of 
cefalexin. When the nascent protein (TSST-1 precursor) is produced, it is 
accompanied by chaperones in the cytoplasm to the translocation machinery present 
on the cytoplasmic membrane. During or after translocation, signal peptidase 
(SPase) acts at the cleavage point of the precursor (ala-ser, amino-acids 40 & 41) 
thus, cleaving the signal peptide. The TSST-1, is now present in the periplasmic 
space in an unfolded state. Immediately the folding catalyst acts on the toxin and the 
mature toxin is released outside the cell since it has no retention signal (Sibbald et 
al., 2006). It is postulated that cefalexin, at 1/16 MIC, binds to the active site of the 
signal peptidase as it is an analogue of the ala-ser residue in much the same way it is 
also an analogue of the ala-ala residue of peptidoglycans. Thus, inhibiting the 
activity of signal peptidase. Therefore, the process of releasing the toxin is inhibited.
The cleavage point of the signal peptide from the toxin is an alanine-serine residue 
(Blomster-Hautamaa et al., 1986). Structurally, serine (HOCH2CHNH2COOH) is very
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similar to alanine (CH3CHNH2COOH), it contains an additional hydroxyl group replacing 
one of the hydrogen atoms (Figure 7.2). This small molecular weight group (OH) is not 
expected to impose any extra steric hindrance to the alanine-serine residue when 
compared to an alanine-alanine residue. Therefore, depending on this structural similarity 
between alanine-alanine and alanine-serine (Figure 7.2), and based on the mode of action 
of p-lactams, it can be hypothesized that cefalexin is also an analogue of alanine-serine 
(amino-acids 40 and 41 of the TSST-1 precursor) and inhibits the signal peptidase by 
binding to it (Figure 7.1). According to this hypothesis, smaller amounts of TSST-1 will 
be cleaved from the precursor toxin in the presence of 1/16 MIC cefalexin. However, the 
increase in production of TSST-1 when S. au r e u s  has been exposed to certain p-lactams 
(Parsonnet et al., 1994; Stevens et al., 2007) could be attributed to the types of P-lactam 
used, their concentrations, bacterial strain and the model of study used.
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Figure 7.2: Similarity in structures between alanine-serine residue (A), that is the 
cleavage point in TSST-1 precursor (amino-acids 40 and 41) and alanine-alanine (B). 
The arrow indicates the cleavage point between the alanine (left) and the serine 
residue (right). Structurally, serine is an alanine with a hydroxyl (OH) group 
(circled) replacing one of the Hydrogen (H) atoms of the methyl (-CH3) moiety. Key 
for the colours: yellow: , green: Nitrogen, black: Carbon, red: Oxygen.
Single lines represent single bonds between atoms and double lines represent double 
bonds.
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7.5 Conclusion
• In order to support the growth of staphylococci, in addition to the basic nutrients 
(organic carbon, nitrogen, iron, magnesium and sources of ions) several amino 
acids are required. Whereas complex media such as brain heart infusion is needed 
to support the growth of staphylococci in Sorbarod model biofilms.
• Exposing Staphylococcus aureus  biofilms to sub-MICs as low as 1/16 MIC of 
cefalexin, ciprofloxacin and roxithromycin resulted in marked changes in protein 
profiles of cellular proteins and secreted ones.
• Secreted proteases were not detected in the eluates of S. a u reus  NCTC 11962 
biofilms or those challenged with sub-MIC of selected antibiotics. However, the 
activity of soluble coagulase was reduced in the eluates of biofilms exposed to the 
protein synthesis inhibitor antibiotic, roxithromycin. Although it was not 
significantly affected by the other antibiotics.
• At a certain range of sub-MICs, cefalexin induced biofilm formation of S. au r e u s  
NCTC 11962, while the effect of sub-MICs of ciprofloxacin and roxithromycin 
treated cells was comparable to the untreated, except at 90% MIC of 
roxithromycin, where no biofilm was detected.
• TSST-1 production was significantly lower in eluates challenged with cefalexin 
than in control and other treatments, an effect that is hypothesized to be related to 
the inhibitory effect of cefalexin on signal peptidase. Thus, inhibiting the cleavage 
of TSST-1 precursor to produce TSST-1. On the other hand, exposing S. a ureus 
biofilms to 1/16 MIC of the selected antibiotics did not affect the proliferative 
activity of the purified TSST-1
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7 .6  S u g g e s t io n s  f o r  F u tu r e  w o r k
• SDS-PAGE and 2D-PAGE analyses, showed the appearance of novel proteins and 
disappearance of others when the S. a u reu s  biofilm was exposed to sub-MIC of 
the selected antibiotics. Identifying these proteins using Mass spectrometry 
(MALDI-TOF), would provide more information about the nature and potential 
role of the proteins and their potential effect on bacterial virulence.
• It has been shown that cefalexin-induced biofilm formation at a certain range of 
sub-MICs, has no effect on biofilm formation at other sub-MICs. The reason was 
attributed to either changes in cell surface hydrophobicity or to stimulatory effect 
to a-toxin production, which is known to play a role in biofilm formation. These 
two suggestions could be tested at different sub-MICs of cefalexin using the same 
bacterial strain. Cell surface hydrophobicity can be determined for bacterial cells 
exposed to sub-MICs and control by either n-Hexadecane assay or by salt 
aggregation test of ammonium sulphate, a-toxin production can be assessed and 
compared between eluate supernatants challenged with antibiotics and control by 
testing the haemolysis of rabbit erythrocytes.
• The proliferative activity of crude eluate supernatants exposed to sub-MIC of 
antibiotics was more than that of purified TSST-1 when equivalent concentrations 
were tested. The reason was linked to the effect of enterotoxin A. Therefore, the 
effect of 1/16 MIC of cefalexin, ciprofloxacin and roxithromycin on the 
production and perhaps the activity of enterotoxin A should be elucidated. 
Enterotoxin A production can be semi-quantified by a method based on antigen- 
antibody reaction such as the one used in this work to quantify TSST-1 or ELISA 
method. Its activity can be determined by purifying the toxin and testing its 
proliferative activity.
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• It was hypothesized that cefalexin at 1/16 MIC inhibits the cleavage of TSST-1 
precursor through inhibiting signal peptidase. Therefore, TSST-1 production is 
reduced. This will necessarily result in accumulation of TSST-1 precursor in the 
cell. In order to test this hypothesis, the abundance of TSST-1 precursor relative to 
TSST-1 could be determined in challenged and control cells. To do so, protein 
spots of TSST-1 precursor and TSST-1 in 2D-gels loaded with equal amounts of 
protein can be measured by densitometer or can be excised, treated and quantified 
by mass spectroscopy.
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